{
  "usdmVersion": "4.0",
  "generatedAt": "2026-01-23T03:00:08.121346",
  "generator": "Protocol2USDM v6.5.0",
  "study": {
    "id": "6d869a83-dd3d-4b2d-af17-cad27822a457",
    "instanceType": "Study",
    "versions": [
      {
        "id": "78e449f6-ea64-4b2f-9983-3700261e70fc",
        "instanceType": "StudyVersion",
        "versionIdentifier": "1.0",
        "studyDesigns": [
          {
            "id": "792afc64-18c6-46c0-8998-611efd611328",
            "name": "Study Design",
            "rationale": "Protocol-defined study design for investigating efficacy and safety",
            "instanceType": "InterventionalStudyDesign",
            "blindingSchema": {
              "id": "a8a9a15b-d376-4849-9bdd-6d928cf1420b",
              "standardCode": {
                "id": "856969dc-8baf-41b6-bc41-005d1b19df54",
                "code": "Double Blind",
                "codeSystem": "http://www.cdisc.org",
                "codeSystemVersion": "2024-09-27",
                "decode": "Double Blind",
                "instanceType": "Code"
              },
              "instanceType": "AliasCode"
            },
            "randomizationType": {
              "code": "Randomized"
            },
            "arms": [
              {
                "id": "04e2d109-c275-46ad-b4e8-8310f4653d66",
                "name": "Group 1: upadacitinib 15 mg QD",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Subjects receive upadacitinib 15 mg once daily for the duration of the study.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "92b5ddb4-583c-42e4-8ee5-e2380d855db0",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "87cd79b2-c4ad-4396-a67e-3d76398af467",
                "name": "Group 2: upadacitinib 30 mg QD",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Subjects receive upadacitinib 30 mg once daily. Note: Per Amendment 8, subjects on 30mg will be switched to 15mg at their next visit.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "219e6248-a3f8-4bfe-ad8e-62eb5228ad12",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "b449ba15-8c71-493b-98fb-16dbc448669c",
                "name": "Group 3: Placebo followed by upadacitinib 15 mg QD",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Subjects receive placebo for the first 24 weeks, then switch to upadacitinib 15 mg once daily.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "bffbef4c-9461-486f-8451-88a3aff0c51d",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              },
              {
                "id": "f3611ff5-9387-435f-9852-cfadffb5dcb3",
                "name": "Group 4: Placebo followed by upadacitinib 30 mg QD",
                "instanceType": "StudyArm",
                "dataOriginDescription": "Collected",
                "description": "Subjects receive placebo for the first 24 weeks, then switch to upadacitinib 30 mg once daily.",
                "type": {
                  "id": "C174266",
                  "code": "C174266",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Investigational Arm",
                  "instanceType": "Code"
                },
                "dataOriginType": {
                  "id": "be1b323a-0dab-49de-b197-107289a89c39",
                  "code": "C70793",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Collected",
                  "instanceType": "Code"
                }
              }
            ],
            "studyCohorts": [
              {
                "id": "081f7a0e-0353-43e3-8901-b0c24aa0d10f",
                "name": "Bio-IR",
                "instanceType": "StudyCohort",
                "characteristic": "Subjects with moderately to severely active Psoriatic Arthritis who have an inadequate response to at least one biologic DMARD"
              }
            ],
            "studyCells": [
              {
                "id": "0247f726-a10d-454c-bab3-b283d140746e",
                "armId": "04e2d109-c275-46ad-b4e8-8310f4653d66",
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "elementIds": [
                  "56c38883-cea1-4766-b535-adfbdf0aa62b"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "44dff579-bb5b-490f-9455-5d724eb4985a",
                "armId": "04e2d109-c275-46ad-b4e8-8310f4653d66",
                "epochId": "70241a10-9987-4405-b634-80ffa6f6e453",
                "elementIds": [
                  "5c9b6023-21c4-4b1b-9bda-eab21f1021b3"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "e742a970-40a7-46c3-8194-a2ddaa436761",
                "armId": "04e2d109-c275-46ad-b4e8-8310f4653d66",
                "epochId": "1b44ec09-6087-4125-833c-fab3c8af1df0",
                "elementIds": [
                  "c05c3084-ba8d-4d1a-bb4f-989031470e73"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "9c7a0ff1-b831-4dd9-b241-dd8c74b53f49",
                "armId": "04e2d109-c275-46ad-b4e8-8310f4653d66",
                "epochId": "715541d3-69e8-4113-a46c-28ec4285d7d0",
                "elementIds": [
                  "2982f958-9170-4f1a-b1ab-1ca2c73a619d"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "75f8a235-958c-433e-a4d7-2238d7b87cf9",
                "armId": "04e2d109-c275-46ad-b4e8-8310f4653d66",
                "epochId": "68f28ea0-83d5-41c4-81a3-df6b236816d2",
                "elementIds": [
                  "b6135a29-a440-4cf7-8ff7-0638b44cea44"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "c3eed11e-70ab-49c8-9d73-9238bceec3a4",
                "armId": "87cd79b2-c4ad-4396-a67e-3d76398af467",
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "elementIds": [
                  "e92d8ad8-30d0-48f1-8e13-20bc8ab66861"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "d50cf9cd-4783-431b-9fc2-e8d8fcecd415",
                "armId": "87cd79b2-c4ad-4396-a67e-3d76398af467",
                "epochId": "70241a10-9987-4405-b634-80ffa6f6e453",
                "elementIds": [
                  "a0da7ea8-27ed-435c-bf08-34af9fbcb5d5"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "34c612f0-80fe-48eb-a4a5-98623bc17ef3",
                "armId": "87cd79b2-c4ad-4396-a67e-3d76398af467",
                "epochId": "1b44ec09-6087-4125-833c-fab3c8af1df0",
                "elementIds": [
                  "efeecc1a-1f38-4477-b97e-909d83c9aaed"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "06cab547-14d9-4741-92f0-0a5f3495c51c",
                "armId": "87cd79b2-c4ad-4396-a67e-3d76398af467",
                "epochId": "715541d3-69e8-4113-a46c-28ec4285d7d0",
                "elementIds": [
                  "2f752751-5862-4ac7-9e0c-b57f56f53927"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "43c4ed68-75ad-4634-9108-929bbb6416ce",
                "armId": "87cd79b2-c4ad-4396-a67e-3d76398af467",
                "epochId": "68f28ea0-83d5-41c4-81a3-df6b236816d2",
                "elementIds": [
                  "216a07b7-38e9-41ed-9a7b-55814d9445bf"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "787414d1-8f58-40a9-a83d-aa2f4f115919",
                "armId": "b449ba15-8c71-493b-98fb-16dbc448669c",
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "elementIds": [
                  "1f2dbb6b-5a23-462a-966a-4726a804cd30"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "14268d8c-a309-4bd6-9dd9-c931acc46d62",
                "armId": "b449ba15-8c71-493b-98fb-16dbc448669c",
                "epochId": "70241a10-9987-4405-b634-80ffa6f6e453",
                "elementIds": [
                  "5c35bcbd-1ecd-4c05-89e5-2f504653c66d"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "57af4b6d-8897-4499-ab61-fa0b1d3cc381",
                "armId": "b449ba15-8c71-493b-98fb-16dbc448669c",
                "epochId": "1b44ec09-6087-4125-833c-fab3c8af1df0",
                "elementIds": [
                  "3eac7c2b-47c4-4afd-9fc6-854077d49631"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "d8798c4b-779f-4cff-bcfc-58aad6ee0576",
                "armId": "b449ba15-8c71-493b-98fb-16dbc448669c",
                "epochId": "715541d3-69e8-4113-a46c-28ec4285d7d0",
                "elementIds": [
                  "a8af42e5-7071-47fa-b233-f79076a564f5"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "b4aac6ec-84d9-4bf3-8821-dde47600e4be",
                "armId": "b449ba15-8c71-493b-98fb-16dbc448669c",
                "epochId": "68f28ea0-83d5-41c4-81a3-df6b236816d2",
                "elementIds": [
                  "d190cc70-79b8-4771-8bd6-cb2697a2bbf9"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "c0c03113-1c53-4220-a2d7-b9e674abeedc",
                "armId": "f3611ff5-9387-435f-9852-cfadffb5dcb3",
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "elementIds": [
                  "5bbf711b-78f6-4282-8652-4ff04996a17f"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "d6b4ad08-4013-4c0e-b6a2-fee0e30cba94",
                "armId": "f3611ff5-9387-435f-9852-cfadffb5dcb3",
                "epochId": "70241a10-9987-4405-b634-80ffa6f6e453",
                "elementIds": [
                  "a2a22641-0bcd-4d0e-9657-ac1f68bd220b"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "47f295a3-5d6d-4ee3-b220-2ef41e46e82d",
                "armId": "f3611ff5-9387-435f-9852-cfadffb5dcb3",
                "epochId": "1b44ec09-6087-4125-833c-fab3c8af1df0",
                "elementIds": [
                  "e0348b30-c91a-4f8e-861a-7d28aa358ef8"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "7a222813-e733-4d64-9264-457f9bf3e693",
                "armId": "f3611ff5-9387-435f-9852-cfadffb5dcb3",
                "epochId": "715541d3-69e8-4113-a46c-28ec4285d7d0",
                "elementIds": [
                  "fce0b60f-9f59-478c-8d71-4d941be7c3e3"
                ],
                "instanceType": "StudyCell"
              },
              {
                "id": "6542e043-410b-4a96-b109-eb015b87782a",
                "armId": "f3611ff5-9387-435f-9852-cfadffb5dcb3",
                "epochId": "68f28ea0-83d5-41c4-81a3-df6b236816d2",
                "elementIds": [
                  "4462697d-c954-4411-a24c-b86bf355b353"
                ],
                "instanceType": "StudyCell"
              }
            ],
            "studyElements": [
              {
                "id": "56c38883-cea1-4766-b535-adfbdf0aa62b",
                "name": "Group 1: upadacitinib 15 mg QD - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 1: upadacitinib 15 mg QD during Screening"
              },
              {
                "id": "5c9b6023-21c4-4b1b-9bda-eab21f1021b3",
                "name": "Group 1: upadacitinib 15 mg QD - Period 1 (Weeks 0-24)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 1: upadacitinib 15 mg QD during Period 1 (Weeks 0-24)"
              },
              {
                "id": "c05c3084-ba8d-4d1a-bb4f-989031470e73",
                "name": "Group 1: upadacitinib 15 mg QD - Period 1 (Weeks 24-56)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 1: upadacitinib 15 mg QD during Period 1 (Weeks 24-56)"
              },
              {
                "id": "2982f958-9170-4f1a-b1ab-1ca2c73a619d",
                "name": "Group 1: upadacitinib 15 mg QD - Period 2",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 1: upadacitinib 15 mg QD during Period 2"
              },
              {
                "id": "b6135a29-a440-4cf7-8ff7-0638b44cea44",
                "name": "Group 1: upadacitinib 15 mg QD - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 1: upadacitinib 15 mg QD during Follow-up"
              },
              {
                "id": "e92d8ad8-30d0-48f1-8e13-20bc8ab66861",
                "name": "Group 2: upadacitinib 30 mg QD - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 2: upadacitinib 30 mg QD during Screening"
              },
              {
                "id": "a0da7ea8-27ed-435c-bf08-34af9fbcb5d5",
                "name": "Group 2: upadacitinib 30 mg QD - Period 1 (Weeks 0-24)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 2: upadacitinib 30 mg QD during Period 1 (Weeks 0-24)"
              },
              {
                "id": "efeecc1a-1f38-4477-b97e-909d83c9aaed",
                "name": "Group 2: upadacitinib 30 mg QD - Period 1 (Weeks 24-56)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 2: upadacitinib 30 mg QD during Period 1 (Weeks 24-56)"
              },
              {
                "id": "2f752751-5862-4ac7-9e0c-b57f56f53927",
                "name": "Group 2: upadacitinib 30 mg QD - Period 2",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 2: upadacitinib 30 mg QD during Period 2"
              },
              {
                "id": "216a07b7-38e9-41ed-9a7b-55814d9445bf",
                "name": "Group 2: upadacitinib 30 mg QD - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 2: upadacitinib 30 mg QD during Follow-up"
              },
              {
                "id": "1f2dbb6b-5a23-462a-966a-4726a804cd30",
                "name": "Group 3: Placebo followed by upadacitinib 15 mg QD - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 3: Placebo followed by upadacitinib 15 mg QD during Screening"
              },
              {
                "id": "5c35bcbd-1ecd-4c05-89e5-2f504653c66d",
                "name": "Group 3: Placebo followed by upadacitinib 15 mg QD - Period 1 (Weeks 0-24)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 3: Placebo followed by upadacitinib 15 mg QD during Period 1 (Weeks 0-24)"
              },
              {
                "id": "3eac7c2b-47c4-4afd-9fc6-854077d49631",
                "name": "Group 3: Placebo followed by upadacitinib 15 mg QD - Period 1 (Weeks 24-56)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 3: Placebo followed by upadacitinib 15 mg QD during Period 1 (Weeks 24-56)"
              },
              {
                "id": "a8af42e5-7071-47fa-b233-f79076a564f5",
                "name": "Group 3: Placebo followed by upadacitinib 15 mg QD - Period 2",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 3: Placebo followed by upadacitinib 15 mg QD during Period 2"
              },
              {
                "id": "d190cc70-79b8-4771-8bd6-cb2697a2bbf9",
                "name": "Group 3: Placebo followed by upadacitinib 15 mg QD - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 3: Placebo followed by upadacitinib 15 mg QD during Follow-up"
              },
              {
                "id": "5bbf711b-78f6-4282-8652-4ff04996a17f",
                "name": "Group 4: Placebo followed by upadacitinib 30 mg QD - Screening",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 4: Placebo followed by upadacitinib 30 mg QD during Screening"
              },
              {
                "id": "a2a22641-0bcd-4d0e-9657-ac1f68bd220b",
                "name": "Group 4: Placebo followed by upadacitinib 30 mg QD - Period 1 (Weeks 0-24)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 4: Placebo followed by upadacitinib 30 mg QD during Period 1 (Weeks 0-24)"
              },
              {
                "id": "e0348b30-c91a-4f8e-861a-7d28aa358ef8",
                "name": "Group 4: Placebo followed by upadacitinib 30 mg QD - Period 1 (Weeks 24-56)",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 4: Placebo followed by upadacitinib 30 mg QD during Period 1 (Weeks 24-56)"
              },
              {
                "id": "fce0b60f-9f59-478c-8d71-4d941be7c3e3",
                "name": "Group 4: Placebo followed by upadacitinib 30 mg QD - Period 2",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 4: Placebo followed by upadacitinib 30 mg QD during Period 2"
              },
              {
                "id": "4462697d-c954-4411-a24c-b86bf355b353",
                "name": "Group 4: Placebo followed by upadacitinib 30 mg QD - Follow-up",
                "instanceType": "StudyElement",
                "description": "Treatment period for Group 4: Placebo followed by upadacitinib 30 mg QD during Follow-up"
              }
            ],
            "maskingRoles": [
              {
                "id": "5c2ec3f9-28be-49e6-9666-618d12f99a15",
                "text": "Subject is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              },
              {
                "id": "f9f0af39-3345-45ff-a27c-60deea68bfc3",
                "text": "Investigator is masked in this Double Blind study",
                "isMasked": true,
                "instanceType": "Masking"
              }
            ],
            "eligibilityCriteria": [
              {
                "id": "690303b9-641e-45c0-8687-6b6e7de470fb",
                "identifier": "1",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "62e1f8da-7bd6-43bd-aa36-78f19677c333",
                "instanceType": "EligibilityCriterion",
                "name": "Age requirement",
                "nextId": "5114b9fd-ec9c-4e71-9727-e944e7b1dde9"
              },
              {
                "id": "5114b9fd-ec9c-4e71-9727-e944e7b1dde9",
                "identifier": "2",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "ab28d78e-3114-4869-941b-cec334301e2a",
                "instanceType": "EligibilityCriterion",
                "name": "PsA Diagnosis and CASPAR",
                "previousId": "690303b9-641e-45c0-8687-6b6e7de470fb",
                "nextId": "8f8fca16-6750-4452-b3d0-d17c9f1e16fb"
              },
              {
                "id": "8f8fca16-6750-4452-b3d0-d17c9f1e16fb",
                "identifier": "3",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d51e77fd-f3dc-4ebb-ab56-f8e2bfc0fb2b",
                "instanceType": "EligibilityCriterion",
                "name": "Active Disease at Baseline",
                "previousId": "5114b9fd-ec9c-4e71-9727-e944e7b1dde9",
                "nextId": "60f1cdb8-8a02-49fa-87da-0e0d2d728a99"
              },
              {
                "id": "60f1cdb8-8a02-49fa-87da-0e0d2d728a99",
                "identifier": "4",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b64440ed-2a4e-48ab-8892-b4c8ccac5444",
                "instanceType": "EligibilityCriterion",
                "name": "Plaque Psoriasis History",
                "previousId": "8f8fca16-6750-4452-b3d0-d17c9f1e16fb",
                "nextId": "043a2d93-d8ff-4cb6-8251-e71d4c296f41"
              },
              {
                "id": "043a2d93-d8ff-4cb6-8251-e71d4c296f41",
                "identifier": "5",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "0605e011-2ba0-4bc5-a83a-0f9d66466809",
                "instanceType": "EligibilityCriterion",
                "name": "bDMARD Inadequate Response",
                "previousId": "60f1cdb8-8a02-49fa-87da-0e0d2d728a99",
                "nextId": "b7c58b74-9961-43bc-91e6-f259637520d9"
              },
              {
                "id": "b7c58b74-9961-43bc-91e6-f259637520d9",
                "identifier": "6",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "8aaf317d-0d8b-4af8-bc82-6cb2b4983f9f",
                "instanceType": "EligibilityCriterion",
                "name": "bDMARD Discontinuation",
                "previousId": "043a2d93-d8ff-4cb6-8251-e71d4c296f41",
                "nextId": "46262ce1-88fd-43e1-9c45-72b7805b1460"
              },
              {
                "id": "46262ce1-88fd-43e1-9c45-72b7805b1460",
                "identifier": "7",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "506672a9-40cd-42a3-ae48-b42b4a68545e",
                "instanceType": "EligibilityCriterion",
                "name": "Concomitant non-biologic DMARDs",
                "previousId": "b7c58b74-9961-43bc-91e6-f259637520d9",
                "nextId": "5dee9d2a-3b39-4408-b45a-232759239e50"
              },
              {
                "id": "5dee9d2a-3b39-4408-b45a-232759239e50",
                "identifier": "8",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "f0e3d450-6dc5-4e8c-beae-237dcbfefb73",
                "instanceType": "EligibilityCriterion",
                "name": "Stable NSAIDs/Corticosteroids",
                "previousId": "46262ce1-88fd-43e1-9c45-72b7805b1460",
                "nextId": "f05b2df3-74b0-4f56-bf79-44336fc28607"
              },
              {
                "id": "f05b2df3-74b0-4f56-bf79-44336fc28607",
                "identifier": "9",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "488e071e-9240-4e88-b6a2-eae7e0322036",
                "instanceType": "EligibilityCriterion",
                "name": "Opiate and TCM Discontinuation",
                "previousId": "5dee9d2a-3b39-4408-b45a-232759239e50",
                "nextId": "cac69be1-36db-4ca5-80b3-ea84d7acb43e"
              },
              {
                "id": "cac69be1-36db-4ca5-80b3-ea84d7acb43e",
                "identifier": "10",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "2a6d020c-3b51-47ae-9719-63857e3ce6ef",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy Test",
                "previousId": "f05b2df3-74b0-4f56-bf79-44336fc28607",
                "nextId": "8db7ae70-dd3d-43cc-8a46-73c7601a2e4b"
              },
              {
                "id": "8db7ae70-dd3d-43cc-8a46-73c7601a2e4b",
                "identifier": "11",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d4ca05b8-9915-4f39-ad72-60b2d06188fd",
                "instanceType": "EligibilityCriterion",
                "name": "Contraception Requirement",
                "previousId": "cac69be1-36db-4ca5-80b3-ea84d7acb43e",
                "nextId": "d8c9c223-bea0-4074-a6a1-1304a22bf693"
              },
              {
                "id": "d8c9c223-bea0-4074-a6a1-1304a22bf693",
                "identifier": "12",
                "category": {
                  "id": "C25532",
                  "code": "C25532",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Inclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "5d43a97e-78ae-492b-9a49-baedd69fca57",
                "instanceType": "EligibilityCriterion",
                "name": "Informed Consent",
                "previousId": "8db7ae70-dd3d-43cc-8a46-73c7601a2e4b"
              },
              {
                "id": "845561f9-4a89-481b-bbbc-6126095b9afe",
                "identifier": "1",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "78088085-6cf2-417e-a8ff-f8eebf4a0560",
                "instanceType": "EligibilityCriterion",
                "name": "JAK Inhibitor Exposure",
                "nextId": "7dfbd525-3078-434f-b626-956ae8124e53"
              },
              {
                "id": "7dfbd525-3078-434f-b626-956ae8124e53",
                "identifier": "2",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "b4f115f4-72f2-4de7-b6aa-f727e40b02b7",
                "instanceType": "EligibilityCriterion",
                "name": "Excessive DMARDs",
                "previousId": "845561f9-4a89-481b-bbbc-6126095b9afe",
                "nextId": "4d7469d0-4c13-4d37-8160-175e98f85613"
              },
              {
                "id": "4d7469d0-4c13-4d37-8160-175e98f85613",
                "identifier": "3",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d3579150-0ceb-4c18-ba45-6ca5e7b919b7",
                "instanceType": "EligibilityCriterion",
                "name": "Investigational Drug Use",
                "previousId": "7dfbd525-3078-434f-b626-956ae8124e53",
                "nextId": "a140b46e-ca71-4168-935b-e12ece45cbff"
              },
              {
                "id": "a140b46e-ca71-4168-935b-e12ece45cbff",
                "identifier": "4",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "d60f6892-4320-488a-99ce-a2f1ef82613c",
                "instanceType": "EligibilityCriterion",
                "name": "Infection History",
                "previousId": "4d7469d0-4c13-4d37-8160-175e98f85613",
                "nextId": "fe3a6019-dc48-4dd8-b771-ab60b3ae67a8"
              },
              {
                "id": "fe3a6019-dc48-4dd8-b771-ab60b3ae67a8",
                "identifier": "5",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "6b36af64-68e4-489c-ae91-b90300277d87",
                "instanceType": "EligibilityCriterion",
                "name": "Underlying Medical Diseases",
                "previousId": "a140b46e-ca71-4168-935b-e12ece45cbff",
                "nextId": "d3ca4dca-f469-4c0f-8574-29cad46d9be8"
              },
              {
                "id": "d3ca4dca-f469-4c0f-8574-29cad46d9be8",
                "identifier": "6",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "62edeee8-28b1-4839-b7d1-b950e9734331",
                "instanceType": "EligibilityCriterion",
                "name": "Psoriasis Treatments",
                "previousId": "fe3a6019-dc48-4dd8-b771-ab60b3ae67a8",
                "nextId": "92357611-0eba-4955-8e5a-2b1c0d66b7f9"
              },
              {
                "id": "92357611-0eba-4955-8e5a-2b1c0d66b7f9",
                "identifier": "11",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "46dda81e-cece-4e5f-b3f6-e699847c6c05",
                "instanceType": "EligibilityCriterion",
                "name": "Other Inflammatory Diseases",
                "previousId": "d3ca4dca-f469-4c0f-8574-29cad46d9be8",
                "nextId": "ae27e643-d1d5-48e9-8bb6-ad65c05aada3"
              },
              {
                "id": "ae27e643-d1d5-48e9-8bb6-ad65c05aada3",
                "identifier": "12",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "79a7104b-bd8a-4c2b-8ba0-49747c1d5688",
                "instanceType": "EligibilityCriterion",
                "name": "Drug or Alcohol Abuse",
                "previousId": "92357611-0eba-4955-8e5a-2b1c0d66b7f9",
                "nextId": "70f6d19e-9ead-4068-bc37-fdcd1770c303"
              },
              {
                "id": "70f6d19e-9ead-4068-bc37-fdcd1770c303",
                "identifier": "13",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "383d8062-3b7b-428e-8e95-0de4d16f2b6a",
                "instanceType": "EligibilityCriterion",
                "name": "Pregnancy and Breastfeeding",
                "previousId": "ae27e643-d1d5-48e9-8bb6-ad65c05aada3",
                "nextId": "5ed39b00-ce8b-422c-8c24-4ee6b17cb166"
              },
              {
                "id": "5ed39b00-ce8b-422c-8c24-4ee6b17cb166",
                "identifier": "14",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "7d63b9e1-34f9-4dc6-b19c-4cd5f453d0d9",
                "instanceType": "EligibilityCriterion",
                "name": "Laboratory Values",
                "previousId": "70f6d19e-9ead-4068-bc37-fdcd1770c303",
                "nextId": "48cb8bce-1812-4ef8-80df-0e78de2c7a20"
              },
              {
                "id": "48cb8bce-1812-4ef8-80df-0e78de2c7a20",
                "identifier": "15",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "32c26b84-8ad3-4bcb-8da6-db24be3a945c",
                "instanceType": "EligibilityCriterion",
                "name": "Other Skin Disease",
                "previousId": "5ed39b00-ce8b-422c-8c24-4ee6b17cb166",
                "nextId": "8f448599-cbf4-475d-b2d4-136538f61486"
              },
              {
                "id": "8f448599-cbf4-475d-b2d4-136538f61486",
                "identifier": "16",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "33bee306-8931-4d90-a5bb-94af2014af49",
                "instanceType": "EligibilityCriterion",
                "name": "Extra-articular Manifestations",
                "previousId": "48cb8bce-1812-4ef8-80df-0e78de2c7a20",
                "nextId": "1f87a973-e4d5-47a3-9669-21caa524112e"
              },
              {
                "id": "1f87a973-e4d5-47a3-9669-21caa524112e",
                "identifier": "17",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "59cb9295-a928-4bbd-a98a-b852b80cebad",
                "instanceType": "EligibilityCriterion",
                "name": "Joint Surgery or Injections",
                "previousId": "8f448599-cbf4-475d-b2d4-136538f61486",
                "nextId": "1c22309c-58df-4e78-84b1-80e94a466c72"
              },
              {
                "id": "1c22309c-58df-4e78-84b1-80e94a466c72",
                "identifier": "18",
                "category": {
                  "id": "C25370",
                  "code": "C25370",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exclusion Criteria",
                  "instanceType": "Code"
                },
                "criterionItemId": "70f39fc0-a43f-48f1-8653-0afaf4b5edc8",
                "instanceType": "EligibilityCriterion",
                "name": "Investigator Discretion",
                "previousId": "1f87a973-e4d5-47a3-9669-21caa524112e"
              }
            ],
            "population": {
              "id": "1edca9da-47eb-465b-9774-78f5431e7f25",
              "name": "Study Population",
              "includesHealthySubjects": false,
              "criterionIds": [
                "690303b9-641e-45c0-8687-6b6e7de470fb",
                "5114b9fd-ec9c-4e71-9727-e944e7b1dde9",
                "8f8fca16-6750-4452-b3d0-d17c9f1e16fb",
                "60f1cdb8-8a02-49fa-87da-0e0d2d728a99",
                "043a2d93-d8ff-4cb6-8251-e71d4c296f41",
                "b7c58b74-9961-43bc-91e6-f259637520d9",
                "46262ce1-88fd-43e1-9c45-72b7805b1460",
                "5dee9d2a-3b39-4408-b45a-232759239e50",
                "f05b2df3-74b0-4f56-bf79-44336fc28607",
                "cac69be1-36db-4ca5-80b3-ea84d7acb43e",
                "8db7ae70-dd3d-43cc-8a46-73c7601a2e4b",
                "d8c9c223-bea0-4074-a6a1-1304a22bf693",
                "845561f9-4a89-481b-bbbc-6126095b9afe",
                "7dfbd525-3078-434f-b626-956ae8124e53",
                "4d7469d0-4c13-4d37-8160-175e98f85613",
                "a140b46e-ca71-4168-935b-e12ece45cbff",
                "fe3a6019-dc48-4dd8-b771-ab60b3ae67a8",
                "d3ca4dca-f469-4c0f-8574-29cad46d9be8",
                "92357611-0eba-4955-8e5a-2b1c0d66b7f9",
                "ae27e643-d1d5-48e9-8bb6-ad65c05aada3",
                "70f6d19e-9ead-4068-bc37-fdcd1770c303",
                "5ed39b00-ce8b-422c-8c24-4ee6b17cb166",
                "48cb8bce-1812-4ef8-80df-0e78de2c7a20",
                "8f448599-cbf4-475d-b2d4-136538f61486",
                "1f87a973-e4d5-47a3-9669-21caa524112e",
                "1c22309c-58df-4e78-84b1-80e94a466c72"
              ],
              "instanceType": "StudyDesignPopulation",
              "description": "Target population defined by eligibility criteria"
            },
            "objectives": [
              {
                "id": "deb079ec-98fe-44b4-b8a5-0cafb528f47b",
                "name": "Primary Efficacy Objective",
                "text": "To evaluate the efficacy of upadacitinib compared to placebo in subjects with active psoriatic arthritis (PsA) who have had an inadequate response or intolerance to at least 1 bDMARD",
                "level": {
                  "id": "C85826",
                  "code": "C85826",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Primary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "0629029a-7b5a-44f1-b6e0-36bc034a639b"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "25ffc61d-71df-4b92-bf88-f16bd69fb3b8",
                "name": "Secondary Efficacy Objectives",
                "text": "To evaluate key secondary efficacy endpoints of upadacitinib versus placebo",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "3f0298a2-440e-4dc8-a8f1-9023d8abf21e",
                  "bc35123c-979a-4509-a4b5-6ff2ad2095eb",
                  "225106cd-8ce4-42bf-a5e9-072aced22568",
                  "a211342e-a606-4564-838c-d7882d13fa06",
                  "59b4b225-04c6-4559-9c60-5138cbe1d850",
                  "a07db70a-4cc6-4b59-93f5-90c669796d69",
                  "529f4af7-4445-4225-8635-581c5c86bf02",
                  "0b61a60d-016a-4c89-b06b-6d9aaf605f11",
                  "b21670f6-2151-43f7-9df4-fbd1652d38e7"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "b59147f9-0aaa-4d25-b473-c41caa36d0cb",
                "name": "Safety Objective",
                "text": "Safety evaluations include adverse event (AE) monitoring, physical examinations, vital sign measurements, electrocardiogram (ECG), and clinical laboratory testing (hematology, chemistry, and urinalysis) as a measure of safety and tolerability for the entire study duration.",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "6ca595f5-b867-4345-9991-0cd541915935"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "5ac2c355-b15b-4158-9e09-4751dde7ddd4",
                "name": "Pharmacokinetic Objective",
                "text": "Blood samples for assay of upadacitinib and possibly other medications in plasma will be collected at each visit after baseline in Period 1.",
                "level": {
                  "id": "C85827",
                  "code": "C85827",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Secondary Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "6cb903c3-9254-4997-bc39-23405e850d2e"
                ],
                "instanceType": "Objective"
              },
              {
                "id": "dc51b4b1-711c-4009-93c5-c6e29ea4f54f",
                "name": "Exploratory Research Objective",
                "text": "Prognostic, surrogate, predictive, and pharmacodynamic biomarkers signatures may be evaluated.",
                "level": {
                  "id": "C163559",
                  "code": "C163559",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Trial Exploratory Objective",
                  "instanceType": "Code"
                },
                "endpointIds": [
                  "8ef3cacd-8512-4b40-ba1a-d2b6c26c874b"
                ],
                "instanceType": "Objective"
              }
            ],
            "endpoints": [
              {
                "id": "0629029a-7b5a-44f1-b6e0-36bc034a639b",
                "name": "Primary Efficacy Endpoint",
                "text": "proportion of subjects achieving ACR20 response at Week 12",
                "level": {
                  "id": "C98772",
                  "code": "C98772",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Primary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "3f0298a2-440e-4dc8-a8f1-9023d8abf21e",
                "name": "Secondary Efficacy Endpoint 1",
                "text": "Change from baseline in HAQ-DI at Week 12",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "bc35123c-979a-4509-a4b5-6ff2ad2095eb",
                "name": "Secondary Efficacy Endpoint 2",
                "text": "Static Investigator Global Assessment (sIGA) of Psoriasis of 0 or 1 and at least a 2-point improvement from baseline at Week 16",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "225106cd-8ce4-42bf-a5e9-072aced22568",
                "name": "Secondary Efficacy Endpoint 3",
                "text": "Psoriasis Area Severity Index (PASI) 75 response at Week 16 (for subjects with  3% BSA psoriasis at baseline)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "a211342e-a606-4564-838c-d7882d13fa06",
                "name": "Secondary Efficacy Endpoint 4",
                "text": "Change from baseline in SF-36 PCS at Week 12",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "59b4b225-04c6-4559-9c60-5138cbe1d850",
                "name": "Secondary Efficacy Endpoint 5",
                "text": "Change from baseline in FACIT-Fatigue Questionnaire at Week 12",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "a07db70a-4cc6-4b59-93f5-90c669796d69",
                "name": "Secondary Efficacy Endpoint 6",
                "text": "Proportion of subjects achieving Minimal Disease Activity (MDA) at Week 24",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "529f4af7-4445-4225-8635-581c5c86bf02",
                "name": "Secondary Efficacy Endpoint 7",
                "text": "Change from baseline in Self-Assessment of Psoriasis Symptoms (SAPS) Questionnaire at Week 16",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "0b61a60d-016a-4c89-b06b-6d9aaf605f11",
                "name": "Secondary Efficacy Endpoint 8",
                "text": "ACR50/70 response at Week 12",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "b21670f6-2151-43f7-9df4-fbd1652d38e7",
                "name": "Secondary Efficacy Endpoint 9",
                "text": "ACR20 response at Week 2",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Efficacy"
              },
              {
                "id": "6ca595f5-b867-4345-9991-0cd541915935",
                "name": "Safety Endpoints",
                "text": "AEs, physical examination, laboratory assessments, ECG, and vital signs",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Safety"
              },
              {
                "id": "6cb903c3-9254-4997-bc39-23405e850d2e",
                "name": "Pharmacokinetic Endpoints",
                "text": "population central values and the empirical Bayesian estimates of the individual values of upadacitinib oral clearance (CL/F) and volume of distribution (V/F)",
                "level": {
                  "id": "C98781",
                  "code": "C98781",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Secondary Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Pharmacokinetic"
              },
              {
                "id": "8ef3cacd-8512-4b40-ba1a-d2b6c26c874b",
                "name": "Exploratory Endpoints",
                "text": "nucleic acids, proteins, metabolites, or lipids",
                "level": {
                  "id": "C98724",
                  "code": "C98724",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.11d",
                  "decode": "Exploratory Outcome Measure",
                  "instanceType": "Code"
                },
                "instanceType": "Endpoint",
                "purpose": "Biomarker"
              }
            ],
            "estimands": [
              {
                "id": "12b3300c-d974-4a06-89c9-c608c4066a3d",
                "name": "Primary Efficacy Estimand",
                "populationSummary": "Adult patients with active PsA and inadequate response or intolerance to at least 1 bDMARD (Full Analysis Set) Summary measure: Difference in proportions (Cochran-Mantel-Haenszel test).",
                "analysisPopulationId": "bc91ccbe-2750-430a-b2a4-b08f1d669fbe",
                "variableOfInterestId": "0629029a-7b5a-44f1-b6e0-36bc034a639b",
                "interventionIds": [
                  "d68bc0a2-850b-49ec-a0de-6d661bb6ef4e"
                ],
                "intercurrentEvents": [
                  {
                    "id": "d3431ac2-894d-4d79-ac06-78f73014d686",
                    "name": "Treatment discontinuation",
                    "text": "Subject discontinues study drug treatment before Week 12",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "052e2e3c-b71c-4a36-a10e-09e3ca2ef73c",
                    "name": "Rescue medication use",
                    "text": "Initiation of rescue therapy for lack of efficacy",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "Upadacitinib (15 mg or 30 mg QD) vs Placebo",
                "analysisPopulation": "Adult patients with active PsA and inadequate response or intolerance to at least 1 bDMARD (Full Analysis Set)",
                "variableOfInterest": "Proportion of subjects achieving ACR20 response at Week 12",
                "summaryMeasure": "Difference in proportions (Cochran-Mantel-Haenszel test)"
              },
              {
                "id": "cd8cb350-a880-4f2e-96eb-3cad7c3461dc",
                "name": "Secondary Efficacy Estimand - HAQ-DI",
                "populationSummary": "Adult patients with active PsA and inadequate response or intolerance to at least 1 bDMARD (Full Analysis Set) Summary measure: Difference in least squares means (ANCOVA).",
                "analysisPopulationId": "a5875435-ddfd-4d00-ad6f-f974dd17d308",
                "variableOfInterestId": "3f0298a2-440e-4dc8-a8f1-9023d8abf21e",
                "interventionIds": [
                  "7525160a-b5cc-4ac0-8976-f18531ca466f"
                ],
                "intercurrentEvents": [
                  {
                    "id": "d3431ac2-894d-4d79-ac06-78f73014d686",
                    "name": "Treatment discontinuation",
                    "text": "Subject discontinues study drug treatment before Week 12",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "Upadacitinib (15 mg or 30 mg QD) vs Placebo",
                "analysisPopulation": "Adult patients with active PsA and inadequate response or intolerance to at least 1 bDMARD (Full Analysis Set)",
                "variableOfInterest": "Change from baseline in HAQ-DI at Week 12",
                "summaryMeasure": "Difference in least squares means (ANCOVA)"
              },
              {
                "id": "0403f69e-2b75-4039-8528-971ac62cf5ac",
                "name": "Secondary Efficacy Estimand - MDA",
                "populationSummary": "Adult patients with active PsA and inadequate response or intolerance to at least 1 bDMARD (Full Analysis Set) Summary measure: Difference in proportions (Cochran-Mantel-Haenszel test).",
                "analysisPopulationId": "3ec36544-17da-4a9b-b8b4-ad324419ef42",
                "variableOfInterestId": "a07db70a-4cc6-4b59-93f5-90c669796d69",
                "interventionIds": [
                  "b49a6631-c6b0-46a9-b591-b91e2443ecb8"
                ],
                "intercurrentEvents": [
                  {
                    "id": "c8ba7ec1-003a-4f28-8e34-cb0d1e29ccc1",
                    "name": "Mandatory treatment switch",
                    "text": "Subjects receiving upadacitinib 30 mg QD switched to 15 mg QD per Protocol Amendment 8",
                    "strategy": "Treatment Policy",
                    "instanceType": "IntercurrentEvent"
                  },
                  {
                    "id": "6239ca55-f385-46aa-bfcb-fe33a9c1e74c",
                    "name": "Lack of efficacy discontinuation",
                    "text": "Discontinuation due to failure to demonstrate 20% improvement in TJC/SJC at Week 36",
                    "strategy": "Composite",
                    "instanceType": "IntercurrentEvent"
                  }
                ],
                "instanceType": "Estimand",
                "treatment": "Upadacitinib (15 mg or 30 mg QD) vs Placebo",
                "analysisPopulation": "Adult patients with active PsA and inadequate response or intolerance to at least 1 bDMARD (Full Analysis Set)",
                "variableOfInterest": "Proportion of subjects achieving Minimal Disease Activity (MDA) at Week 24",
                "summaryMeasure": "Difference in proportions (Cochran-Mantel-Haenszel test)"
              }
            ],
            "scheduleTimelines": [
              {
                "id": "c2d366b6-8c9c-44b9-9e52-56d6eae13e07",
                "name": "Main Schedule Timeline",
                "mainTimeline": true,
                "instanceType": "ScheduleTimeline",
                "entryCondition": "Subject enrolled in study",
                "entryId": "aac5857a-483b-40bd-8ded-bc9ace17a79d",
                "instances": [
                  {
                    "id": "aac5857a-483b-40bd-8ded-bc9ace17a79d",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_1",
                    "encounterId": "c88c087e-c8a5-4756-9c94-8c6da740cc87",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "1d7c95d1-eb71-4c62-a0dc-1d13d251ff4c",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_2",
                    "encounterId": "b39b56e7-fb9c-4c4f-a9f2-b42e4d8fbee2",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "123d05cf-317d-46cf-97a2-f81241ddfda1",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_3",
                    "encounterId": "94420499-94e1-48b4-859b-f373d266aae8",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "e8b5c669-1bb7-43df-a801-3895ca9f6523",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_4",
                    "encounterId": "76c485ab-02a0-4d55-a031-47d6eeb72aa6",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "ec47194d-1c80-49c2-b502-878940e25ea8",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_5",
                    "encounterId": "1d1dbca0-8467-4aea-8ffa-6996ae92c5ea",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "d0608ddd-6a5c-4417-ac3e-bab0725bce9d",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_6",
                    "encounterId": "059be2fd-d8be-474e-8551-7be567e6f952",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "695f6856-f737-4d84-a7b7-f77c2919e7e1",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_7",
                    "encounterId": "5a5d869d-8be1-421e-a460-258abb340dc7",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "6d492e1b-a161-4055-9b72-a59ca32c2726",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_8",
                    "encounterId": "0f220136-48f9-4a5c-ad0c-b7313b56bd5d",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "cf9353e1-acfd-44b0-9f15-634566aef95e",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_9",
                    "encounterId": "ba876f78-2fd4-4e7c-8f00-6d0c84cb7261",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "6bdd58e5-65f1-45c7-90c9-18dec127b7dc",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_10",
                    "encounterId": "9bc1c910-5c98-4a2e-a934-b74d42b9f36a",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "aecbfd4b-8192-4520-8877-5eb99ff3fff1",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_11",
                    "encounterId": "462da4e9-819e-4aa2-a921-938d3ba8ab55",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "c118a5ca-e533-4bbd-aa13-2c11520bd895",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_12",
                    "encounterId": "c62eb52f-6727-4522-8ab0-8c3b5b9684b7",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "73080fea-7a08-41e4-b539-6c2a6dcb5e8b",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_13",
                    "encounterId": "538498ac-36ff-4eda-87a0-bb3d2255494f",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "957d2415-f2bd-40b8-9a89-f8ce5bad698a",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_14",
                    "encounterId": "53f9317a-ea61-4923-b313-0b8cb4454255",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "04ae041c-fc00-4639-86be-70c870a6fc47",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_15",
                    "encounterId": "90206b0d-bf2d-4ab1-a390-b3f5b18d4fd8",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "672b47c8-0cde-4887-8c68-06b3652ba91b",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_16",
                    "encounterId": "39ad7ecf-cf36-402f-a403-c73180094e3c",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "38a4fbb1-e204-457a-b61e-2c9e83b58f98",
                    "activityIds": [
                      "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_1@enc_17",
                    "encounterId": "501e31f9-9732-4840-8ec2-84022898186d",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "6132d501-9a36-4601-9ca9-52d9621f841b",
                    "activityIds": [
                      "728539c8-a292-4724-a811-23f524bb81eb"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_2@enc_2",
                    "encounterId": "b39b56e7-fb9c-4c4f-a9f2-b42e4d8fbee2",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "254f8e20-7b9e-4b6d-a336-bdeb74fac7d0",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_2",
                    "encounterId": "b39b56e7-fb9c-4c4f-a9f2-b42e4d8fbee2",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "7d7b3dca-18f6-4de1-87c7-f466d7167fb4",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_3",
                    "encounterId": "94420499-94e1-48b4-859b-f373d266aae8",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "0b34a5d9-54a6-4c33-b796-67640d4c9e18",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_4",
                    "encounterId": "76c485ab-02a0-4d55-a031-47d6eeb72aa6",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "d05f360b-2f87-4328-937d-0642f43b7a87",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_5",
                    "encounterId": "1d1dbca0-8467-4aea-8ffa-6996ae92c5ea",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "eea84e25-1666-4318-9509-60ca957c1ad0",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_6",
                    "encounterId": "059be2fd-d8be-474e-8551-7be567e6f952",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "5308c289-ff1c-43a3-b261-c7f35b62fa2d",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_7",
                    "encounterId": "5a5d869d-8be1-421e-a460-258abb340dc7",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "c857c766-858f-49a0-8384-ba39c1fa30be",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_9",
                    "encounterId": "ba876f78-2fd4-4e7c-8f00-6d0c84cb7261",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "6b0135f7-6a69-45ef-847f-044744977328",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_10",
                    "encounterId": "9bc1c910-5c98-4a2e-a934-b74d42b9f36a",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "6cc8da75-88a3-4950-ba00-a7cf9feae41a",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_11",
                    "encounterId": "462da4e9-819e-4aa2-a921-938d3ba8ab55",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "14d29db9-c5b4-4072-b26a-56dcc3d9e202",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_12",
                    "encounterId": "c62eb52f-6727-4522-8ab0-8c3b5b9684b7",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "c1045e10-bda9-43c0-8015-6efb22611ca6",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_13",
                    "encounterId": "538498ac-36ff-4eda-87a0-bb3d2255494f",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "6a83e49b-b485-4f43-89d2-87c77da893ba",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_14",
                    "encounterId": "53f9317a-ea61-4923-b313-0b8cb4454255",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "91260dcd-4834-4067-96bb-e7eb813d7aed",
                    "activityIds": [
                      "31e61afe-c4fa-4d5a-972b-6cac1abaaa31"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_3@enc_15",
                    "encounterId": "90206b0d-bf2d-4ab1-a390-b3f5b18d4fd8",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "a7df149d-6e2f-4993-abf9-a2d17d01f927",
                    "activityIds": [
                      "32fe4cef-152c-4887-aa45-532d0f5001bf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_6",
                    "encounterId": "059be2fd-d8be-474e-8551-7be567e6f952",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "212da8a8-f33b-4558-9236-747096dfe7c3",
                    "activityIds": [
                      "32fe4cef-152c-4887-aa45-532d0f5001bf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_7",
                    "encounterId": "5a5d869d-8be1-421e-a460-258abb340dc7",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "43e12b2f-ca97-460c-b349-f07f0d9daf5c",
                    "activityIds": [
                      "32fe4cef-152c-4887-aa45-532d0f5001bf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_12",
                    "encounterId": "c62eb52f-6727-4522-8ab0-8c3b5b9684b7",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "5ffb0638-c517-436e-ac36-720a040a5e41",
                    "activityIds": [
                      "32fe4cef-152c-4887-aa45-532d0f5001bf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_13",
                    "encounterId": "538498ac-36ff-4eda-87a0-bb3d2255494f",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "eb61ddb0-9779-4510-9818-561ee09a07a7",
                    "activityIds": [
                      "32fe4cef-152c-4887-aa45-532d0f5001bf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_14",
                    "encounterId": "53f9317a-ea61-4923-b313-0b8cb4454255",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "28e42caf-c361-4a8e-9fe1-d0fbd9badf58",
                    "activityIds": [
                      "32fe4cef-152c-4887-aa45-532d0f5001bf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_15",
                    "encounterId": "90206b0d-bf2d-4ab1-a390-b3f5b18d4fd8",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "3322e826-9ff9-400c-811a-b810da1a8868",
                    "activityIds": [
                      "32fe4cef-152c-4887-aa45-532d0f5001bf"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_4@enc_16",
                    "encounterId": "39ad7ecf-cf36-402f-a403-c73180094e3c",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "b41a1980-b637-4de8-89f0-6115cdd015e7",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_3",
                    "encounterId": "94420499-94e1-48b4-859b-f373d266aae8",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "b6635dd2-9d1d-46e1-8674-fac21c111a6a",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_4",
                    "encounterId": "76c485ab-02a0-4d55-a031-47d6eeb72aa6",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "b644275f-cb00-42ef-805d-31587cf75c58",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_5",
                    "encounterId": "1d1dbca0-8467-4aea-8ffa-6996ae92c5ea",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "49f26ad1-2ae0-4c15-a5db-2c9c91895b51",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_6",
                    "encounterId": "059be2fd-d8be-474e-8551-7be567e6f952",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "0bc5ec41-69d4-4835-8883-bbb1a1218ff1",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_7",
                    "encounterId": "5a5d869d-8be1-421e-a460-258abb340dc7",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "0f998b34-0186-413d-a841-04eece58b88f",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_8",
                    "encounterId": "0f220136-48f9-4a5c-ad0c-b7313b56bd5d",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "5110f68f-69ba-48fe-b3d3-9856bb6e1379",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_9",
                    "encounterId": "ba876f78-2fd4-4e7c-8f00-6d0c84cb7261",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "3c451ffd-45e2-4296-a98a-da093934efb2",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_10",
                    "encounterId": "9bc1c910-5c98-4a2e-a934-b74d42b9f36a",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "955d3090-9b60-41ee-bcac-8fb417453a65",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_11",
                    "encounterId": "462da4e9-819e-4aa2-a921-938d3ba8ab55",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "17aa826b-33d8-49c7-b539-72bc52e403e2",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_12",
                    "encounterId": "c62eb52f-6727-4522-8ab0-8c3b5b9684b7",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "6a4b522c-ce9f-4c8c-8835-6869aa1eb5d6",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_13",
                    "encounterId": "538498ac-36ff-4eda-87a0-bb3d2255494f",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "dc74e85d-41ce-4b02-aa92-507fdef17c34",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_14",
                    "encounterId": "53f9317a-ea61-4923-b313-0b8cb4454255",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "f29b1725-4c87-45ec-95da-0ba55864afc3",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_15",
                    "encounterId": "90206b0d-bf2d-4ab1-a390-b3f5b18d4fd8",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "0a5f30c1-e3e8-47d3-bf98-693d71ca2282",
                    "activityIds": [
                      "a2914b92-8aff-49fd-b913-58ce7291eadc"
                    ],
                    "instanceType": "ScheduledActivityInstance",
                    "name": "act_5@enc_16",
                    "encounterId": "39ad7ecf-cf36-402f-a403-c73180094e3c",
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "d2c577c1-6c14-45f8-bc9e-18dc12cb7a6d",
                    "name": "Anchor: Visit Window Up to Week 36",
                    "activityIds": [],
                    "encounterId": "c88c087e-c8a5-4756-9c94-8c6da740cc87",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "d8af6269-7629-4764-a367-c88386dc4505",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "a82343cf-b1bd-4ed3-9b69-29dcf59c4d0c",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "01a2fb74-666f-46b4-a000-2a4ab08b8439",
                    "name": "Anchor: Visit Window After Week 36",
                    "activityIds": [],
                    "encounterId": "c88c087e-c8a5-4756-9c94-8c6da740cc87",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "c9521edf-d698-457c-a647-723cb017374c",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "40b78827-6797-4669-b005-95f59ef0de85",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "aae04d8a-a928-4f35-91a4-4069ac4222b3",
                    "name": "Anchor: Premature Discontinuation Visit",
                    "activityIds": [],
                    "encounterId": "c88c087e-c8a5-4756-9c94-8c6da740cc87",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "c4e9bf55-1f63-4cfd-9018-00cd3aa47589",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "72eb2d8b-edc6-4976-8b09-8c367821b807",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  },
                  {
                    "id": "80dd2a9f-4075-47ef-80ac-c7ce96dffc5a",
                    "name": "Anchor: Follow-up Visit",
                    "activityIds": [],
                    "encounterId": "c88c087e-c8a5-4756-9c94-8c6da740cc87",
                    "instanceType": "ScheduledActivityInstance",
                    "extensionAttributes": [
                      {
                        "id": "f28aed40-83d0-4a10-9f76-8e587462cf3e",
                        "url": "http://example.org/usdm/instanceSource",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "execution_model"
                      },
                      {
                        "id": "414d7c81-8ab4-45c8-af4a-af3f4cc32dab",
                        "url": "http://example.org/usdm/anchorClassification",
                        "instanceType": "ExtensionAttribute",
                        "valueString": "Visit"
                      }
                    ],
                    "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5"
                  }
                ],
                "timings": [
                  {
                    "id": "6f938b74-c98a-4969-9a2d-9458fbb61419",
                    "name": "Screening Window",
                    "type": {
                      "id": "0c9e270e-cba7-4177-ab20-1989bb8b1a99",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P35D",
                    "valueLabel": "Day 35",
                    "relativeToFrom": {
                      "id": "ea9439bb-2750-4c8a-ba2a-51849efd75f9",
                      "code": "C71159",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Baseline",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "8e17292a-41f2-4c5a-880d-7199a73b91f0",
                    "instanceType": "Timing",
                    "windowLower": "-P35D",
                    "windowUpper": "P0D"
                  },
                  {
                    "id": "9945b0ba-c197-4ac8-9283-efbb69d6d8ad",
                    "name": "Period 1 Duration",
                    "type": {
                      "id": "f96a9688-1e3d-4a87-8f84-3c3be63a82b2",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P56W",
                    "valueLabel": "56 weeks",
                    "relativeToFrom": {
                      "id": "720e4820-d3cb-4b48-9317-5aa20dc6e297",
                      "code": "C71159",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Baseline",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "d1cbc490-e278-4873-8d4f-fe8cf291c0a2",
                    "instanceType": "Timing",
                    "windowLower": "P0W",
                    "windowUpper": "P0W"
                  },
                  {
                    "id": "ef8f9e57-9e6d-49a9-96df-0a3823678ab1",
                    "name": "Visit Window Up to Week 36",
                    "type": {
                      "id": "1fc01e9b-a4d2-4ba3-8887-8d39d07f4851",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P0D",
                    "valueLabel": "Day 0",
                    "relativeToFrom": {
                      "id": "9c149cee-3fc8-4417-92cf-82fd8f302fbc",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "d2c577c1-6c14-45f8-bc9e-18dc12cb7a6d",
                    "instanceType": "Timing",
                    "windowLower": "-P3D",
                    "windowUpper": "P3D"
                  },
                  {
                    "id": "cf892e90-091d-45d6-8d30-7f4d9fa5572e",
                    "name": "Visit Window After Week 36",
                    "type": {
                      "id": "205400f3-ba1f-451d-b6b9-6c19ec3610f1",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P0D",
                    "valueLabel": "Day 0",
                    "relativeToFrom": {
                      "id": "0f921c3e-9532-4491-b808-ad35720c4468",
                      "code": "C71157",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Previous Visit",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "01a2fb74-666f-46b4-a000-2a4ab08b8439",
                    "instanceType": "Timing",
                    "windowLower": "-P7D",
                    "windowUpper": "P7D"
                  },
                  {
                    "id": "9d4968eb-6989-4318-bb2b-acadba79b621",
                    "name": "Premature Discontinuation Visit",
                    "type": {
                      "id": "7824e0be-3d4f-4132-96d1-105ed906917b",
                      "code": "C71151",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Within",
                      "instanceType": "Code"
                    },
                    "value": "P2W",
                    "valueLabel": "2 weeks",
                    "relativeToFrom": {
                      "id": "9f4f8fd8-9e4f-436b-b3ef-c1ab4ebfb8c0",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "aae04d8a-a928-4f35-91a4-4069ac4222b3",
                    "instanceType": "Timing",
                    "windowLower": "P0W",
                    "windowUpper": "P14W"
                  },
                  {
                    "id": "c1a6c654-29f3-47a5-a962-46b798684eca",
                    "name": "Follow-up Visit",
                    "type": {
                      "id": "c5a8b83f-a712-41d6-b456-7729fadfacf0",
                      "code": "C71148",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Fixed Reference",
                      "instanceType": "Code"
                    },
                    "value": "P30D",
                    "valueLabel": "Day 30",
                    "relativeToFrom": {
                      "id": "a95ea173-186b-442a-a75b-8b0f073efb32",
                      "code": "C71156",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Last Dose",
                      "instanceType": "Code"
                    },
                    "relativeFromScheduledInstanceId": "80dd2a9f-4075-47ef-80ac-c7ce96dffc5a",
                    "instanceType": "Timing",
                    "windowLower": "-P3D",
                    "windowUpper": "P3D"
                  }
                ],
                "exits": [
                  {
                    "id": "be31ce9f-4c0e-49e2-a22a-91520e88448e",
                    "name": "Withdrawal of Consent",
                    "exitType": "Early Termination",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Subjects may withdraw for any reason at any time"
                  },
                  {
                    "id": "7788dfd9-322c-403f-b669-ef1a8e99b3df",
                    "name": "Study Completion",
                    "exitType": "Completion",
                    "instanceType": "ScheduleTimelineExit",
                    "description": "Completion of Week 152 visit and 30-day follow-up"
                  }
                ]
              }
            ],
            "encounters": [
              {
                "id": "94420499-94e1-48b4-859b-f373d266aae8",
                "name": "Wk 2 (D 15)",
                "instanceType": "Encounter",
                "type": {
                  "id": "8461fd12-09d4-4cb5-a245-92684bccd44d",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "a1f2e171-87c8-457a-85ae-b875f56e13a7",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "8cf2e93c-9b39-4c60-a6ca-083684408370",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "2bacb4cb-bf1d-4322-9b50-2439b5f9d675",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 2
                  }
                ]
              },
              {
                "id": "76c485ab-02a0-4d55-a031-47d6eeb72aa6",
                "name": "Wk 4 (D 29)",
                "instanceType": "Encounter",
                "type": {
                  "id": "d5712e5a-4ab8-4c69-a46f-bcc885eb9f8a",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "a3b9ff15-e0e2-4b2f-85bb-02a0808e4945",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "5813db64-d114-48e8-8518-fdf0bd622c91",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "9759e9cc-8e4e-47cf-8541-bbb133023a7c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 4
                  }
                ]
              },
              {
                "id": "1d1dbca0-8467-4aea-8ffa-6996ae92c5ea",
                "name": "Wk 8 (D 57)",
                "instanceType": "Encounter",
                "type": {
                  "id": "bdb17eb3-690a-44ed-8b25-9ae8a0b98584",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "2392f4b6-e5d9-40bc-9e3e-67cf04db6331",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "69e95c43-a563-40bf-a8b9-f5b97d96b568",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "598b0b45-c93f-4252-a43d-f4ef28193681",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 8
                  }
                ]
              },
              {
                "id": "059be2fd-d8be-474e-8551-7be567e6f952",
                "name": "Wk 12 (D 85)",
                "instanceType": "Encounter",
                "type": {
                  "id": "ed0e60bd-5d54-4fc2-ae8e-845f8b0d87ca",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "2c0761c3-0147-482e-9173-25c7fa50b38b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "1196afec-b236-491c-bfa8-675a91ecb28c",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "5f5ee2bc-1aa3-491c-9d5b-3775bf3ec747",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 12
                  }
                ]
              },
              {
                "id": "5a5d869d-8be1-421e-a460-258abb340dc7",
                "name": "Wk 16 (D 113)",
                "instanceType": "Encounter",
                "type": {
                  "id": "304bdbe8-aee1-435f-8530-1fad06d70978",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "4294bf3e-b80a-4e33-ad94-e61952ff7f15",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "43b070d5-7164-4926-aeef-19fcbe6d9141",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "f315a8fd-62c7-4e3a-a490-6580b7be3dfb",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 16
                  }
                ]
              },
              {
                "id": "0f220136-48f9-4a5c-ad0c-b7313b56bd5d",
                "name": "Wk 20 (D 141)",
                "instanceType": "Encounter",
                "type": {
                  "id": "957f4ad5-9876-4262-9077-ca3967ea3982",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "bd4a7665-71bb-46fc-a1a5-ead3607fb9fd",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "34258f01-146a-4caf-a4fe-67dd1ac0d7a0",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "18edc6ae-97f3-4b1c-8637-cb0aff8dae88",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 20
                  }
                ]
              },
              {
                "id": "ba876f78-2fd4-4e7c-8f00-6d0c84cb7261",
                "name": "Wk 24 (D 169)",
                "instanceType": "Encounter",
                "type": {
                  "id": "1f424fdc-3d02-4600-8fe0-044fcd5c360b",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "93c77cd4-06b7-468e-be31-b92e3d4d4be1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "830fad08-4c61-4a50-8a9c-75461dba3bd0",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "c69d9863-1a66-42d3-8b23-a22dc8061745",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 24
                  }
                ]
              },
              {
                "id": "9bc1c910-5c98-4a2e-a934-b74d42b9f36a",
                "name": "Wk 28 (D 197)",
                "instanceType": "Encounter",
                "type": {
                  "id": "06e8bd99-621e-4ade-9a35-832a67702166",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "1298c92a-81bb-49bb-810e-7062b36ebcb7",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "009960eb-07b2-488e-83b8-996304341c57",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "aab909de-df36-401a-a53d-13d6098231ad",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 28
                  }
                ]
              },
              {
                "id": "462da4e9-819e-4aa2-a921-938d3ba8ab55",
                "name": "Wk 32 (D 225)",
                "instanceType": "Encounter",
                "type": {
                  "id": "33400b91-8c27-4df3-954f-6812348bf33b",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "a4ad2806-3688-4368-aeae-bd9005b4b446",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "81485a44-f5ca-4bcf-b557-7fcf0eed5bcc",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "b679fc46-8115-46f5-8e49-70985b48db08",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 32
                  }
                ]
              },
              {
                "id": "c62eb52f-6727-4522-8ab0-8c3b5b9684b7",
                "name": "Wk 36 (D 253)",
                "instanceType": "Encounter",
                "type": {
                  "id": "00e4e743-7140-425b-b316-3903adcfc688",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "b3528dcb-8258-4614-87d3-57cfb12024f6",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "894a1e6b-eed4-4292-9bf3-c3fae1a5e84b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "653907d5-bab0-4d16-ac92-12a7d2b02474",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 36
                  }
                ]
              },
              {
                "id": "538498ac-36ff-4eda-87a0-bb3d2255494f",
                "name": "Wk 44 (D 309)",
                "instanceType": "Encounter",
                "type": {
                  "id": "bfa22e69-6c8d-4ded-8ad0-3b6673b1e87e",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "e983ca9c-afb3-41c6-a37f-c9afcc704df1",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "63c22a3c-d0af-48fd-87a4-6390aa863aa3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "59328ee5-a486-4a31-aecc-0b366043833d",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 44
                  }
                ]
              },
              {
                "id": "53f9317a-ea61-4923-b313-0b8cb4454255",
                "name": "Wk 56 (D 393)",
                "instanceType": "Encounter",
                "type": {
                  "id": "91169168-8bcb-4c2a-bf86-c1a48d1b0b49",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "ee442e8c-53eb-4715-a32f-77109c4c60ed",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "8eadb156-c1f2-4bbe-bc07-60b0b9cf09e3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "bbdf2404-ab7f-45e5-9c98-b4b55f5ce95e",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 56
                  }
                ]
              },
              {
                "id": "90206b0d-bf2d-4ab1-a390-b3f5b18d4fd8",
                "name": "Wk 68 to Wk 140 (D 477 to D 981)",
                "instanceType": "Encounter",
                "type": {
                  "id": "cb0b93d8-415a-4faf-ae12-d8f8b2c1274e",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "aff08b7c-9444-440c-81b0-e19118ef0107",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "214fdab6-8686-4c9b-b442-0b3171e104c9",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "5f717f85-6830-4022-b45d-b99174ea32c9",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 68
                  }
                ]
              },
              {
                "id": "39ad7ecf-cf36-402f-a403-c73180094e3c",
                "name": "Wk 152 or PD (D 1065)",
                "instanceType": "Encounter",
                "type": {
                  "id": "8349a006-c95b-4b3a-bebd-e143c9b9064a",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "305e5add-c606-4304-9b2d-dcffd4d25bc4",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "6727830c-0cce-4180-a260-612bf552681a",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  },
                  {
                    "id": "6c71e061-5a60-46d3-bce3-18b7ee215906",
                    "url": "https://protocol2usdm.io/extensions/x-encounterStudyWeek",
                    "instanceType": "ExtensionAttribute",
                    "valueInteger": 152
                  }
                ]
              },
              {
                "id": "501e31f9-9732-4840-8ec2-84022898186d",
                "name": "30 Day F/U Visit/Call (D 1095)",
                "instanceType": "Encounter",
                "type": {
                  "id": "d2ccfe93-e4e4-481c-b05d-cf593826ba0a",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "a5160f75-7c37-4836-83ba-c51a12fb7744",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "a4fc5e87-f3cf-4fa2-a6b5-22c95a885ff3",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "phone"
                  }
                ]
              },
              {
                "id": "b39b56e7-fb9c-4c4f-a9f2-b42e4d8fbee2",
                "name": "BL (D 1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "f2b58c4d-c449-4a05-bc95-3c0338acc00e",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "0d53379f-d33e-4942-b5e1-c5bf1f923d2b",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "9e2db23f-8038-48f5-afde-9dda41f36746",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              },
              {
                "id": "c88c087e-c8a5-4756-9c94-8c6da740cc87",
                "name": "SCR (D -35 to D -1)",
                "instanceType": "Encounter",
                "type": {
                  "id": "e3ae44e3-fb9b-492b-904a-7db440631f4b",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Study Visit",
                  "instanceType": "Code"
                },
                "epochId": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "extensionAttributes": [
                  {
                    "id": "93f87ca2-6600-4039-a68c-bb0d1fe6dbc4",
                    "url": "https://protocol2usdm.io/extensions/x-encounterSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "b74f3982-0d1a-48d7-b8fc-ad06325b0749",
                    "url": "https://protocol2usdm.io/extensions/x-encounterType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "visit"
                  }
                ]
              }
            ],
            "activities": [
              {
                "id": "718dc06b-1dd8-4e7c-8fe1-05ff4318d13f",
                "name": "12-Lead Electrocardiogram",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "718dc06b-1dd8-4e7c-8fe1-05ff4318d13f",
                    "name": "12-Lead Electrocardiogram",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "1973c64d-4329-4a02-b03f-59e0e6f886f2",
                      "code": "93000",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "ECG",
                    "description": "Resting 12-lead ECG to monitor cardiac safety and QTcF intervals"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "ac070511-7722-4c74-938d-0da60a6e4b3a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "271039c8-fad8-4eee-a721-4338aed513b9",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "73c48ac5-9fff-4a15-956c-97252ec338ed",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd",
                "name": "Adverse Event Assessment",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "974a9402-57cc-4173-a968-bb9b82fac57c",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "aa7abe7e-3e73-4ced-aab0-790d0851e9af",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "dab3a32e-6bc6-408d-8702-07a90c74def3",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "d19311fc-daea-49de-aa27-cc136d65ca1f",
                "name": "Blood Draw",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "d19311fc-daea-49de-aa27-cc136d65ca1f",
                    "name": "Blood Draw",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "99545328-714c-4751-8922-a62ddd8bfd6b",
                      "code": "36415",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Collection of venous blood by venipuncture",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Venipuncture",
                    "description": "Collection of blood samples for pharmacokinetic assay, biomarkers, and clinical laboratory testing"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "72fd2e73-c79e-4b19-b0a5-e354fdcd1fa7",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "28919e04-fce0-413a-9daa-d4f32a694bef",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "1ff9f7ae-bce2-4593-82ee-6724f60966ef",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "32fe4cef-152c-4887-aa45-532d0f5001bf",
                "name": "Calculation of TJC/SJC responses",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "4330aef7-03b1-4bda-88d0-dde87f51bd96",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "430a86b3-9568-45c3-8b56-977d2b76f4ab",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "other"
                  },
                  {
                    "id": "c3ecdc04-664a-4cbe-b0ad-efecd75329ef",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "4c706752-f06b-4b8b-950f-b0ed67ee9e4c",
                "name": "Chest X-Ray",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "4c706752-f06b-4b8b-950f-b0ed67ee9e4c",
                    "name": "Chest X-Ray",
                    "procedureType": "Imaging Technique",
                    "code": {
                      "id": "9dd75799-4b89-453e-bbff-8802e8885645",
                      "code": "71045",
                      "codeSystem": "CPT",
                      "codeSystemVersion": "",
                      "decode": "Radiologic examination, chest; single view",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "CXR",
                    "description": "Imaging of the chest for TB screening and safety monitoring"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "dfac787f-f20c-472d-b3da-f5c4fbcbd9e4",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "c617c1c5-6972-4dde-98e3-db411f02336d",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "8050f6cf-0ccd-4219-b0f1-240b00357340",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "31e61afe-c4fa-4d5a-972b-6cac1abaaa31",
                "name": "Dispense Study Drug and Subject Diary",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d9757112-0950-45e8-8b45-55d45795e586",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "78ffebe8-6591-4358-8379-d512c9ea9b04",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "assessment"
                  },
                  {
                    "id": "1c46f2ae-222a-4ac6-8747-63884369face",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a5b7dc9b-c300-4e26-849c-7b4e29cf425e",
                "name": "Intra-articular Injection",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "a5b7dc9b-c300-4e26-849c-7b4e29cf425e",
                    "name": "Intra-articular Injection",
                    "procedureType": "Therapeutic Procedure",
                    "code": {
                      "id": "985aaa6f-2584-4ac1-859a-4bf6cc337654",
                      "code": "C49236",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Therapeutic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Corticosteroid Injection",
                    "description": "Therapeutic injection into joints, bursae, or tendon sheaths"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "7d4a4ea7-0cc7-4b50-b3ac-a667de005507",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "853b2cd6-bcc6-45e6-b097-5bebeb3517d3",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "d99333ff-d085-449c-b617-30ff77bade83",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "02bc953e-6fef-4edc-a551-0ee251deab9a",
                "name": "Physical Examination",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "02bc953e-6fef-4edc-a551-0ee251deab9a",
                    "name": "Physical Examination",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "9fcede5e-68d9-4618-9d07-d34eae711a69",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "PE",
                    "description": "Complete or symptom-directed physical assessment"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "bcc67a0c-128c-4d76-bf78-48546c9d7749",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "0304b3f8-6f8d-4792-8ae2-44c6e5c9b05b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "2c4ab1d7-ac93-4423-bc93-fbe94d59aaea",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "30cdc39d-84c7-4217-9284-71adabc08a00",
                "name": "QuantiFERON Tuberculosis Gold test",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "30cdc39d-84c7-4217-9284-71adabc08a00",
                    "name": "QuantiFERON Tuberculosis Gold test",
                    "procedureType": "Diagnostic Procedure",
                    "code": {
                      "id": "f15f41bb-2f63-4a9d-959d-d2674f0d5571",
                      "code": "C25391",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Diagnostic Procedure",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "IGRA",
                    "description": "Interferon-Gamma Release Assay for TB testing"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "697d021b-6f2d-448f-ae46-e90f2e08ede1",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "2bf2b5d2-d052-4230-906f-13792e953607",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "bc4147a8-9454-4a20-92d9-74ba21bb43be",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "728539c8-a292-4724-a811-23f524bb81eb",
                "name": "Randomization",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "cdf43d46-08df-4109-812a-d2408ef1f665",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "04888358-2fff-477b-8f19-9e1c5e69fe9f",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "documentation"
                  },
                  {
                    "id": "9e4eed3a-eccf-4629-b1f9-d74988063cc6",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "a2914b92-8aff-49fd-b913-58ce7291eadc",
                "name": "Subject Diary Review",
                "instanceType": "Activity",
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "70a51790-0575-402c-9e1a-3f3d49c7543e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "29aa94ca-36bd-461c-a09b-a909b06d800b",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "assessment"
                  },
                  {
                    "id": "b7657e4b-302b-47bf-9d2f-6139e1515c8d",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "soa",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "88250b58-bd2e-4d34-93e1-50fc63ec0bda",
                "name": "Swollen Joint Count",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "88250b58-bd2e-4d34-93e1-50fc63ec0bda",
                    "name": "Swollen Joint Count",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "b9f5cfee-e892-4111-9b68-99e2b170cde8",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "SJC",
                    "description": "Assessment of joint swelling for efficacy evaluation"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "bddac66f-cea6-417e-be68-8cf257092266",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "83bd775d-af38-4839-a2cd-92a23541dfc3",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "7995240e-4975-4b09-b55c-e7b9164491a7",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "1f3ecb90-9a4e-4154-8497-21f90ff30604",
                "name": "Tender Joint Count",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "1f3ecb90-9a4e-4154-8497-21f90ff30604",
                    "name": "Tender Joint Count",
                    "procedureType": "Assessment",
                    "code": {
                      "id": "7f230a52-70e1-424d-b698-704855765822",
                      "code": "C25218",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Assessment",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "TJC",
                    "description": "Assessment of joint tenderness for efficacy evaluation"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d464d7a4-7544-4cf3-978c-10e97df53123",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "a704cd6d-3bf0-4182-882f-47a67acedcd7",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "7379ecd2-805f-4394-b30f-f530551edfa5",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "21ff9caf-b00e-4e50-88f9-f6ef607eb6a9",
                "name": "Urine Collection",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "21ff9caf-b00e-4e50-88f9-f6ef607eb6a9",
                    "name": "Urine Collection",
                    "procedureType": "Biospecimen Collection",
                    "code": {
                      "id": "7645aa95-66f5-4f22-b6eb-c609250a12d4",
                      "code": "C70793",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Biospecimen Collection",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Urinalysis",
                    "description": "Collection of urine for clinical laboratory testing"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "8e730a2a-d508-49cd-a897-f656e70bd66e",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "9274cdb4-2c9b-40ee-b13b-7622c4412b69",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "999c5df3-c472-45b3-b955-6f0a2b356642",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              },
              {
                "id": "fb7c2d03-68af-4f42-b7f6-8645f98f8c9f",
                "name": "Vital Signs Measurement",
                "instanceType": "Activity",
                "definedProcedures": [
                  {
                    "id": "fb7c2d03-68af-4f42-b7f6-8645f98f8c9f",
                    "name": "Vital Signs Measurement",
                    "procedureType": "Monitoring",
                    "code": {
                      "id": "8f7bef61-30f9-4175-a578-2fdee0933d99",
                      "code": "C25548",
                      "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                      "codeSystemVersion": "25.01d",
                      "decode": "Monitoring",
                      "instanceType": "Code"
                    },
                    "instanceType": "Procedure",
                    "label": "Vitals",
                    "description": "Measurement of blood pressure, pulse rate, respiratory rate, and body temperature"
                  }
                ],
                "biomedicalConcepts": [],
                "extensionAttributes": [
                  {
                    "id": "d77ed6ad-32f9-4daa-83ab-e4ff9644445a",
                    "url": "https://protocol2usdm.io/extensions/x-activitySources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedures"
                  },
                  {
                    "id": "af0eb53f-40b7-49e5-9d40-092fe41b270e",
                    "url": "https://protocol2usdm.io/extensions/x-activityType",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "procedure"
                  },
                  {
                    "id": "541b0253-0cec-4012-8ac1-d5541c14c608",
                    "url": "http://example.org/usdm/activitySource",
                    "valueString": "procedure_enrichment",
                    "instanceType": "ExtensionAttribute"
                  }
                ]
              }
            ],
            "epochs": [
              {
                "id": "fdb30dcd-97ef-452c-9ed8-733ff280beb5",
                "name": "Study Period | Safety Follow-up",
                "instanceType": "StudyEpoch",
                "type": {
                  "id": "1d68230c-2862-4574-8991-0875d8b7e0ef",
                  "code": "C98780",
                  "codeSystem": "http://www.cdisc.org",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Treatment Epoch",
                  "instanceType": "Code"
                },
                "extensionAttributes": [
                  {
                    "id": "b6939792-73ba-4843-9467-a6ec437ead34",
                    "url": "https://protocol2usdm.io/extensions/x-studyepochSources",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "soa"
                  },
                  {
                    "id": "0780fb26-bde2-405f-8afb-dcff28caa782",
                    "url": "https://protocol2usdm.io/extensions/x-epochCategory",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "main"
                  },
                  {
                    "id": "2d3fa422-edb2-4363-acf5-12157ddb05fe",
                    "url": "https://protocol2usdm.io/extensions/x-epochSequenceOrder",
                    "instanceType": "ExtensionAttribute",
                    "valueString": "1"
                  }
                ]
              }
            ],
            "activityGroups": [
              {
                "id": "fda669f9-77fe-43fa-ac0b-ee8d769a024b",
                "name": "Activity",
                "description": null,
                "childIds": [
                  "98cb2e1e-2c49-44e3-a206-a7bb353f6cfd",
                  "728539c8-a292-4724-a811-23f524bb81eb",
                  "31e61afe-c4fa-4d5a-972b-6cac1abaaa31",
                  "32fe4cef-152c-4887-aa45-532d0f5001bf",
                  "a2914b92-8aff-49fd-b913-58ce7291eadc"
                ],
                "instanceType": "Activity",
                "activityNames": [
                  "Adverse Event Assessment",
                  "Randomization",
                  "Dispense Study Drug and Subject Diary",
                  "Calculation of TJC/SJC responses",
                  "Subject Diary Review"
                ]
              }
            ],
            "notes": [
              {
                "id": "61fcc371-fa80-4c5e-90cd-d5b609b66d65",
                "text": "a. These visits every 12 weeks are at: Wk 68, Wk 80, Wk 92, Wk 104, Wk 116, Wk 128, and Wk 140.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "371e352c-b9ee-4db4-ac3c-56c1d5c60a75",
                "text": "b. This on-site visit is 30 days after the last dose of study drug. For those subjects who prematurely discontinue from the study (withdrawal of informed consent) a 30-day follow-up phone call visit (and not an on-site visit) may be allowed...",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "b4fa24d7-108d-4914-8a84-a6e18e65e187",
                "text": "c. Obtain informed consent prior to performing any study related procedures.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "fdb63547-9649-4c06-8e53-2d39ab996711",
                "text": "d. Note herpes zoster, herpes zoster vaccination and hepatitis B vaccination status in medical history.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a6541e9f-7cc8-4633-bd9e-956813219609",
                "text": "e. Blood pressure, pulse rate, body temperature, body weight, and respiratory rate should be performed before blood draws are performed.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "52286d79-66bf-4d36-a7ee-ebfbfc7d343a",
                "text": "f. Height will be measured at Screening visit only (with shoes off).",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "77124873-dee3-4175-8732-66508c98b8fe",
                "text": "g. For concomitant medications, at Week 36 (after Week 36 assessments have been performed), per Investigator judgment, may add non-biologic DMARDs...",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "d0ee79e4-5818-4c4a-902a-bd55bf70ead9",
                "text": "aa. Collect serious AEs and protocol-related nonserious AEs that occur after a subject signs the informed consent; prior to the first dose of study drug.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "61509e7a-8e7c-4d78-816e-27c1a4df77ff",
                "text": "bb. At Week 24, all placebo subjects will be randomized to blinded upadacitinib regardless of clinical response.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "48d30100-f208-4b57-b26d-3a59be07a913",
                "text": "cc. At Week 16, subjects who do not achieve  20% improvement in either or both TJC and SJC compared to baseline at both Weeks 12 and 16 will be offered rescue therapy.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "74623d8f-d165-4a11-9c6b-514901e6cf32",
                "text": "dd. Starting at Week 36, subjects who failed to show at least 20% improvement in either or both TJC and SJC compared to baseline at 2 consecutive visits will be discontinued from study drug treatment.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "e8611c59-8ed5-49eb-be4d-328dd2ba24c9",
                "text": "Note: Visit window is  3 days for the first 36 weeks and  7 days for the remainder of the study. Any of the procedures may be performed at an unscheduled visit at the discretion of the Investigator.",
                "instanceType": "CommentAnnotation"
              },
              {
                "id": "a2e3d522-e801-47c7-946a-40c821723618",
                "text": "a. These visits every 12 weeks are at: Wk 68, Wk 80, Wk 92, Wk 104, Wk 116, Wk 128, and Wk 140.",
                "instanceType": "Note"
              },
              {
                "id": "9d037b56-b418-4ce2-bf9c-46882dbefab4",
                "text": "d. Note herpes zoster, herpes zoster vaccination and hepatitis B vaccination status in medical history.",
                "instanceType": "Note"
              },
              {
                "id": "96a87649-d7bf-4ed7-b9d6-dd2ab0805ec3",
                "text": "e. Blood pressure, pulse rate, body temperature, body weight, and respiratory rate should be performed before blood draws are performed.",
                "instanceType": "Note"
              },
              {
                "id": "2b4ce617-be9a-41d2-9fc0-eebcbbfbc004",
                "text": "f. Height will be measured at Screening visit only (with shoes off).",
                "instanceType": "Note"
              }
            ],
            "model": {
              "id": "7403e919-6929-4cb5-b0e9-b011d529ebf6",
              "code": "C49649",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Crossover Study",
              "instanceType": "Code"
            },
            "indications": [
              {
                "id": "d4236907-6129-47cb-aa25-b64e2931d19f",
                "name": "Active Psoriatic Arthritis",
                "isRareDisease": false,
                "instanceType": "Indication",
                "description": "Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (bDMARD)"
              }
            ],
            "procedures": [
              {
                "id": "d19311fc-daea-49de-aa27-cc136d65ca1f",
                "name": "Blood Draw",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "99545328-714c-4751-8922-a62ddd8bfd6b",
                  "code": "36415",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Collection of venous blood by venipuncture",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Venipuncture",
                "description": "Collection of blood samples for pharmacokinetic assay, biomarkers, and clinical laboratory testing"
              },
              {
                "id": "4c706752-f06b-4b8b-950f-b0ed67ee9e4c",
                "name": "Chest X-Ray",
                "procedureType": "Imaging Technique",
                "code": {
                  "id": "9dd75799-4b89-453e-bbff-8802e8885645",
                  "code": "71045",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Radiologic examination, chest; single view",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "CXR",
                "description": "Imaging of the chest for TB screening and safety monitoring"
              },
              {
                "id": "718dc06b-1dd8-4e7c-8fe1-05ff4318d13f",
                "name": "12-Lead Electrocardiogram",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "1973c64d-4329-4a02-b03f-59e0e6f886f2",
                  "code": "93000",
                  "codeSystem": "CPT",
                  "codeSystemVersion": "",
                  "decode": "Electrocardiogram, routine ECG with at least 12 leads",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "ECG",
                "description": "Resting 12-lead ECG to monitor cardiac safety and QTcF intervals"
              },
              {
                "id": "fb7c2d03-68af-4f42-b7f6-8645f98f8c9f",
                "name": "Vital Signs Measurement",
                "procedureType": "Monitoring",
                "code": {
                  "id": "8f7bef61-30f9-4175-a578-2fdee0933d99",
                  "code": "C25548",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Monitoring",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Vitals",
                "description": "Measurement of blood pressure, pulse rate, respiratory rate, and body temperature"
              },
              {
                "id": "02bc953e-6fef-4edc-a551-0ee251deab9a",
                "name": "Physical Examination",
                "procedureType": "Assessment",
                "code": {
                  "id": "9fcede5e-68d9-4618-9d07-d34eae711a69",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "PE",
                "description": "Complete or symptom-directed physical assessment"
              },
              {
                "id": "21ff9caf-b00e-4e50-88f9-f6ef607eb6a9",
                "name": "Urine Collection",
                "procedureType": "Biospecimen Collection",
                "code": {
                  "id": "7645aa95-66f5-4f22-b6eb-c609250a12d4",
                  "code": "C70793",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Biospecimen Collection",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Urinalysis",
                "description": "Collection of urine for clinical laboratory testing"
              },
              {
                "id": "a5b7dc9b-c300-4e26-849c-7b4e29cf425e",
                "name": "Intra-articular Injection",
                "procedureType": "Therapeutic Procedure",
                "code": {
                  "id": "985aaa6f-2584-4ac1-859a-4bf6cc337654",
                  "code": "C49236",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Therapeutic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "Corticosteroid Injection",
                "description": "Therapeutic injection into joints, bursae, or tendon sheaths"
              },
              {
                "id": "1f3ecb90-9a4e-4154-8497-21f90ff30604",
                "name": "Tender Joint Count",
                "procedureType": "Assessment",
                "code": {
                  "id": "7f230a52-70e1-424d-b698-704855765822",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "TJC",
                "description": "Assessment of joint tenderness for efficacy evaluation"
              },
              {
                "id": "88250b58-bd2e-4d34-93e1-50fc63ec0bda",
                "name": "Swollen Joint Count",
                "procedureType": "Assessment",
                "code": {
                  "id": "b9f5cfee-e892-4111-9b68-99e2b170cde8",
                  "code": "C25218",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Assessment",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "SJC",
                "description": "Assessment of joint swelling for efficacy evaluation"
              },
              {
                "id": "30cdc39d-84c7-4217-9284-71adabc08a00",
                "name": "QuantiFERON Tuberculosis Gold test",
                "procedureType": "Diagnostic Procedure",
                "code": {
                  "id": "f15f41bb-2f63-4a9d-959d-d2674f0d5571",
                  "code": "C25391",
                  "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                  "codeSystemVersion": "25.01d",
                  "decode": "Diagnostic Procedure",
                  "instanceType": "Code"
                },
                "instanceType": "Procedure",
                "label": "IGRA",
                "description": "Interferon-Gamma Release Assay for TB testing"
              }
            ],
            "analysisPopulations": [
              {
                "id": "1edca9da-47eb-465b-9774-78f5431e7f25",
                "name": "Full Analysis Set",
                "text": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug. The FAS will be used for all efficacy and baseline analyses.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "FAS",
                "populationDescription": "The Full Analysis Set (FAS) includes all randomized subjects who received at least one dose of study drug. The FAS will be used for all efficacy and baseline analyses.",
                "criteria": "Randomized AND received >=1 dose of study drug"
              },
              {
                "id": "cf8be586-6df7-4974-a41b-d3a3864b9724",
                "name": "Per Protocol Analysis Set",
                "text": "The Per Protocol Analysis Set represents a subset of the FAS and consists of all FAS subjects who did not have any major protocol deviations that are determined to have a potential impact on the primary efficacy endpoint up to Week 12 in Period 1 of the study.",
                "populationType": "Efficacy",
                "instanceType": "AnalysisPopulation",
                "label": "PPS",
                "populationDescription": "The Per Protocol Analysis Set represents a subset of the FAS and consists of all FAS subjects who did not have any major protocol deviations that are determined to have a potential impact on the primary efficacy endpoint up to Week 12 in Period 1 of the study.",
                "criteria": "FAS subject AND no major protocol deviations affecting primary efficacy endpoint through Week 12"
              },
              {
                "id": "94ba1def-3ddd-4df4-8dab-5de6b4d84303",
                "name": "Safety Analysis Set",
                "text": "The Safety Analysis Set consists of all subjects who received at least one dose of study drug. For the Safety Analysis Set, subjects will be analyzed 'as treated,' regardless of the treatment randomized.",
                "populationType": "Safety",
                "instanceType": "AnalysisPopulation",
                "label": "SAF",
                "populationDescription": "The Safety Analysis Set consists of all subjects who received at least one dose of study drug. For the Safety Analysis Set, subjects will be analyzed 'as treated,' regardless of the treatment randomized.",
                "criteria": "Received >=1 dose of study drug"
              }
            ],
            "characteristics": [
              {
                "id": "1002631d-f78a-47c1-8c55-97e8c0cc2110",
                "code": "SEX",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Sex",
                "instanceType": "Code"
              },
              {
                "id": "14b70a30-4d05-4bda-810f-7182ea9a50a4",
                "code": "AGE",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Age",
                "instanceType": "Code"
              },
              {
                "id": "6585dfec-3647-43e0-b002-26b718ba0e73",
                "code": "WEIGHT",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Weight",
                "instanceType": "Code"
              },
              {
                "id": "743ece99-bada-4af3-a36a-7e76cab24090",
                "code": "DURATION_OF_PSA_SYMP",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Duration of PsA symptoms",
                "instanceType": "Code"
              },
              {
                "id": "d080aedc-a06c-4e2d-8b42-2a982971a924",
                "code": "TENDER_JOINT_COUNT_(",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Tender joint count (TJC68)",
                "instanceType": "Code"
              },
              {
                "id": "9e9e0413-a714-45ee-aef5-33811b905b34",
                "code": "SWOLLEN_JOINT_COUNT_",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "Swollen joint count (SJC66)",
                "instanceType": "Code"
              },
              {
                "id": "378baa5a-e973-41d2-bef8-f371edef8f21",
                "code": "HSCRP",
                "codeSystem": "http://www.cdisc.org/baseline-characteristics",
                "codeSystemVersion": "2024-03-29",
                "decode": "hsCRP",
                "instanceType": "Code"
              }
            ],
            "extensionAttributes": [
              {
                "id": "ext_conceptual_e0be8b29-68f5-461b-bfc0-7882dfe05618",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-conceptualAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"d1cbc490-e278-4873-8d4f-fe8cf291c0a2\", \"name\": \"Period 1 Duration\", \"classification\": \"Conceptual\", \"note\": \"Pure timing reference - no visit or activity instance\"}]"
              },
              {
                "id": "a7f17bb8-e28f-4d4b-9bf6-5011aa815b27",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-promotionIssues",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"severity\": \"warning\", \"category\": \"timing_reference_remapped\", \"message\": \"Timing 'Screening Window' reference remapped: fde2190e-a30d-40b7-9f86-762d1ee4b96b \\u2192 anchor_inst_anchor_3\", \"affectedPath\": \"$.timings[?(@.id=='timing_1')]\"}, {\"severity\": \"info\", \"category\": \"conceptual_anchor_stored\", \"message\": \"CONCEPTUAL anchor 'Period 1 Duration' stored as timing reference (no visit)\", \"affectedPath\": \"$.extensionAttributes[?(@.url contains 'conceptualAnchors')]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: d2c577c1-6c14-45f8-bc9e-18dc12cb7a6d (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 01a2fb74-666f-46b4-a000-2a4ab08b8439 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: aae04d8a-a928-4f35-91a4-4069ac4222b3 (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}, {\"severity\": \"info\", \"category\": \"visit_anchor_created\", \"message\": \"Created VISIT anchor instance: 80dd2a9f-4075-47ef-80ac-c7ce96dffc5a (encounter: enc_1)\", \"affectedPath\": \"$.scheduleTimelines[0].instances[-1]\"}]"
              },
              {
                "id": "c5b81d77-c623-4116-9e74-69f7212160a7",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-timeAnchors",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"f79f542c-941c-4488-b056-0c3529b5a518\", \"definition\": \"First administration of investigational product\", \"anchorType\": \"FirstDose\", \"classification\": \"Event\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 60, \"sourceText\": \"first dose of study drug\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"8bb6eab4-2f3b-44d6-9db0-8b04a246a70d\", \"definition\": \"Baseline visit/assessment\", \"anchorType\": \"Baseline\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 50, \"sourceText\": \"baseline visit\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"939f5954-c76e-48e5-b427-88a04973c27b\", \"definition\": \"Screening visit\", \"anchorType\": \"Screening\", \"classification\": \"Visit\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 20, \"sourceText\": \"Screening visit\", \"encounterId\": null, \"activityId\": null}, {\"id\": \"05fdcf99-8738-43a7-bdbd-5852238ed3c4\", \"definition\": \"symptom onset\", \"anchorType\": \"Custom\", \"classification\": \"Conceptual\", \"timelineId\": null, \"dayValue\": 1, \"intraDayOrder\": 100, \"sourceText\": \"symptom onset\", \"encounterId\": null, \"activityId\": null}]"
              },
              {
                "id": "e203d915-3bef-4119-8b80-0671abbc77d5",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-repetitions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"8158af0d-a6d7-4548-82b8-a234aee6aa8f\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"once daily\"}, {\"id\": \"9d8acf5e-8821-425a-954b-a59555ebaa22\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"Once Daily\"}, {\"id\": \"24e9b92e-45b1-432c-bc69-e6c2f4840ccb\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"QD\"}, {\"id\": \"beb7b415-7fd9-4fc2-83a8-20b7245dff86\", \"type\": \"Daily\", \"interval\": \"P1D\", \"sourceText\": \"od\"}, {\"id\": \"a674a216-3cee-447f-8d6d-0c6642753d33\", \"type\": \"Interval\", \"sourceText\": \"BID\"}, {\"id\": \"8c281a2d-4649-4d4e-8d9a-9e3eb5e6ab91\", \"type\": \"Continuous\", \"sourceText\": \"Treatment Period\"}, {\"id\": \"1e9d4493-4628-404f-80bb-d364e25b485b\", \"type\": \"Continuous\", \"sourceText\": \"30 days after\"}, {\"id\": \"56b5784e-e64f-44fc-98ec-c079ccccf9b0\", \"type\": \"Daily\", \"startOffset\": \"P0D\", \"endOffset\": \"P152W\", \"interval\": \"P1D\", \"minObservations\": 1064, \"exitCondition\": \"Completion of 152 weeks or discontinuation due to lack of 20% improvement in TJC/SJC at 2 consecutive visits starting at Week 36\", \"sourceText\": \"15 mg, or 30 mg once daily\"}, {\"id\": \"a214db7e-9633-464f-ad67-a5e20e180fe7\", \"type\": \"Daily\", \"startOffset\": \"P0D\", \"endOffset\": \"P152W\", \"interval\": \"P1D\", \"minObservations\": 1064, \"exitCondition\": \"Completion of treatment duration\", \"sourceText\": \"Matching placebo for upadacitinib (ABT-494) Dose: 1 tablet once daily\"}, {\"id\": \"35b6dd4b-3639-4700-b9c9-916551c45d58\", \"type\": \"Cycle\", \"startOffset\": \"P0W\", \"endOffset\": \"P152W\", \"interval\": \"P1W\", \"minObservations\": 152, \"exitCondition\": \"End of study duration\", \"sourceText\": \"Blood samples for assay of upadacitinib and possibly other medications in plasma will be collected at each visit after baseline in Period 1.\"}, {\"id\": \"eaa47f89-43b1-4222-97ca-261113efc21a\", \"type\": \"Continuous\", \"startOffset\": \"P0D\", \"endOffset\": \"P152W\", \"interval\": \"P1D\", \"minObservations\": 1, \"exitCondition\": \"End of study duration\", \"sourceText\": \"Safety evaluations include adverse event (AE) monitoring, physical examinations, vital sign measurements, electrocardiogram (ECG), and clinical laboratory testing (hematology, chemistry, and urinalysis) as a measure of safety and tolerability for the entire study duration.\"}]"
              },
              {
                "id": "0cafd418-f219-4050-80fa-cac2134fa1db",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-crossoverDesign",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"c08b3aea-f2d7-4739-b55d-5bce4c71916d\", \"isCrossover\": true, \"numPeriods\": 2, \"numSequences\": 2, \"periods\": [\"Period 1\", \"Period 2\"], \"sequences\": [\"AB\", \"BA\"], \"washoutRequired\": false, \"sourceText\": \"Period 1 and Period 2\"}"
              },
              {
                "id": "fe05bcc3-2e57-48b6-be65-9742c423a40a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-entityMappings",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"abstractConcept\": \"PERIOD_2_LONG_TERM_EXTENSION\", \"entityType\": \"epoch\", \"resolvedId\": \"5d02f752-042c-4e7e-b5b5-2e5445b94712\", \"resolvedName\": \"Period 2\", \"confidence\": 1.0, \"reasoning\": \"The concept explicitly refers to 'Period 2', which directly matches the epoch named 'Period 2'. 'Long-term extension' is a descriptor of this period.\"}, {\"abstractConcept\": \"PERIOD_1_RANDOMIZED_CONTROLLED\", \"entityType\": \"epoch\", \"resolvedId\": \"30c00b6e-9e4e-4aa8-8e6a-ca3bdbd5204e\", \"resolvedName\": \"Period 1\", \"confidence\": 1.0, \"reasoning\": \"The concept explicitly refers to 'Period 1', which directly matches the epoch named 'Period 1'. 'Randomized controlled' is a descriptor of this period.\"}, {\"abstractConcept\": \"PERIOD_1_BLINDED_TREATMENT\", \"entityType\": \"epoch\", \"resolvedId\": \"30c00b6e-9e4e-4aa8-8e6a-ca3bdbd5204e\", \"resolvedName\": \"Period 1\", \"confidence\": 1.0, \"reasoning\": \"The concept explicitly refers to 'Period 1', which directly matches the epoch named 'Period 1'. 'Blinded treatment' is a descriptor of this period.\"}]"
              },
              {
                "id": "fdfd51ad-c16d-4593-b222-0baa1fae3c83",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-traversalConstraints",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"93c03d5b-955f-4de9-bcdd-dab3265dc880\", \"requiredSequence\": [\"period_1\", \"period_2\", \"epoch_end_of_study\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [], \"sourceText\": \"Period 1 and Period 2\"}, {\"id\": \"9553e7bb-4a17-4dbf-9159-83adb71f39bf\", \"requiredSequence\": [\"period_1\", \"period_1\", \"period_2\"], \"allowEarlyExit\": true, \"exitEpochIds\": [], \"mandatoryVisits\": [], \"sourceText\": \"[{'condition': 'Subjects assigned to placebo at baseline', 'path': ['PLACEBO_W0_TO_W24', 'UPADACITINIB_W24_TO_W56']}, {'condition': 'Premature discontinuation of study drug', 'path': ['DISCONTINUATION_VISIT', '30_DAY_FOLLOW_UP']}, {'condition': 'State of emergency or pandemic', 'path': ['PHONE_OR_VIDEO_CONFERENCE_VISITS', 'REMOTE_VITAL_SIGNS', 'DELAYED_PHYSICAL_EXAM_OR_CXR']}]\"}]"
              },
              {
                "id": "9b2aaea8-e036-4b02-b428-9d99320931c2",
                "url": "https://protocol2usdm.io/extensions/x-footnoteConditions",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"71e94094-67af-4d37-a057-e4cbe71d1d0a\", \"conditionType\": \"general\", \"text\": \"a. These visits every 12 weeks are at: Wk 68, Wk 80, Wk 92, Wk 104, Wk 116, Wk 128, and Wk 140.\", \"footnoteId\": \"26a81646-5e3d-4850-b4b3-9067b5096253\", \"sourceText\": \"a. These visits every 12 weeks are at: Wk 68, Wk 80, Wk 92, Wk 104, Wk 116, Wk 128, and Wk 140.\"}, {\"id\": \"2675869c-1c1f-4080-bf44-14dda73df22a\", \"conditionType\": \"timing_after\", \"text\": \"b. This on-site visit is 30 days after the last dose of study drug. For those subjects who prematurely discontinue from the study (withdrawal of informed consent) a 30-day follow-up phone call visit (and not an on-site visit) may be allowed...\", \"footnoteId\": \"897bed8f-8ca0-457a-82cf-ebcf5cb12169\", \"sourceText\": \"b. This on-site visit is 30 days after the last dose of study drug. For those subjects who premature\", \"appliesToActivityIds\": [\"31e61afe-c4fa-4d5a-972b-6cac1abaaa31\"]}, {\"id\": \"ffde37c3-29f9-4ec3-82b2-7a242a6e125e\", \"conditionType\": \"timing_before\", \"text\": \"c. Obtain informed consent prior to performing any study related procedures.\", \"footnoteId\": \"30c8a53d-74d7-49e7-8abf-6017836e82bd\", \"sourceText\": \"c. Obtain informed consent prior to performing any study related procedures.\", \"appliesToActivityIds\": [\"31e61afe-c4fa-4d5a-972b-6cac1abaaa31\"]}, {\"id\": \"a2b25929-a6cf-4a03-acfe-34ed58f6b7ae\", \"conditionType\": \"general\", \"text\": \"d. Note herpes zoster, herpes zoster vaccination and hepatitis B vaccination status in medical history.\", \"footnoteId\": \"963ab33d-733f-4875-ad97-afeb77bdc6cd\", \"sourceText\": \"d. Note herpes zoster, herpes zoster vaccination and hepatitis B vaccination status in medical histo\"}, {\"id\": \"a84d8d8b-10d1-4180-9410-96204d574921\", \"conditionType\": \"timing_before\", \"text\": \"e. Blood pressure, pulse rate, body temperature, body weight, and respiratory rate should be performed before blood draws are performed.\", \"footnoteId\": \"950eccd5-ac74-4a75-9a61-76ef32ea5c01\", \"sourceText\": \"e. Blood pressure, pulse rate, body temperature, body weight, and respiratory rate should be perform\"}, {\"id\": \"c0834a5a-53b5-435c-805f-0c05aef889cb\", \"conditionType\": \"general\", \"text\": \"f. Height will be measured at Screening visit only (with shoes off).\", \"footnoteId\": \"00b499c8-af91-4132-b85f-6773607b7b3c\", \"sourceText\": \"f. Height will be measured at Screening visit only (with shoes off).\"}, {\"id\": \"f96ad5c9-3c8d-403c-9e27-48d64166fa4b\", \"conditionType\": \"timing_after\", \"text\": \"g. For concomitant medications, at Week 36 (after Week 36 assessments have been performed), per Investigator judgment, may add non-biologic DMARDs...\", \"footnoteId\": \"76757c03-36d9-48dc-8171-4bd0858ebf27\", \"sourceText\": \"g. For concomitant medications, at Week 36 (after Week 36 assessments have been performed), per Inve\", \"appliesToActivityIds\": [\"98cb2e1e-2c49-44e3-a206-a7bb353f6cfd\"]}, {\"id\": \"8da84c66-499c-4215-847b-05bb6f19a89b\", \"conditionType\": \"timing_before\", \"text\": \"aa. Collect serious AEs and protocol-related nonserious AEs that occur after a subject signs the informed consent; prior to the first dose of study drug.\", \"footnoteId\": \"be85d9db-b2be-40a8-a61d-f37072111f2c\", \"sourceText\": \"aa. Collect serious AEs and protocol-related nonserious AEs that occur after a subject signs the inf\", \"appliesToActivityIds\": [\"31e61afe-c4fa-4d5a-972b-6cac1abaaa31\"]}, {\"id\": \"bd887219-4d64-4825-a49d-798b5fbcc270\", \"conditionType\": \"timing_at\", \"text\": \"bb. At Week 24, all placebo subjects will be randomized to blinded upadacitinib regardless of clinical response.\", \"footnoteId\": \"e26e5da8-6328-4211-9684-f2c9d9c3fa0e\", \"sourceText\": \"bb. At Week 24, all placebo subjects will be randomized to blinded upadacitinib regardless of clinic\", \"appliesToActivityIds\": [\"31e61afe-c4fa-4d5a-972b-6cac1abaaa31\"]}, {\"id\": \"00d58e11-c141-4e44-92b2-d7fd74309390\", \"conditionType\": \"timing_at\", \"text\": \"cc. At Week 16, subjects who do not achieve \\u2265 20% improvement in either or both TJC and SJC compared to baseline at both Weeks 12 and 16 will be offered rescue therapy.\", \"footnoteId\": \"9f0b538b-1008-4a2f-a193-d6b2af712316\", \"sourceText\": \"cc. At Week 16, subjects who do not achieve \\u2265 20% improvement in either or both TJC and SJC compared\", \"appliesToActivityIds\": [\"31e61afe-c4fa-4d5a-972b-6cac1abaaa31\"]}, {\"id\": \"c7181323-1ec2-4607-8257-d6d7ea20571b\", \"conditionType\": \"timing_at\", \"text\": \"dd. Starting at Week 36, subjects who failed to show at least 20% improvement in either or both TJC and SJC compared to baseline at 2 consecutive visits will be discontinued from study drug treatment.\", \"footnoteId\": \"4eeb0a56-1e90-4eab-92a7-2487f1f4074a\", \"sourceText\": \"dd. Starting at Week 36, subjects who failed to show at least 20% improvement in either or both TJC \", \"appliesToActivityIds\": [\"31e61afe-c4fa-4d5a-972b-6cac1abaaa31\"]}, {\"id\": \"0214e244-3d50-4941-95af-f05cb8d5567a\", \"conditionType\": \"general\", \"text\": \"Note: Visit window is \\u00b1 3 days for the first 36 weeks and \\u00b1 7 days for the remainder of the study. Any of the procedures may be performed at an unscheduled visit at the discretion of the Investigator.\", \"footnoteId\": \"bb280455-91aa-47cd-8cc2-1f4926d7408e\", \"sourceText\": \"Note: Visit window is \\u00b1 3 days for the first 36 weeks and \\u00b1 7 days for the remainder of the study. A\", \"appliesToActivityIds\": [\"31e61afe-c4fa-4d5a-972b-6cac1abaaa31\"]}]"
              },
              {
                "id": "4b1efcb9-f926-433c-8b94-64c511a7fe0a",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-endpointAlgorithms",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"0629029a-7b5a-44f1-b6e0-36bc034a639b\", \"name\": \"Primary: ACR20 response at Week 12\", \"endpointType\": \"Primary\", \"inputs\": [\"TJC\", \"SJC\", \"Patient's Assessment of Pain NRS\", \"PtGA of Disease Activity NRS\", \"PGA of Disease Activity NRS\", \"HAQ-DI\", \"hs-CRP\"], \"timeWindow\": {\"reference\": \"Baseline\", \"duration\": \"Week 12\"}, \"algorithm\": \">= 20% improvement in TJC AND >= 20% improvement in SJC AND >= 20% improvement in 3 of the 5 remaining measures (Pain, PtGA, PGA, HAQ-DI, or hs-CRP)\", \"successCriteria\": \"Proportion of subjects achieving ACR20 response\", \"sourceText\": \"The primary efficacy endpoint is the proportion of subjects achieving ACR20 response at Week 12. ACR20/50/70 response rates will be determined based on 20%/50%/70% or greater improvement in TJC and SJ\"}, {\"id\": \"3f0298a2-440e-4dc8-a8f1-9023d8abf21e\", \"name\": \"Secondary: Change from baseline in HAQ-DI at Week 12\", \"endpointType\": \"Secondary\", \"inputs\": [\"HAQ-DI_Baseline\", \"HAQ-DI_Week12\"], \"timeWindow\": {\"reference\": \"Baseline\", \"duration\": \"Week 12\"}, \"algorithm\": \"HAQ-DI_Week12 - HAQ-DI_Baseline\", \"successCriteria\": \"Mean change from baseline\", \"sourceText\": \"Change from baseline in HAQ-DI at Week 12\"}, {\"id\": \"bc35123c-979a-4509-a4b5-6ff2ad2095eb\", \"name\": \"Secondary: sIGA of Psoriasis 0 or 1\", \"endpointType\": \"Secondary\", \"inputs\": [\"sIGA_Baseline\", \"sIGA_Week16\"], \"timeWindow\": {\"reference\": \"Baseline\", \"duration\": \"Week 16\"}, \"algorithm\": \"sIGA_Week16 <= 1 AND (sIGA_Baseline - sIGA_Week16) >= 2\", \"successCriteria\": \"Score of 0 or 1 and at least a 2-point improvement from baseline\", \"sourceText\": \"Static Investigator Global Assessment (sIGA) of Psoriasis of 0 or 1 and at least a 2-point improvement from baseline at Week 16\"}, {\"id\": \"225106cd-8ce4-42bf-a5e9-072aced22568\", \"name\": \"Secondary: PASI 75 response at Week 16\", \"endpointType\": \"Secondary\", \"inputs\": [\"PASI_Baseline\", \"PASI_Week16\", \"BSA_Baseline\"], \"timeWindow\": {\"reference\": \"Baseline\", \"duration\": \"Week 16\"}, \"algorithm\": \"((PASI_Baseline - PASI_Week16) / PASI_Baseline) >= 0.75\", \"successCriteria\": \">= 75% reduction in PASI score for subjects with >= 3% BSA psoriasis at baseline\", \"sourceText\": \"Psoriasis Area Severity Index (PASI) 75 response at Week 16 (for subjects with \\u2265 3% BSA psoriasis at baseline)\"}, {\"id\": \"a211342e-a606-4564-838c-d7882d13fa06\", \"name\": \"Secondary: Minimal Disease Activity (MDA) at Week 24\", \"endpointType\": \"Secondary\", \"inputs\": [\"TJC\", \"SJC\", \"PASI\", \"BSA-Ps\", \"Pain NRS\", \"PtGA-disease activity NRS\", \"HAQ-DI\", \"Tender entheseal points\"], \"timeWindow\": {\"reference\": \"Baseline\", \"duration\": \"Week 24\"}, \"algorithm\": \"Count of (TJC <= 1, SJC <= 1, PASI <= 1 OR BSA-Ps <= 3%, Pain <= 1.5, PtGA <= 2, HAQ-DI <= 0.5, Entheseal points <= 1) >= 5\", \"successCriteria\": \"Fulfilling 5 of 7 outcome measures\", \"sourceText\": \"The proportion of subjects achieving MDA will be determined based on subjects fulfilling 5 of 7 outcome measures: TJC \\u2264 1; SJC \\u2264 1; PASI \\u2264 1 or BSA-Ps \\u2264 3%; patient assessment of pain \\u2264 1.5 (0 \\u2013 10 NR\"}, {\"id\": \"59b4b225-04c6-4559-9c60-5138cbe1d850\", \"name\": \"Secondary: ACR20 response at Week 2\", \"endpointType\": \"Secondary\", \"inputs\": [\"TJC\", \"SJC\", \"Pain NRS\", \"PtGA\", \"PGA\", \"HAQ-DI\", \"hs-CRP\"], \"timeWindow\": {\"reference\": \"Baseline\", \"duration\": \"Week 2\"}, \"algorithm\": \">= 20% improvement in TJC AND >= 20% improvement in SJC AND >= 20% improvement in 3 of the 5 remaining measures\", \"successCriteria\": \"Proportion of subjects achieving ACR20 response\", \"sourceText\": \"ACR20 response at Week 2.\"}, {\"id\": \"a07db70a-4cc6-4b59-93f5-90c669796d69\", \"name\": \"Secondary: Clinically meaningful improvement in HAQ-DI\", \"endpointType\": \"Secondary\", \"inputs\": [\"HAQ-DI_Baseline\", \"HAQ-DI_PostBaseline\"], \"timeWindow\": {\"reference\": \"Baseline\", \"duration\": \"Scheduled time points\"}, \"algorithm\": \"(HAQ-DI_Baseline - HAQ-DI_PostBaseline) >= 0.35\", \"successCriteria\": \"Reduction in HAQ-DI score of 0.35 or greater\", \"sourceText\": \"Proportion of subjects achieving a clinically meaningful improvement in HAQ-DI (\\u2265 0.35).\"}]"
              },
              {
                "id": "4865dd6c-2851-4294-b370-d9d78f3adc49",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-derivedVariables",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"60ca2276-19d3-48d8-a999-3b289fd7d368\", \"name\": \"ACR20 Response\", \"variableType\": \"Composite\", \"sourceVariables\": [\"TJC\", \"SJC\", \"Patient's Assessment of Pain NRS\", \"PtGA of Disease Activity NRS\", \"PGA of Disease Activity NRS\", \"HAQ-DI\", \"hs-CRP\"], \"derivationRule\": \"20% or greater improvement in TJC and SJC AND 20% or greater improvement in at least 3 of the 5 remaining measures (Pain, PtGA, PGA, HAQ-DI, or hs-CRP).\", \"baselineDefinition\": \"Last non-missing value prior to first dose\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Week 12 (Primary), Week 2\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Boolean\"}, {\"id\": \"45889e1a-b958-4747-a1c1-040edbcc9f1e\", \"name\": \"Change from baseline in HAQ-DI\", \"variableType\": \"ChangeFromBaseline\", \"sourceVariables\": [\"HAQ-DI\"], \"derivationRule\": \"post_baseline_value - baseline_value\", \"baselineDefinition\": \"Last non-missing value prior to first dose\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Week 12\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Score\"}, {\"id\": \"2ce8ec26-a6c0-41aa-875d-0cd4e5017262\", \"name\": \"sIGA Response\", \"variableType\": \"Categorical\", \"sourceVariables\": [\"sIGA\"], \"derivationRule\": \"sIGA score of 0 or 1 AND at least a 2-point improvement from baseline\", \"baselineDefinition\": \"Last non-missing value prior to first dose\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Week 16\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Boolean\"}, {\"id\": \"37c0489b-be1b-48bf-b75f-8ebd2f122f00\", \"name\": \"PASI 75 Response\", \"variableType\": \"PercentChange\", \"sourceVariables\": [\"PASI\", \"BSA\"], \"derivationRule\": \"At least 75% reduction from baseline in PASI score; only for subjects with >= 3% BSA psoriasis at baseline\", \"baselineDefinition\": \"Last non-missing value prior to first dose\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Week 16\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Boolean\"}, {\"id\": \"48305b44-b96a-4319-b74d-d453a71b717f\", \"name\": \"Minimal Disease Activity (MDA)\", \"variableType\": \"Composite\", \"sourceVariables\": [\"TJC\", \"SJC\", \"PASI\", \"BSA-Ps\", \"Patient assessment of pain NRS\", \"PtGA-disease activity NRS\", \"HAQ-DI\", \"Tender entheseal points\"], \"derivationRule\": \"Fulfilling 5 of 7 outcome measures: TJC <= 1; SJC <= 1; PASI <= 1 or BSA-Ps <= 3%; Pain <= 1.5; PtGA <= 2; HAQ-DI <= 0.5; Tender entheseal points <= 1\", \"baselineDefinition\": \"Last non-missing value prior to first dose\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Week 24\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Boolean\"}, {\"id\": \"746cbaa6-ff9c-4ee7-abde-d89ff284501c\", \"name\": \"Clinically meaningful improvement in HAQ-DI\", \"variableType\": \"Custom\", \"sourceVariables\": [\"HAQ-DI\"], \"derivationRule\": \"Decrease from baseline in HAQ-DI score >= 0.35\", \"baselineDefinition\": \"Last non-missing value prior to first dose\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Not specified\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Boolean\"}, {\"id\": \"5e03abbd-3c76-4ad5-8730-c3a85ddaf467\", \"name\": \"Morning stiffness\", \"variableType\": \"Composite\", \"sourceVariables\": [\"BASDAI Question 5\", \"BASDAI Question 6\"], \"derivationRule\": \"Mean of BASDAI Questions 5 and 6\", \"baselineDefinition\": \"Last non-missing value prior to first dose\", \"baselineVisit\": \"Baseline\", \"analysisWindow\": \"Not specified\", \"imputationRule\": \"Not specified in text\", \"unit\": \"Score\"}]"
              },
              {
                "id": "db6dd14a-4123-4f30-a63f-c697b4f6f2aa",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-stateMachine",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"9b3d36c1-8fb8-4f19-bac3-730e46277277\", \"initialState\": \"Screening\", \"terminalStates\": [\"Early Termination\", \"Completed\"], \"states\": [\"Screening\", \"Period 1 Randomized Controlled\", \"Period 1 Blinded Treatment\", \"Period 2 Long Term Extension\", \"Follow Up\", \"Early Termination\"], \"transitions\": [{\"fromState\": \"Screening\", \"toState\": \"Period 1 Randomized Controlled\", \"trigger\": \"Progress to Period 1 Randomized Controlled\"}, {\"fromState\": \"Period 1 Randomized Controlled\", \"toState\": \"Period 1 Blinded Treatment\", \"trigger\": \"Progress to Period 1 Blinded Treatment\"}, {\"fromState\": \"Period 1 Blinded Treatment\", \"toState\": \"Period 2 Long Term Extension\", \"trigger\": \"Progress to Period 2 Long Term Extension\"}, {\"fromState\": \"Period 2 Long Term Extension\", \"toState\": \"Follow Up\", \"trigger\": \"Progress to Follow Up\"}, {\"fromState\": \"Period 1 Randomized Controlled\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}, {\"fromState\": \"Period 1 Blinded Treatment\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}, {\"fromState\": \"Period 2 Long Term Extension\", \"toState\": \"Early Termination\", \"trigger\": \"Subject exits to Early Termination\"}], \"epochIds\": {\"Screening\": \"SCREENING\", \"Period 1 Randomized Controlled\": \"PERIOD_1_RANDOMIZED_CONTROLLED\", \"Period 1 Blinded Treatment\": \"PERIOD_1_BLINDED_TREATMENT\", \"Period 2 Long Term Extension\": \"PERIOD_2_LONG_TERM_EXTENSION\", \"Follow Up\": \"FOLLOW_UP\", \"Early Termination\": \"EARLY_TERMINATION\"}}"
              },
              {
                "id": "3532ad4a-ed62-4c40-9bc1-05b15252aa14",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-dosingRegimens",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"4e2bdf3e-8b5c-4010-b265-439d000eee5d\", \"treatmentName\": \"Upadacitinib\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"doseLevels\": [{\"amount\": 15.0, \"unit\": \"mg\", \"description\": \"Optimal dose for patients with active psoriatic arthritis and proposed dose for marketing authorization.\"}, {\"amount\": 30.0, \"unit\": \"mg\", \"description\": \"Previous dose in Period 2; subjects switched to 15 mg QD upon approval of Amendment 8.\"}], \"durationDescription\": \"Not specified in provided text\", \"doseModifications\": [\"Subjects currently on upadacitinib 30 mg QD are switched to upadacitinib 15 mg QD in Period 2 upon approval of protocol amendment 8.\", \"Guidelines for interruption of study drug in subjects with signs/symptoms or suspicion of COVID-19 infection.\", \"Specific Toxicity Management Guidelines for Abnormal Laboratory Values (e.g., AST/ALT > 8 x ULN).\"]}, {\"id\": \"0cc24c67-6ad1-4e93-83eb-05f5e7753c18\", \"treatmentName\": \"Placebo\", \"frequency\": \"QD\", \"route\": \"Oral\", \"startDay\": 1, \"durationDescription\": \"Not specified in provided text\"}]"
              },
              {
                "id": "8ed1ae12-8178-4446-aed5-d8b32db758a7",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-visitWindows",
                "instanceType": "ExtensionAttribute",
                "valueString": "[{\"id\": \"c3c5fd33-c265-480d-a7d4-13d8b22a125d\", \"visitName\": \"screening\", \"targetDay\": -14, \"windowBefore\": 7, \"windowAfter\": 34, \"isRequired\": true, \"visitNumber\": 1, \"epoch\": \"Screening\", \"sourceText\": \"The study duration will include a 35-day screening period; a 56-week blinded period which includes 24 weeks of double-blind, placebo-controlled treatment followed by 32 weeks of treatment blinded to t\"}, {\"id\": \"9cfbf37d-705c-4c65-97cb-17d2b3ad3942\", \"visitName\": \"Early Termination\", \"targetDay\": null, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 2, \"sourceText\": \"To compare the safety and tolerability of upadacitinib 15 mg QD and 30 mg QD versus placebo in subjects with moderately to severely active PsA who have an inadequate response to bDMARDs. Period 2\"}, {\"id\": \"25f42103-dcfa-4efa-958c-fe4f5e02e1cc\", \"visitName\": \"baseline\", \"targetDay\": 0, \"windowBefore\": 1, \"windowAfter\": 1, \"isRequired\": true, \"visitNumber\": 3, \"sourceText\": \"Subjects who were assigned to placebo at baseline will be preassigned to receiving either upadacitinib 15 mg QD or upadacitinib 30 mg QD starting at Week 24 in a 1:1 ratio. Subjects who complete the W\"}, {\"id\": \"6b696df7-5d14-4093-982d-80a391e8b0b7\", \"visitName\": \"Period 2 Extension\", \"targetDay\": null, \"windowBefore\": null, \"windowAfter\": null, \"isRequired\": true, \"visitNumber\": 8, \"epoch\": \"Period 2\"}, {\"id\": \"47b562a9-6ba4-4f51-aec1-6e4b0f15341d\", \"visitName\": \"randomization\", \"targetDay\": 1, \"windowBefore\": 0, \"windowAfter\": 0, \"isRequired\": true, \"visitNumber\": 5, \"epoch\": \"Period 1\", \"sourceText\": \"response to) biologic DMARDs (1 vs > 1), except for subjects from Japan, for which randomization will be stratified by extent of psoriasis (\\u2265 3% body surface area [BSA] or < 3% BSA) only, and then wil\"}, {\"id\": \"c0092cda-f95e-458b-a46e-c077ae0e0d67\", \"visitName\": \"Week 2\", \"targetDay\": 8, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 6, \"targetWeek\": 2, \"sourceText\": \"ACR20 response at Week 2. ACR20/50/70 response rates will be determined based on 20%/50%/70% or greater improvement in TJC and SJC and \\u2265 3 of the 5 measures of Patient's Assessment of Pain NRS, PtGA o\"}, {\"id\": \"ef5ff239-26e4-4123-adc0-d32254a17f0a\", \"visitName\": \"Week 12\", \"targetDay\": 78, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 7, \"targetWeek\": 12, \"epoch\": \"Period 1\", \"sourceText\": \"in either or both tender joint count (TJC) and swollen joint count (SJC) at both Week 12 and Week 16) will add or modify background therapy for PsA. At Week 24, all subjects allocated to placebo at Ba\"}, {\"id\": \"fab4b97e-c63f-4360-9c9e-8e7c54135a36\", \"visitName\": \"Week 16\", \"targetDay\": 106, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 8, \"targetWeek\": 16, \"epoch\": \"Period 1\", \"sourceText\": \"At Week 16, subjects classified as non-responders (defined as not achieving at least 20% improvement in either or both tender joint count (TJC) and swollen joint count (SJC) at both Week 12 and Week 1\"}, {\"id\": \"425b3521-36e2-438a-a0ca-9ded1cfb18b2\", \"visitName\": \"Week 24\", \"targetDay\": 162, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 9, \"targetWeek\": 24, \"epoch\": \"Period 1\", \"sourceText\": \"15 mg QD or upadacitinib 30 mg QD starting at Week 24 in a 1:1 ratio. Subjects who complete the Week 56 visit (end of Period 1) will enter the long-term extension portion of the study, Period 2 (total\"}, {\"id\": \"3dd530b0-7002-4e9d-b322-8a02daaeb081\", \"visitName\": \"Week 36\", \"targetDay\": 246, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 10, \"targetWeek\": 36, \"epoch\": \"Period 1\", \"sourceText\": \"of study drug and remain at stable dose through Week 36 of the study; the non-biologic DMARD dose may be decreased only for safety reasons. In addition, all subjects taking MTX should take a dietary s\"}, {\"id\": \"43ba3a09-b617-4d17-9854-e43c1e85b47e\", \"visitName\": \"Follow-up\", \"targetDay\": 365, \"windowBefore\": 7, \"windowAfter\": 7, \"isRequired\": true, \"visitNumber\": 11, \"epoch\": \"Follow-up\", \"sourceText\": \"30-day follow-up call or visit.\"}, {\"id\": \"c1b9f9ef-006f-4c37-9e43-c5e83b2705df\", \"visitName\": \"Week 56\", \"targetDay\": 386, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 12, \"targetWeek\": 56, \"epoch\": \"Period 1\", \"sourceText\": \"Week 56 visit (end of Period 1) will enter the long-term extension portion of the study, Period 2 (total study duration up to approximately 3 years). Subjects will continue study treatment as assigned\"}, {\"id\": \"27faa9e9-d0ef-4e9d-a4b8-e334008504a6\", \"visitName\": \"Week 152\", \"targetDay\": 1058, \"windowBefore\": 3, \"windowAfter\": 3, \"isRequired\": true, \"visitNumber\": 13, \"targetWeek\": 152, \"sourceText\": \"The last dose of oral study drug is taken the day prior to the Week 152 visit. Upon approval of protocol amendment 8, subjects receiving upadacitinib 30 mg QD will be switched to upadacitinib 15 mg QD\"}]"
              },
              {
                "id": "72f3a26a-c78e-4024-9e57-5fd3f6de71d6",
                "url": "https://protocol2usdm.io/extensions/x-executionModel-randomizationScheme",
                "instanceType": "ExtensionAttribute",
                "valueString": "{\"id\": \"d3fc430f-4ef5-4756-b7b3-2822688f03af\", \"ratio\": \"2:2:1:1\", \"method\": \"Stratified randomization\", \"centralRandomization\": true, \"stratificationFactors\": [{\"id\": \"d32f203c-8129-46b4-a983-3a3b290f768e\", \"name\": \"Extent of psoriasis (Global)\", \"categories\": [\"\\u2265 3% body surface area [BSA]\", \"< 3% BSA\"], \"isBlocking\": false}, {\"id\": \"31580e95-58ce-4676-8cb7-772a7f0fcfa9\", \"name\": \"Current use of DMARDs (Global)\", \"categories\": [\"At least 1 DMARD\", \"No DMARD\"], \"isBlocking\": false}, {\"id\": \"b4294613-a63f-40a5-85e1-0c36448e6631\", \"name\": \"Number of prior failed biologic DMARDs (Global)\", \"categories\": [\"1\", \"> 1\"], \"isBlocking\": false}, {\"id\": \"b154d1ce-809f-493b-bd23-d9eb250cccc1\", \"name\": \"Extent of psoriasis (Japan only)\", \"categories\": [\"\\u2265 3% body surface area [BSA]\", \"< 3% BSA\"], \"isBlocking\": false}], \"sourceText\": \"Upadacitinib\\nM15-554 Protocol Amendment 8\\nEudraCT 2016-004152-30\\n9\\nMethodology (Continued):\\nSubjects who meet eligibility criteria will be stratified by extent of psoriasis (\\u2265 3% body surface area \\n[B\"}"
              },
              {
                "id": "ext_execution_model_929ab8bc-cbfd-492c-b4c7-c3e16c73c48c",
                "url": "https://protocol2usdm.io/extensions/x-executionModel",
                "instanceType": "ExtensionAttribute",
                "valueObject": {
                  "schemaVersion": "1.0.0",
                  "extractionTimestamp": "2026-01-23T03:00:34.674340",
                  "executionModel": {
                    "timeAnchors": [
                      {
                        "id": "f79f542c-941c-4488-b056-0c3529b5a518",
                        "definition": "First administration of investigational product",
                        "anchorType": "FirstDose",
                        "classification": "Event",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 60,
                        "sourceText": "first dose of study drug",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "8bb6eab4-2f3b-44d6-9db0-8b04a246a70d",
                        "definition": "Baseline visit/assessment",
                        "anchorType": "Baseline",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 50,
                        "sourceText": "baseline visit",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "939f5954-c76e-48e5-b427-88a04973c27b",
                        "definition": "Screening visit",
                        "anchorType": "Screening",
                        "classification": "Visit",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 20,
                        "sourceText": "Screening visit",
                        "encounterId": null,
                        "activityId": null
                      },
                      {
                        "id": "05fdcf99-8738-43a7-bdbd-5852238ed3c4",
                        "definition": "symptom onset",
                        "anchorType": "Custom",
                        "classification": "Conceptual",
                        "timelineId": null,
                        "dayValue": 1,
                        "intraDayOrder": 100,
                        "sourceText": "symptom onset",
                        "encounterId": null,
                        "activityId": null
                      }
                    ],
                    "repetitions": [
                      {
                        "id": "8158af0d-a6d7-4548-82b8-a234aee6aa8f",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "once daily"
                      },
                      {
                        "id": "9d8acf5e-8821-425a-954b-a59555ebaa22",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "Once Daily"
                      },
                      {
                        "id": "24e9b92e-45b1-432c-bc69-e6c2f4840ccb",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "QD"
                      },
                      {
                        "id": "beb7b415-7fd9-4fc2-83a8-20b7245dff86",
                        "type": "Daily",
                        "interval": "P1D",
                        "sourceText": "od"
                      },
                      {
                        "id": "a674a216-3cee-447f-8d6d-0c6642753d33",
                        "type": "Interval",
                        "sourceText": "BID"
                      },
                      {
                        "id": "8c281a2d-4649-4d4e-8d9a-9e3eb5e6ab91",
                        "type": "Continuous",
                        "sourceText": "Treatment Period"
                      },
                      {
                        "id": "1e9d4493-4628-404f-80bb-d364e25b485b",
                        "type": "Continuous",
                        "sourceText": "30 days after"
                      },
                      {
                        "id": "56b5784e-e64f-44fc-98ec-c079ccccf9b0",
                        "type": "Daily",
                        "startOffset": "P0D",
                        "endOffset": "P152W",
                        "interval": "P1D",
                        "minObservations": 1064,
                        "exitCondition": "Completion of 152 weeks or discontinuation due to lack of 20% improvement in TJC/SJC at 2 consecutive visits starting at Week 36",
                        "sourceText": "15 mg, or 30 mg once daily"
                      },
                      {
                        "id": "a214db7e-9633-464f-ad67-a5e20e180fe7",
                        "type": "Daily",
                        "startOffset": "P0D",
                        "endOffset": "P152W",
                        "interval": "P1D",
                        "minObservations": 1064,
                        "exitCondition": "Completion of treatment duration",
                        "sourceText": "Matching placebo for upadacitinib (ABT-494) Dose: 1 tablet once daily"
                      },
                      {
                        "id": "35b6dd4b-3639-4700-b9c9-916551c45d58",
                        "type": "Cycle",
                        "startOffset": "P0W",
                        "endOffset": "P152W",
                        "interval": "P1W",
                        "minObservations": 152,
                        "exitCondition": "End of study duration",
                        "sourceText": "Blood samples for assay of upadacitinib and possibly other medications in plasma will be collected at each visit after baseline in Period 1."
                      },
                      {
                        "id": "eaa47f89-43b1-4222-97ca-261113efc21a",
                        "type": "Continuous",
                        "startOffset": "P0D",
                        "endOffset": "P152W",
                        "interval": "P1D",
                        "minObservations": 1,
                        "exitCondition": "End of study duration",
                        "sourceText": "Safety evaluations include adverse event (AE) monitoring, physical examinations, vital sign measurements, electrocardiogram (ECG), and clinical laboratory testing (hematology, chemistry, and urinalysis) as a measure of safety and tolerability for the entire study duration."
                      }
                    ],
                    "samplingConstraints": [],
                    "traversalConstraints": [
                      {
                        "id": "93c03d5b-955f-4de9-bcdd-dab3265dc880",
                        "requiredSequence": [
                          "SCREENING",
                          "PERIOD_1",
                          "PERIOD_2",
                          "END_OF_STUDY"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "3e0c9217-1a7b-4578-986a-0920aad6f0c5"
                        ],
                        "mandatoryVisits": [
                          "Screening",
                          "Day 1",
                          "End of Study"
                        ],
                        "sourceText": "Period 1 and Period 2"
                      },
                      {
                        "id": "9553e7bb-4a17-4dbf-9159-83adb71f39bf",
                        "requiredSequence": [
                          "SCREENING",
                          "PERIOD_1_RANDOMIZED_CONTROLLED",
                          "PERIOD_1_BLINDED_TREATMENT",
                          "PERIOD_2_LONG_TERM_EXTENSION",
                          "FOLLOW_UP"
                        ],
                        "allowEarlyExit": true,
                        "exitEpochIds": [
                          "3e0c9217-1a7b-4578-986a-0920aad6f0c5"
                        ],
                        "mandatoryVisits": [
                          "End of Study",
                          "Week 56",
                          "Safety Follow-up",
                          "Day 1",
                          "Screening",
                          "Week 24",
                          "Baseline"
                        ],
                        "sourceText": "[{'condition': 'Subjects assigned to placebo at baseline', 'path': ['PLACEBO_W0_TO_W24', 'UPADACITINIB_W24_TO_W56']}, {'condition': 'Premature discontinuation of study drug', 'path': ['DISCONTINUATION_VISIT', '30_DAY_FOLLOW_UP']}, {'condition': 'State of emergency or pandemic', 'path': ['PHONE_OR_VIDEO_CONFERENCE_VISITS', 'REMOTE_VITAL_SIGNS', 'DELAYED_PHYSICAL_EXAM_OR_CXR']}]"
                      }
                    ],
                    "executionTypes": [
                      {
                        "activityId": "Blood Sample",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 5; RECURRING signals: 2"
                      },
                      {
                        "activityId": "Vital Signs",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 14"
                      },
                      {
                        "activityId": "Electrocardiogram",
                        "executionType": "Episode",
                        "rationale": "EPISODE signals: 1; SINGLE signals: 1"
                      },
                      {
                        "activityId": "Pe",
                        "executionType": "Single",
                        "rationale": "No strong signals detected"
                      },
                      {
                        "activityId": "Adverse Event",
                        "executionType": "Episode",
                        "rationale": "EPISODE signals: 1"
                      },
                      {
                        "activityId": "Laboratory Tests",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Pharmacokinetic",
                        "executionType": "Recurring",
                        "rationale": "SINGLE signals: 1; RECURRING signals: 2"
                      },
                      {
                        "activityId": "Pharmacodynamic",
                        "executionType": "Recurring",
                        "rationale": "RECURRING signals: 2"
                      },
                      {
                        "activityId": "Dosing",
                        "executionType": "Single",
                        "rationale": "EPISODE signals: 1; SINGLE signals: 5"
                      },
                      {
                        "activityId": "bcaf82be-0931-4283-86e4-ccbf66cbfe19",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 9"
                      },
                      {
                        "activityId": "Questionnaire",
                        "executionType": "Single",
                        "rationale": "SINGLE signals: 2"
                      },
                      {
                        "activityId": "Upadacitinib 30 mg to 15 mg Dose Switch",
                        "executionType": "Single",
                        "rationale": "Conditional workflow requiring subjects currently on 30 mg to switch to 15 mg at their next scheduled visit upon approval of the amendment."
                      },
                      {
                        "activityId": "Discontinuation Visit",
                        "executionType": "Single",
                        "rationale": "A one-time assessment to be completed preferably prior to initiation of another therapy upon study withdrawal."
                      },
                      {
                        "activityId": "Vital Signs and Weight",
                        "executionType": "Single",
                        "rationale": "Scheduled assessments performed at study visits, with flexibility for phone/video or caregiver performance during emergencies."
                      },
                      {
                        "activityId": "34afe5c5-024c-415c-bf05-d19a76c472ec",
                        "executionType": "Single",
                        "rationale": "Scheduled assessments to be performed at specific visits, with instructions to defer to the next feasible visit if interrupted."
                      },
                      {
                        "activityId": "Annual TB Testing/TB Prophylaxis",
                        "executionType": "Single",
                        "rationale": "Assessments performed on an annual basis throughout the study duration."
                      },
                      {
                        "activityId": "01c5ac15-6487-4213-8962-a493db25eee0",
                        "executionType": "Single",
                        "rationale": "Conditional workflow triggered only if a subject has seroconversion on an annual TB test without risk factors."
                      },
                      {
                        "activityId": "Clinical Laboratory Tests",
                        "executionType": "Single",
                        "rationale": "Standard scheduled monitoring, with provision for local lab use during state of emergency/pandemic."
                      }
                    ],
                    "crossoverDesign": {
                      "id": "c08b3aea-f2d7-4739-b55d-5bce4c71916d",
                      "isCrossover": true,
                      "numPeriods": 2,
                      "numSequences": 2,
                      "periods": [
                        "Period 1",
                        "Period 2"
                      ],
                      "sequences": [
                        "AB",
                        "BA"
                      ],
                      "washoutRequired": false,
                      "sourceText": "Period 1 and Period 2"
                    },
                    "footnoteConditions": [
                      {
                        "id": "71e94094-67af-4d37-a057-e4cbe71d1d0a",
                        "conditionType": "general",
                        "text": "a. These visits every 12 weeks are at: Wk 68, Wk 80, Wk 92, Wk 104, Wk 116, Wk 128, and Wk 140.",
                        "footnoteId": "26a81646-5e3d-4850-b4b3-9067b5096253",
                        "sourceText": "a. These visits every 12 weeks are at: Wk 68, Wk 80, Wk 92, Wk 104, Wk 116, Wk 128, and Wk 140."
                      },
                      {
                        "id": "2675869c-1c1f-4080-bf44-14dda73df22a",
                        "conditionType": "timing_after",
                        "text": "b. This on-site visit is 30 days after the last dose of study drug. For those subjects who prematurely discontinue from the study (withdrawal of informed consent) a 30-day follow-up phone call visit (and not an on-site visit) may be allowed...",
                        "footnoteId": "897bed8f-8ca0-457a-82cf-ebcf5cb12169",
                        "sourceText": "b. This on-site visit is 30 days after the last dose of study drug. For those subjects who premature"
                      },
                      {
                        "id": "ffde37c3-29f9-4ec3-82b2-7a242a6e125e",
                        "conditionType": "timing_before",
                        "text": "c. Obtain informed consent prior to performing any study related procedures.",
                        "footnoteId": "30c8a53d-74d7-49e7-8abf-6017836e82bd",
                        "sourceText": "c. Obtain informed consent prior to performing any study related procedures."
                      },
                      {
                        "id": "a2b25929-a6cf-4a03-acfe-34ed58f6b7ae",
                        "conditionType": "general",
                        "text": "d. Note herpes zoster, herpes zoster vaccination and hepatitis B vaccination status in medical history.",
                        "footnoteId": "963ab33d-733f-4875-ad97-afeb77bdc6cd",
                        "sourceText": "d. Note herpes zoster, herpes zoster vaccination and hepatitis B vaccination status in medical histo"
                      },
                      {
                        "id": "a84d8d8b-10d1-4180-9410-96204d574921",
                        "conditionType": "timing_before",
                        "text": "e. Blood pressure, pulse rate, body temperature, body weight, and respiratory rate should be performed before blood draws are performed.",
                        "footnoteId": "950eccd5-ac74-4a75-9a61-76ef32ea5c01",
                        "sourceText": "e. Blood pressure, pulse rate, body temperature, body weight, and respiratory rate should be perform"
                      },
                      {
                        "id": "c0834a5a-53b5-435c-805f-0c05aef889cb",
                        "conditionType": "general",
                        "text": "f. Height will be measured at Screening visit only (with shoes off).",
                        "footnoteId": "00b499c8-af91-4132-b85f-6773607b7b3c",
                        "sourceText": "f. Height will be measured at Screening visit only (with shoes off)."
                      },
                      {
                        "id": "f96ad5c9-3c8d-403c-9e27-48d64166fa4b",
                        "conditionType": "timing_after",
                        "text": "g. For concomitant medications, at Week 36 (after Week 36 assessments have been performed), per Investigator judgment, may add non-biologic DMARDs...",
                        "footnoteId": "76757c03-36d9-48dc-8171-4bd0858ebf27",
                        "sourceText": "g. For concomitant medications, at Week 36 (after Week 36 assessments have been performed), per Inve"
                      },
                      {
                        "id": "8da84c66-499c-4215-847b-05bb6f19a89b",
                        "conditionType": "timing_before",
                        "text": "aa. Collect serious AEs and protocol-related nonserious AEs that occur after a subject signs the informed consent; prior to the first dose of study drug.",
                        "footnoteId": "be85d9db-b2be-40a8-a61d-f37072111f2c",
                        "sourceText": "aa. Collect serious AEs and protocol-related nonserious AEs that occur after a subject signs the inf"
                      },
                      {
                        "id": "bd887219-4d64-4825-a49d-798b5fbcc270",
                        "conditionType": "timing_at",
                        "text": "bb. At Week 24, all placebo subjects will be randomized to blinded upadacitinib regardless of clinical response.",
                        "footnoteId": "e26e5da8-6328-4211-9684-f2c9d9c3fa0e",
                        "sourceText": "bb. At Week 24, all placebo subjects will be randomized to blinded upadacitinib regardless of clinic"
                      },
                      {
                        "id": "00d58e11-c141-4e44-92b2-d7fd74309390",
                        "conditionType": "timing_at",
                        "text": "cc. At Week 16, subjects who do not achieve  20% improvement in either or both TJC and SJC compared to baseline at both Weeks 12 and 16 will be offered rescue therapy.",
                        "footnoteId": "9f0b538b-1008-4a2f-a193-d6b2af712316",
                        "sourceText": "cc. At Week 16, subjects who do not achieve  20% improvement in either or both TJC and SJC compared"
                      },
                      {
                        "id": "c7181323-1ec2-4607-8257-d6d7ea20571b",
                        "conditionType": "timing_at",
                        "text": "dd. Starting at Week 36, subjects who failed to show at least 20% improvement in either or both TJC and SJC compared to baseline at 2 consecutive visits will be discontinued from study drug treatment.",
                        "footnoteId": "4eeb0a56-1e90-4eab-92a7-2487f1f4074a",
                        "sourceText": "dd. Starting at Week 36, subjects who failed to show at least 20% improvement in either or both TJC "
                      },
                      {
                        "id": "0214e244-3d50-4941-95af-f05cb8d5567a",
                        "conditionType": "general",
                        "text": "Note: Visit window is  3 days for the first 36 weeks and  7 days for the remainder of the study. Any of the procedures may be performed at an unscheduled visit at the discretion of the Investigator.",
                        "footnoteId": "bb280455-91aa-47cd-8cc2-1f4926d7408e",
                        "sourceText": "Note: Visit window is  3 days for the first 36 weeks and  7 days for the remainder of the study. A"
                      }
                    ],
                    "endpointAlgorithms": [
                      {
                        "id": "0629029a-7b5a-44f1-b6e0-36bc034a639b",
                        "name": "Primary: ACR20 response at Week 12",
                        "endpointType": "Primary",
                        "inputs": [
                          "TJC",
                          "SJC",
                          "Patient's Assessment of Pain NRS",
                          "PtGA of Disease Activity NRS",
                          "PGA of Disease Activity NRS",
                          "HAQ-DI",
                          "hs-CRP"
                        ],
                        "timeWindow": {
                          "reference": "Baseline",
                          "duration": "Week 12"
                        },
                        "algorithm": ">= 20% improvement in TJC AND >= 20% improvement in SJC AND >= 20% improvement in 3 of the 5 remaining measures (Pain, PtGA, PGA, HAQ-DI, or hs-CRP)",
                        "successCriteria": "Proportion of subjects achieving ACR20 response",
                        "sourceText": "The primary efficacy endpoint is the proportion of subjects achieving ACR20 response at Week 12. ACR20/50/70 response rates will be determined based on 20%/50%/70% or greater improvement in TJC and SJ"
                      },
                      {
                        "id": "3f0298a2-440e-4dc8-a8f1-9023d8abf21e",
                        "name": "Secondary: Change from baseline in HAQ-DI at Week 12",
                        "endpointType": "Secondary",
                        "inputs": [
                          "HAQ-DI_Baseline",
                          "HAQ-DI_Week12"
                        ],
                        "timeWindow": {
                          "reference": "Baseline",
                          "duration": "Week 12"
                        },
                        "algorithm": "HAQ-DI_Week12 - HAQ-DI_Baseline",
                        "successCriteria": "Mean change from baseline",
                        "sourceText": "Change from baseline in HAQ-DI at Week 12"
                      },
                      {
                        "id": "bc35123c-979a-4509-a4b5-6ff2ad2095eb",
                        "name": "Secondary: sIGA of Psoriasis 0 or 1",
                        "endpointType": "Secondary",
                        "inputs": [
                          "sIGA_Baseline",
                          "sIGA_Week16"
                        ],
                        "timeWindow": {
                          "reference": "Baseline",
                          "duration": "Week 16"
                        },
                        "algorithm": "sIGA_Week16 <= 1 AND (sIGA_Baseline - sIGA_Week16) >= 2",
                        "successCriteria": "Score of 0 or 1 and at least a 2-point improvement from baseline",
                        "sourceText": "Static Investigator Global Assessment (sIGA) of Psoriasis of 0 or 1 and at least a 2-point improvement from baseline at Week 16"
                      },
                      {
                        "id": "225106cd-8ce4-42bf-a5e9-072aced22568",
                        "name": "Secondary: PASI 75 response at Week 16",
                        "endpointType": "Secondary",
                        "inputs": [
                          "PASI_Baseline",
                          "PASI_Week16",
                          "BSA_Baseline"
                        ],
                        "timeWindow": {
                          "reference": "Baseline",
                          "duration": "Week 16"
                        },
                        "algorithm": "((PASI_Baseline - PASI_Week16) / PASI_Baseline) >= 0.75",
                        "successCriteria": ">= 75% reduction in PASI score for subjects with >= 3% BSA psoriasis at baseline",
                        "sourceText": "Psoriasis Area Severity Index (PASI) 75 response at Week 16 (for subjects with  3% BSA psoriasis at baseline)"
                      },
                      {
                        "id": "a211342e-a606-4564-838c-d7882d13fa06",
                        "name": "Secondary: Minimal Disease Activity (MDA) at Week 24",
                        "endpointType": "Secondary",
                        "inputs": [
                          "TJC",
                          "SJC",
                          "PASI",
                          "BSA-Ps",
                          "Pain NRS",
                          "PtGA-disease activity NRS",
                          "HAQ-DI",
                          "Tender entheseal points"
                        ],
                        "timeWindow": {
                          "reference": "Baseline",
                          "duration": "Week 24"
                        },
                        "algorithm": "Count of (TJC <= 1, SJC <= 1, PASI <= 1 OR BSA-Ps <= 3%, Pain <= 1.5, PtGA <= 2, HAQ-DI <= 0.5, Entheseal points <= 1) >= 5",
                        "successCriteria": "Fulfilling 5 of 7 outcome measures",
                        "sourceText": "The proportion of subjects achieving MDA will be determined based on subjects fulfilling 5 of 7 outcome measures: TJC  1; SJC  1; PASI  1 or BSA-Ps  3%; patient assessment of pain  1.5 (0  10 NR"
                      },
                      {
                        "id": "59b4b225-04c6-4559-9c60-5138cbe1d850",
                        "name": "Secondary: ACR20 response at Week 2",
                        "endpointType": "Secondary",
                        "inputs": [
                          "TJC",
                          "SJC",
                          "Pain NRS",
                          "PtGA",
                          "PGA",
                          "HAQ-DI",
                          "hs-CRP"
                        ],
                        "timeWindow": {
                          "reference": "Baseline",
                          "duration": "Week 2"
                        },
                        "algorithm": ">= 20% improvement in TJC AND >= 20% improvement in SJC AND >= 20% improvement in 3 of the 5 remaining measures",
                        "successCriteria": "Proportion of subjects achieving ACR20 response",
                        "sourceText": "ACR20 response at Week 2."
                      },
                      {
                        "id": "a07db70a-4cc6-4b59-93f5-90c669796d69",
                        "name": "Secondary: Clinically meaningful improvement in HAQ-DI",
                        "endpointType": "Secondary",
                        "inputs": [
                          "HAQ-DI_Baseline",
                          "HAQ-DI_PostBaseline"
                        ],
                        "timeWindow": {
                          "reference": "Baseline",
                          "duration": "Scheduled time points"
                        },
                        "algorithm": "(HAQ-DI_Baseline - HAQ-DI_PostBaseline) >= 0.35",
                        "successCriteria": "Reduction in HAQ-DI score of 0.35 or greater",
                        "sourceText": "Proportion of subjects achieving a clinically meaningful improvement in HAQ-DI ( 0.35)."
                      }
                    ],
                    "derivedVariables": [
                      {
                        "id": "60ca2276-19d3-48d8-a999-3b289fd7d368",
                        "name": "ACR20 Response",
                        "variableType": "Composite",
                        "sourceVariables": [
                          "TJC",
                          "SJC",
                          "Patient's Assessment of Pain NRS",
                          "PtGA of Disease Activity NRS",
                          "PGA of Disease Activity NRS",
                          "HAQ-DI",
                          "hs-CRP"
                        ],
                        "derivationRule": "20% or greater improvement in TJC and SJC AND 20% or greater improvement in at least 3 of the 5 remaining measures (Pain, PtGA, PGA, HAQ-DI, or hs-CRP).",
                        "baselineDefinition": "Last non-missing value prior to first dose",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Week 12 (Primary), Week 2",
                        "imputationRule": "Not specified in text",
                        "unit": "Boolean"
                      },
                      {
                        "id": "45889e1a-b958-4747-a1c1-040edbcc9f1e",
                        "name": "Change from baseline in HAQ-DI",
                        "variableType": "ChangeFromBaseline",
                        "sourceVariables": [
                          "HAQ-DI"
                        ],
                        "derivationRule": "post_baseline_value - baseline_value",
                        "baselineDefinition": "Last non-missing value prior to first dose",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Week 12",
                        "imputationRule": "Not specified in text",
                        "unit": "Score"
                      },
                      {
                        "id": "2ce8ec26-a6c0-41aa-875d-0cd4e5017262",
                        "name": "sIGA Response",
                        "variableType": "Categorical",
                        "sourceVariables": [
                          "sIGA"
                        ],
                        "derivationRule": "sIGA score of 0 or 1 AND at least a 2-point improvement from baseline",
                        "baselineDefinition": "Last non-missing value prior to first dose",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Week 16",
                        "imputationRule": "Not specified in text",
                        "unit": "Boolean"
                      },
                      {
                        "id": "37c0489b-be1b-48bf-b75f-8ebd2f122f00",
                        "name": "PASI 75 Response",
                        "variableType": "PercentChange",
                        "sourceVariables": [
                          "PASI",
                          "BSA"
                        ],
                        "derivationRule": "At least 75% reduction from baseline in PASI score; only for subjects with >= 3% BSA psoriasis at baseline",
                        "baselineDefinition": "Last non-missing value prior to first dose",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Week 16",
                        "imputationRule": "Not specified in text",
                        "unit": "Boolean"
                      },
                      {
                        "id": "48305b44-b96a-4319-b74d-d453a71b717f",
                        "name": "Minimal Disease Activity (MDA)",
                        "variableType": "Composite",
                        "sourceVariables": [
                          "TJC",
                          "SJC",
                          "PASI",
                          "BSA-Ps",
                          "Patient assessment of pain NRS",
                          "PtGA-disease activity NRS",
                          "HAQ-DI",
                          "Tender entheseal points"
                        ],
                        "derivationRule": "Fulfilling 5 of 7 outcome measures: TJC <= 1; SJC <= 1; PASI <= 1 or BSA-Ps <= 3%; Pain <= 1.5; PtGA <= 2; HAQ-DI <= 0.5; Tender entheseal points <= 1",
                        "baselineDefinition": "Last non-missing value prior to first dose",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Week 24",
                        "imputationRule": "Not specified in text",
                        "unit": "Boolean"
                      },
                      {
                        "id": "746cbaa6-ff9c-4ee7-abde-d89ff284501c",
                        "name": "Clinically meaningful improvement in HAQ-DI",
                        "variableType": "Custom",
                        "sourceVariables": [
                          "HAQ-DI"
                        ],
                        "derivationRule": "Decrease from baseline in HAQ-DI score >= 0.35",
                        "baselineDefinition": "Last non-missing value prior to first dose",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Not specified",
                        "imputationRule": "Not specified in text",
                        "unit": "Boolean"
                      },
                      {
                        "id": "5e03abbd-3c76-4ad5-8730-c3a85ddaf467",
                        "name": "Morning stiffness",
                        "variableType": "Composite",
                        "sourceVariables": [
                          "BASDAI Question 5",
                          "BASDAI Question 6"
                        ],
                        "derivationRule": "Mean of BASDAI Questions 5 and 6",
                        "baselineDefinition": "Last non-missing value prior to first dose",
                        "baselineVisit": "Baseline",
                        "analysisWindow": "Not specified",
                        "imputationRule": "Not specified in text",
                        "unit": "Score"
                      }
                    ],
                    "stateMachine": {
                      "id": "9b3d36c1-8fb8-4f19-bac3-730e46277277",
                      "initialState": "Screening",
                      "terminalStates": [
                        "Early Termination",
                        "Completed"
                      ],
                      "states": [
                        "Screening",
                        "Period 1 Randomized Controlled",
                        "Period 1 Blinded Treatment",
                        "Period 2 Long Term Extension",
                        "Follow Up",
                        "Early Termination"
                      ],
                      "transitions": [
                        {
                          "fromState": "Screening",
                          "toState": "Period 1 Randomized Controlled",
                          "trigger": "Progress to Period 1 Randomized Controlled"
                        },
                        {
                          "fromState": "Period 1 Randomized Controlled",
                          "toState": "Period 1 Blinded Treatment",
                          "trigger": "Progress to Period 1 Blinded Treatment"
                        },
                        {
                          "fromState": "Period 1 Blinded Treatment",
                          "toState": "Period 2 Long Term Extension",
                          "trigger": "Progress to Period 2 Long Term Extension"
                        },
                        {
                          "fromState": "Period 2 Long Term Extension",
                          "toState": "Follow Up",
                          "trigger": "Progress to Follow Up"
                        },
                        {
                          "fromState": "Period 1 Randomized Controlled",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        },
                        {
                          "fromState": "Period 1 Blinded Treatment",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        },
                        {
                          "fromState": "Period 2 Long Term Extension",
                          "toState": "Early Termination",
                          "trigger": "Subject exits to Early Termination"
                        }
                      ],
                      "epochIds": {
                        "Screening": "SCREENING",
                        "Period 1 Randomized Controlled": "PERIOD_1_RANDOMIZED_CONTROLLED",
                        "Period 1 Blinded Treatment": "PERIOD_1_BLINDED_TREATMENT",
                        "Period 2 Long Term Extension": "PERIOD_2_LONG_TERM_EXTENSION",
                        "Follow Up": "FOLLOW_UP",
                        "Early Termination": "EARLY_TERMINATION"
                      }
                    },
                    "dosingRegimens": [
                      {
                        "id": "4e2bdf3e-8b5c-4010-b265-439d000eee5d",
                        "treatmentName": "Upadacitinib",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "doseLevels": [
                          {
                            "amount": 15.0,
                            "unit": "mg",
                            "description": "Optimal dose for patients with active psoriatic arthritis and proposed dose for marketing authorization."
                          },
                          {
                            "amount": 30.0,
                            "unit": "mg",
                            "description": "Previous dose in Period 2; subjects switched to 15 mg QD upon approval of Amendment 8."
                          }
                        ],
                        "durationDescription": "Not specified in provided text",
                        "doseModifications": [
                          "Subjects currently on upadacitinib 30 mg QD are switched to upadacitinib 15 mg QD in Period 2 upon approval of protocol amendment 8.",
                          "Guidelines for interruption of study drug in subjects with signs/symptoms or suspicion of COVID-19 infection.",
                          "Specific Toxicity Management Guidelines for Abnormal Laboratory Values (e.g., AST/ALT > 8 x ULN)."
                        ]
                      },
                      {
                        "id": "0cc24c67-6ad1-4e93-83eb-05f5e7753c18",
                        "treatmentName": "Placebo",
                        "frequency": "QD",
                        "route": "Oral",
                        "startDay": 1,
                        "durationDescription": "Not specified in provided text"
                      }
                    ],
                    "visitWindows": [
                      {
                        "id": "c3c5fd33-c265-480d-a7d4-13d8b22a125d",
                        "visitName": "screening",
                        "targetDay": -14,
                        "windowBefore": 7,
                        "windowAfter": 34,
                        "isRequired": true,
                        "visitNumber": 1,
                        "epoch": "Screening",
                        "sourceText": "The study duration will include a 35-day screening period; a 56-week blinded period which includes 24 weeks of double-blind, placebo-controlled treatment followed by 32 weeks of treatment blinded to t"
                      },
                      {
                        "id": "9cfbf37d-705c-4c65-97cb-17d2b3ad3942",
                        "visitName": "Early Termination",
                        "targetDay": null,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 2,
                        "sourceText": "To compare the safety and tolerability of upadacitinib 15 mg QD and 30 mg QD versus placebo in subjects with moderately to severely active PsA who have an inadequate response to bDMARDs. Period 2"
                      },
                      {
                        "id": "25f42103-dcfa-4efa-958c-fe4f5e02e1cc",
                        "visitName": "baseline",
                        "targetDay": 0,
                        "windowBefore": 1,
                        "windowAfter": 1,
                        "isRequired": true,
                        "visitNumber": 3,
                        "sourceText": "Subjects who were assigned to placebo at baseline will be preassigned to receiving either upadacitinib 15 mg QD or upadacitinib 30 mg QD starting at Week 24 in a 1:1 ratio. Subjects who complete the W"
                      },
                      {
                        "id": "6b696df7-5d14-4093-982d-80a391e8b0b7",
                        "visitName": "Period 2 Extension",
                        "targetDay": null,
                        "windowBefore": null,
                        "windowAfter": null,
                        "isRequired": true,
                        "visitNumber": 8,
                        "epoch": "Period 2"
                      },
                      {
                        "id": "47b562a9-6ba4-4f51-aec1-6e4b0f15341d",
                        "visitName": "randomization",
                        "targetDay": 1,
                        "windowBefore": 0,
                        "windowAfter": 0,
                        "isRequired": true,
                        "visitNumber": 5,
                        "epoch": "Period 1",
                        "sourceText": "response to) biologic DMARDs (1 vs > 1), except for subjects from Japan, for which randomization will be stratified by extent of psoriasis ( 3% body surface area [BSA] or < 3% BSA) only, and then wil"
                      },
                      {
                        "id": "c0092cda-f95e-458b-a46e-c077ae0e0d67",
                        "visitName": "Week 2",
                        "targetDay": 8,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 6,
                        "targetWeek": 2,
                        "sourceText": "ACR20 response at Week 2. ACR20/50/70 response rates will be determined based on 20%/50%/70% or greater improvement in TJC and SJC and  3 of the 5 measures of Patient's Assessment of Pain NRS, PtGA o"
                      },
                      {
                        "id": "ef5ff239-26e4-4123-adc0-d32254a17f0a",
                        "visitName": "Week 12",
                        "targetDay": 78,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 7,
                        "targetWeek": 12,
                        "epoch": "Period 1",
                        "sourceText": "in either or both tender joint count (TJC) and swollen joint count (SJC) at both Week 12 and Week 16) will add or modify background therapy for PsA. At Week 24, all subjects allocated to placebo at Ba"
                      },
                      {
                        "id": "fab4b97e-c63f-4360-9c9e-8e7c54135a36",
                        "visitName": "Week 16",
                        "targetDay": 106,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 8,
                        "targetWeek": 16,
                        "epoch": "Period 1",
                        "sourceText": "At Week 16, subjects classified as non-responders (defined as not achieving at least 20% improvement in either or both tender joint count (TJC) and swollen joint count (SJC) at both Week 12 and Week 1"
                      },
                      {
                        "id": "425b3521-36e2-438a-a0ca-9ded1cfb18b2",
                        "visitName": "Week 24",
                        "targetDay": 162,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 9,
                        "targetWeek": 24,
                        "epoch": "Period 1",
                        "sourceText": "15 mg QD or upadacitinib 30 mg QD starting at Week 24 in a 1:1 ratio. Subjects who complete the Week 56 visit (end of Period 1) will enter the long-term extension portion of the study, Period 2 (total"
                      },
                      {
                        "id": "3dd530b0-7002-4e9d-b322-8a02daaeb081",
                        "visitName": "Week 36",
                        "targetDay": 246,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 10,
                        "targetWeek": 36,
                        "epoch": "Period 1",
                        "sourceText": "of study drug and remain at stable dose through Week 36 of the study; the non-biologic DMARD dose may be decreased only for safety reasons. In addition, all subjects taking MTX should take a dietary s"
                      },
                      {
                        "id": "43ba3a09-b617-4d17-9854-e43c1e85b47e",
                        "visitName": "Follow-up",
                        "targetDay": 365,
                        "windowBefore": 7,
                        "windowAfter": 7,
                        "isRequired": true,
                        "visitNumber": 11,
                        "epoch": "Follow-up",
                        "sourceText": "30-day follow-up call or visit."
                      },
                      {
                        "id": "c1b9f9ef-006f-4c37-9e43-c5e83b2705df",
                        "visitName": "Week 56",
                        "targetDay": 386,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 12,
                        "targetWeek": 56,
                        "epoch": "Period 1",
                        "sourceText": "Week 56 visit (end of Period 1) will enter the long-term extension portion of the study, Period 2 (total study duration up to approximately 3 years). Subjects will continue study treatment as assigned"
                      },
                      {
                        "id": "27faa9e9-d0ef-4e9d-a4b8-e334008504a6",
                        "visitName": "Week 152",
                        "targetDay": 1058,
                        "windowBefore": 3,
                        "windowAfter": 3,
                        "isRequired": true,
                        "visitNumber": 13,
                        "targetWeek": 152,
                        "sourceText": "The last dose of oral study drug is taken the day prior to the Week 152 visit. Upon approval of protocol amendment 8, subjects receiving upadacitinib 30 mg QD will be switched to upadacitinib 15 mg QD"
                      }
                    ],
                    "randomizationScheme": {
                      "id": "d3fc430f-4ef5-4756-b7b3-2822688f03af",
                      "ratio": "2:2:1:1",
                      "method": "Stratified randomization",
                      "centralRandomization": true,
                      "stratificationFactors": [
                        {
                          "id": "d32f203c-8129-46b4-a983-3a3b290f768e",
                          "name": "Extent of psoriasis (Global)",
                          "categories": [
                            " 3% body surface area [BSA]",
                            "< 3% BSA"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "31580e95-58ce-4676-8cb7-772a7f0fcfa9",
                          "name": "Current use of DMARDs (Global)",
                          "categories": [
                            "At least 1 DMARD",
                            "No DMARD"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "b4294613-a63f-40a5-85e1-0c36448e6631",
                          "name": "Number of prior failed biologic DMARDs (Global)",
                          "categories": [
                            "1",
                            "> 1"
                          ],
                          "isBlocking": false
                        },
                        {
                          "id": "b154d1ce-809f-493b-bd23-d9eb250cccc1",
                          "name": "Extent of psoriasis (Japan only)",
                          "categories": [
                            " 3% body surface area [BSA]",
                            "< 3% BSA"
                          ],
                          "isBlocking": false
                        }
                      ],
                      "sourceText": "Upadacitinib\nM15-554 Protocol Amendment 8\nEudraCT 2016-004152-30\n9\nMethodology (Continued):\nSubjects who meet eligibility criteria will be stratified by extent of psoriasis ( 3% body surface area \n[B"
                    }
                  }
                }
              },
              {
                "id": "67413bbe-109c-483a-8b41-ed61a1b5a719",
                "url": "https://protocol2usdm.io/extensions/x-soaFootnotes",
                "valueString": "[\"a. These visits every 12 weeks are at: Wk 68, Wk 80, Wk 92, Wk 104, Wk 116, Wk 128, and Wk 140.\", \"b. This on-site visit is 30 days after the last dose of study drug. For those subjects who prematurely discontinue from the study (withdrawal of informed consent) a 30-day follow-up phone call visit (and not an on-site visit) may be allowed...\", \"c. Obtain informed consent prior to performing any study related procedures.\", \"d. Note herpes zoster, herpes zoster vaccination and hepatitis B vaccination status in medical history.\", \"e. Blood pressure, pulse rate, body temperature, body weight, and respiratory rate should be performed before blood draws are performed.\", \"f. Height will be measured at Screening visit only (with shoes off).\", \"g. For concomitant medications, at Week 36 (after Week 36 assessments have been performed), per Investigator judgment, may add non-biologic DMARDs...\", \"aa. Collect serious AEs and protocol-related nonserious AEs that occur after a subject signs the informed consent; prior to the first dose of study drug.\", \"bb. At Week 24, all placebo subjects will be randomized to blinded upadacitinib regardless of clinical response.\", \"cc. At Week 16, subjects who do not achieve \\u2265 20% improvement in either or both TJC and SJC compared to baseline at both Weeks 12 and 16 will be offered rescue therapy.\", \"dd. Starting at Week 36, subjects who failed to show at least 20% improvement in either or both TJC and SJC compared to baseline at 2 consecutive visits will be discontinued from study drug treatment.\", \"Note: Visit window is \\u00b1 3 days for the first 36 weeks and \\u00b1 7 days for the remainder of the study. Any of the procedures may be performed at an unscheduled visit at the discretion of the Investigator.\"]",
                "instanceType": "ExtensionAttribute"
              }
            ],
            "administrations": [
              {
                "id": "2e9a86b4-7e77-4e95-aa23-6612cdcf5107",
                "name": "Upadacitinib Administration",
                "instanceType": "Administration",
                "dose": "15.0 mg / 30.0 mg",
                "doseFrequency": "QD",
                "route": {
                  "id": "7184ca75-9505-462f-84f9-e1e96147e0c6",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "duration": "Not specified in provided text"
              },
              {
                "id": "1e847cdf-0e9b-4e2b-9897-de426beff628",
                "name": "Placebo Administration",
                "instanceType": "Administration",
                "doseFrequency": "QD",
                "route": {
                  "id": "5be62316-dadd-4632-bf8e-5dc5749ab4f3",
                  "code": "Oral",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Oral",
                  "instanceType": "Code"
                },
                "duration": "Not specified in provided text"
              }
            ]
          }
        ],
        "titles": [
          {
            "id": "221c9bbd-1a77-4361-93ff-871c1b82b079",
            "text": "A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (bDMARD)  SELECT  PsA 2",
            "type": {
              "id": "ea238617-64f1-4424-9040-c6de012b6b25",
              "code": "Official Study Title",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Official Study Title",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          },
          {
            "id": "78b71ccc-d63b-4d0b-84fb-39f2538e5b78",
            "text": "SELECT  PsA 2",
            "type": {
              "id": "69a1ab5f-e8b6-4a52-a402-cb6b5ee7a3f6",
              "code": "Study Acronym",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Acronym",
              "instanceType": "Code"
            },
            "instanceType": "StudyTitle"
          }
        ],
        "studyIdentifiers": [
          {
            "id": "66f4a29f-bac5-4957-b052-67e98559e463",
            "text": "NCT03104374",
            "instanceType": "StudyIdentifier",
            "scopeId": "a98a3e48-edeb-4f0b-a923-f226c768aba2",
            "type": {
              "code": "C172240",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinicaltrials.gov Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "28228c8b-fa7b-4e4c-8ca1-7f7cc0bdfbbf",
            "text": "M15-554",
            "instanceType": "StudyIdentifier",
            "scopeId": "38de3542-f964-4228-869b-36f61d400161",
            "type": {
              "code": "C132351",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Sponsor Protocol Identifier",
              "instanceType": "Code"
            }
          },
          {
            "id": "48bc1e81-6176-4a47-aa05-b6b91b7402e3",
            "text": "2016-004152-30",
            "instanceType": "StudyIdentifier",
            "scopeId": "99981ef7-7a24-4592-9d39-58b102add71a",
            "type": {
              "code": "C98714",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-09-27",
              "decode": "Clinical Trial Registry Identifier",
              "instanceType": "Code"
            }
          }
        ],
        "organizations": [
          {
            "id": "38de3542-f964-4228-869b-36f61d400161",
            "name": "AbbVie Inc.",
            "type": {
              "id": "ccd4a093-aeaa-441a-998f-22eefc6ac220",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "AbbVie Inc.",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "ba988083-246b-455f-b5cf-3e7aa3b1d2d8",
            "name": "AbbVie Deutschland GmbH & Co. KG",
            "type": {
              "id": "7523b9e0-a39c-440e-a0ac-869832c4ea65",
              "code": "C54086",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Pharmaceutical Company",
              "instanceType": "Code"
            },
            "identifier": "AbbVie Deutschland GmbH & Co. KG",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "a98a3e48-edeb-4f0b-a923-f226c768aba2",
            "name": "ClinicalTrials.gov",
            "type": {
              "id": "73ca617b-ce0a-4ff3-b32d-5c8306773da1",
              "code": "C19326",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Healthcare Facility",
              "instanceType": "Code"
            },
            "identifier": "ClinicalTrials.gov",
            "identifierScheme": "DUNS",
            "instanceType": "Organization"
          },
          {
            "id": "38de3542-f964-4228-869b-36f61d400161",
            "name": "Alabama Medical Group, PC /ID# 159836",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "1",
            "type": {
              "id": "dabc74a6-0af3-4d0d-8554-08b6d23e9829",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ba988083-246b-455f-b5cf-3e7aa3b1d2d8",
            "name": "Arizona Arthritis & Rheumatology Research, PLLC /ID# 160047",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "2",
            "type": {
              "id": "24c41f52-b11a-4e52-8f6d-26520fc2f0f2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a98a3e48-edeb-4f0b-a923-f226c768aba2",
            "name": "Sun Valley Arthritis Center Ltd. /ID# 161203",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "3",
            "type": {
              "id": "6b87afa4-7ce6-40eb-a587-57a9a9d4284c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7700dce3-03a8-4758-a407-66b0826e0ef3",
            "name": "Duplicate_AZ Arthritis and Rheumotology Research, PLLC /ID# 160006",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "4",
            "type": {
              "id": "8decc0f6-42ef-4a4d-8915-def35252fb7d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6943ca5b-b228-468a-ae88-b8af5ec6b856",
            "name": "Osteoporosis Medical Center /ID# 161411",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "5",
            "type": {
              "id": "1c9a6d2c-9351-4e5c-8db9-722634a2820c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5031a9df-1a4f-4043-b87b-0a26dabf24f6",
            "name": "Covina Arthritis Clinic /ID# 159919",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "6",
            "type": {
              "id": "6491de18-8878-4d1f-ac41-e3554e235201",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f366ebb1-f6e1-4adb-9b3e-756782edeabd",
            "name": "Triwest Research Associates /ID# 159915",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "7",
            "type": {
              "id": "ddc41bd3-aa90-4a04-960c-82ba54d15025",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2ea8a229-3178-4fbd-8971-995b470bbafc",
            "name": "Duplicate_Providence Medical Foundation /ID# 160005",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "8",
            "type": {
              "id": "b6d5a805-23e0-4935-8ba6-21e0f9eae9ab",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "30cc116c-113a-4fe5-b44a-f395007fea95",
            "name": "C.V. Mehta MD, Med Corporation /ID# 161192",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "9",
            "type": {
              "id": "104e064d-9a04-4c19-87b9-10c580a8d03b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "91bce9c9-616f-4bf0-9e45-149eedebd3f0",
            "name": "Care Access Research, Huntington Beach /ID# 160049",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "10",
            "type": {
              "id": "28913218-8c94-4a3b-8166-b9093efe9974",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "99abd5c3-36a5-49a7-8224-22de0f7e46e2",
            "name": "Purushotham & Akther Kotha MD, Inc /ID# 159834",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "11",
            "type": {
              "id": "b3e11a0b-46c7-47aa-a526-67b84b93319b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "066083ab-d38b-4cc2-ae7a-d2ac5242e76f",
            "name": "Stanford University School of Med /ID# 161402",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "12",
            "type": {
              "id": "873f4a8e-f0c0-4afe-9235-626d3e58e30d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9d6a2a6f-2bea-4ed5-96b6-f99854f27537",
            "name": "Inland Rheum Clin Trials Inc. /ID# 159839",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "13",
            "type": {
              "id": "cb6a3574-9708-4691-9320-e97c7c851570",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "80a40dee-4d93-4069-ab00-00a9cdd3077b",
            "name": "Medvin Clinical Research /ID# 160045",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "14",
            "type": {
              "id": "f6b8a633-5700-4d9a-88e9-944dce644927",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b01fbd24-1b79-4f60-ad27-2a01087dfb4f",
            "name": "Denver Arthritis Clinic /ID# 159899",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "15",
            "type": {
              "id": "e8f8712c-667b-439b-b96f-9e01a7faa4e5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "116536f0-6081-4a86-8ceb-87e558ac0a59",
            "name": "Colorado Arthritis Associates /ID# 159856",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "16",
            "type": {
              "id": "c26d69a6-3a70-4bc7-91f0-a01f6ecd5682",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "53e12e7e-9900-4f97-af55-d06d531bea2a",
            "name": "Duplicate_Arthritis & Rheumatic Disease Specialties /ID# 161409",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "17",
            "type": {
              "id": "70a7d5bc-66a6-4080-8f6b-62905a74b7bf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "438866c4-04a8-488a-b56f-1ccff2db9a17",
            "name": "International Medical Research /ID# 160051",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "18",
            "type": {
              "id": "69fcbc7b-cd4e-462b-ac2d-4a848f9de59f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5f8c5137-7bd1-4a86-b986-2f0c8ac85eef",
            "name": "Precision Research Organization /ID# 161293",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "19",
            "type": {
              "id": "0ab764a7-385b-4685-b4d5-f5f8773037a5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4bbd9c82-4c9a-4dee-8a45-b8bb11fd48c1",
            "name": "Duplicate_Suncoast Clinical Research /ID# 161417",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "20",
            "type": {
              "id": "dd545ce5-52bc-499f-a0ae-74902ee9dec0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0ec5859b-7189-49df-9850-5a6f29a9b99a",
            "name": "Millennium Research /ID# 159833",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "21",
            "type": {
              "id": "349d502c-2a95-42c8-aef0-43699cb0ab7f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1e62e514-9b72-49d8-ae9b-0eeb9fbc9fa5",
            "name": "Arthritis Center, Inc. /ID# 163463",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "22",
            "type": {
              "id": "13b04a6a-8bac-4d86-ab30-94727b23d8d6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e8c1117d-493e-49eb-8583-d8820363ef60",
            "name": "Gulf Region Clinical Res Inst /ID# 159860",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "23",
            "type": {
              "id": "43f40963-2fff-4a0b-9260-dba5dc7dcf7c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7710ccf6-e036-40cb-882b-7e59b791c125",
            "name": "Sarasota Arthritis Center /ID# 159854",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "24",
            "type": {
              "id": "10105fcb-9115-4cf2-9468-2406c83ae1ae",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "733e9055-cb5b-4b83-9f3d-a0aa7447b38d",
            "name": "BayCare Medical Group /ID# 161405",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "25",
            "type": {
              "id": "a9f0acf1-c370-4123-a56a-6c055303de18",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2e31e24d-5787-405a-b7c4-d288ed38a311",
            "name": "West Broward Rheumatology Associates /ID# 161412",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "26",
            "type": {
              "id": "823056c8-6f5c-4f8a-8d4a-beffd74b0cbf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fe8e7258-9698-4fa8-a3f7-cb9eadcae4db",
            "name": "Clinical Research of West Florida - Tampa /ID# 160069",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "27",
            "type": {
              "id": "ff600874-3d0d-4689-b91a-2a9a5bd984aa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "34129287-fa2e-43e2-bdf1-6adeb3907538",
            "name": "Clinical Research of West Florida, Inc /ID# 159840",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "28",
            "type": {
              "id": "a66d0487-ec00-4a16-9d77-1cdfe8e6886a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5fcd19bc-4ee7-4305-94d5-db3733727cce",
            "name": "USF Health Morsani Center for /ID# 161291",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "29",
            "type": {
              "id": "22e39ba8-fbf2-4c47-a00f-fe0eb4df8d12",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4a268a3f-fe67-4069-811b-0fabfa8d775a",
            "name": "BayCare Medical Group, Inc. /ID# 159912",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "30",
            "type": {
              "id": "f3eba0fb-c6e9-4680-9944-ec77de2e5ac1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d68088ff-1819-4ca7-90d8-331120a5af42",
            "name": "Florida Medical Clinic /ID# 160013",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "31",
            "type": {
              "id": "79a93958-95ef-41db-8ba8-925b1d9ea133",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "00fb0999-ee71-4488-9cc2-f2addfb3e979",
            "name": "Jefrey D. Lieberman, MD, P.C. /ID# 159842",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "32",
            "type": {
              "id": "b07d5f0e-64f5-438d-a6d0-8d63af6652b5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c30268bc-094a-4e07-ad92-06f95ead14f3",
            "name": "Atlanta Research Center for Rheumatology /ID# 161201",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "33",
            "type": {
              "id": "7e7947f0-9b90-4dd4-9cd0-f2302c06c774",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cda4c63e-b07b-417b-a3b6-370ff1321a35",
            "name": "Velocity Clinical Research - Boise /ID# 159922",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "34",
            "type": {
              "id": "65447dec-3c33-40eb-89e9-2e78d6e7f458",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4c42fc1b-8070-47ab-9073-92c54fd0d392",
            "name": "Great Lakes Clinical Trials /ID# 163438",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "35",
            "type": {
              "id": "46693710-e633-4f8b-9bf8-158d2c64e317",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f62078aa-8ddc-46b5-a13a-1ff0854dfeae",
            "name": "Deerbrook Medical Associates /ID# 159815",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "36",
            "type": {
              "id": "7a5d79d6-504f-469d-b656-e975ddf6b9c4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "855d51af-c650-41eb-ae18-51ce3f5b4fad",
            "name": "Duplicate_Clinic of Robert Hozman/Clinical Investigation Specialists /ID# 160068",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "37",
            "type": {
              "id": "6e267d56-dfd5-4be4-8d14-ddae636a7909",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8c10a19d-9008-43a5-9101-20003dffbe41",
            "name": "The Arthritis & Diabetes Clinic, Inc. /ID# 161294",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "38",
            "type": {
              "id": "3077bde3-86f4-4517-9b86-209394b47d77",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ee55b859-f5cf-4070-b8e1-9eae5fab4b83",
            "name": "Arthritis Treatment Center /ID# 160053",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "39",
            "type": {
              "id": "a2d5eaa4-c184-4799-86df-4179a1dd6f8b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c3064c2c-8515-413e-8c29-aa9632c09ecd",
            "name": "The Center for Rheumatology and Bone Research /ID# 159900",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "40",
            "type": {
              "id": "9156594b-51b2-4b99-bdef-88797d4068df",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dcb23b04-2e39-457d-b250-f56cecee5322",
            "name": "Clinical Pharmacology Study Group /ID# 158712",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "41",
            "type": {
              "id": "6ecd17f8-4b65-4ed5-8469-f987ffbaf16f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6967bbc0-67f4-480f-8c2d-a695040e4197",
            "name": "Clinvest Research LLC /ID# 161208",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "42",
            "type": {
              "id": "a0622955-7bb9-43af-adce-6a305785f475",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b2bd5996-52cd-4493-8745-c99bd68ccd33",
            "name": "Westroads Clinical Research /ID# 160004",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "43",
            "type": {
              "id": "a8f23152-12ad-447e-87b7-b5eb935bcc3b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ca919438-518f-4dcd-aece-cb036bd3dba2",
            "name": "Atlantic Coast Research /ID# 159810",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "44",
            "type": {
              "id": "4d2a0cd6-b020-4cf0-a0f9-588b52257152",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9d7a765c-0a6f-4ad2-9209-86153208e9fe",
            "name": "Duplicate_Arthritis and Osteo Assoc /ID# 160015",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "45",
            "type": {
              "id": "6bcae123-54da-4f88-b65d-7b69e680fe22",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9de175bd-5787-4d63-b022-c4f0ee76b6fb",
            "name": "Center for Rheumatology LLP /ID# 167046",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "46",
            "type": {
              "id": "8425e5b0-4c07-4f70-a1c8-7646a094ad59",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "deb9c1f3-645b-4abe-a2bf-af0905d25984",
            "name": "St. Lawrence Health System /ID# 159857",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "47",
            "type": {
              "id": "3d27a039-c47a-4ac2-ae9f-a0c243713fde",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a9e1dd4e-0ebe-428d-ad9c-e895cd4cdf35",
            "name": "DJL Clinical Research, PLLC /ID# 161414",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "48",
            "type": {
              "id": "57003188-4fbb-48be-8d4b-39da452663ef",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "06ba12a8-7fe2-489e-b56a-67aaef848d4c",
            "name": "Physicians East, PA /ID# 159898",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "49",
            "type": {
              "id": "80e05922-23cc-431c-858d-2a123d05f638",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5386582a-d443-4e42-84e8-e4f567d6838a",
            "name": "Shanahan Rheuma & Immuno /ID# 160012",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "50",
            "type": {
              "id": "22c2b45d-3432-4ebf-9791-d06c9bb4ca06",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f91f30d7-2216-430b-848a-541159bb4cb8",
            "name": "PMG Research of Wilmington LLC /ID# 161403",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "51",
            "type": {
              "id": "6e908db5-2e1f-45d0-a61d-41486dc81a53",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e9e4e973-4b51-49af-95ee-4081a863bfbc",
            "name": "Trinity Health Med Arts Clinic /ID# 159811",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "52",
            "type": {
              "id": "427eace9-0461-4afa-98a3-8564856c025e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "bcc874a4-f85a-44cf-ac7a-feb3e236717c",
            "name": "STAT Research, Inc. /ID# 161416",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "53",
            "type": {
              "id": "d566032b-fa52-4175-a586-76f174aa0f26",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0ecc75e2-6283-4ca4-85ac-445924eff292",
            "name": "Health Research of Oklahoma /ID# 159913",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "54",
            "type": {
              "id": "1e79ccd6-ee6d-4b1d-b870-e08e23d72165",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1a49bfd3-acd4-445c-b47e-a1248d7d59bb",
            "name": "Altoona Ctr Clinical Res /ID# 159861",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "55",
            "type": {
              "id": "367f8925-3205-461a-befb-0101faae3ca3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b0c2f54d-59ec-4d28-b113-dc8326b572ed",
            "name": "University of Pittsburgh MC /ID# 161193",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "56",
            "type": {
              "id": "ab494103-ff2d-4899-8b3f-2953049a4bdd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "5f5b1cb4-7e44-40f3-b952-5b6a14457e4b",
            "name": "Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology /ID# 163462",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "57",
            "type": {
              "id": "f2701f1d-32a7-4140-a235-96e3f449ee82",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "809155a9-6ae9-4949-b6aa-c902ce358b43",
            "name": "Rheumatology Consultants, PLLC /ID# 161408",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "58",
            "type": {
              "id": "8fa3e3cf-9b48-42b9-b3f5-3c251c6bcfdc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0325899c-c5e7-4911-a155-d57be4b060da",
            "name": "Dr. Ramesh Gupta /ID# 160067",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "59",
            "type": {
              "id": "c12844d2-9484-4731-b6e1-9bba533e844d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0a1f772a-3ac0-4e1f-9dad-858ad4fe5cf9",
            "name": "Tekton Research, Inc. /ID# 160008",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "60",
            "type": {
              "id": "5617fe10-4c3a-4033-b64d-7e84cac8a218",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7cb19065-a55a-4e2b-a5cf-84b283bce625",
            "name": "Diagnostic Group /ID# 161406",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "61",
            "type": {
              "id": "d04086b4-f89a-4838-a18e-39631f5bffa6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "eb499d59-e17a-4bdd-90e9-b017c099b2b2",
            "name": "Arthritis and Osteoporosis Clinic Of Brazos Valley /ID# 163439",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "62",
            "type": {
              "id": "8b87d3a3-a225-4d8a-a882-72d475a6731b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "22ecb887-30da-4045-91d6-67ffe2c9cdbb",
            "name": "Adriana Pop-Moody MD Clinic PA /ID# 160009",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "63",
            "type": {
              "id": "3848120d-3599-4c7a-9b90-7f9e6b286ba1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "0b54f25c-5cd0-4d79-8aa6-7211c13a1c13",
            "name": "Metroplex Clinical Research /ID# 159818",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "64",
            "type": {
              "id": "366f339e-5d1a-4863-b05d-0b309c5b342d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fa0f2f6f-cb53-4998-9335-a0dbd71ba7f5",
            "name": "Rheumatic Disease Clin Res Ctr /ID# 161252",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "65",
            "type": {
              "id": "44e4d192-a56e-4415-b066-785eaad83537",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "4af14fbc-b3ea-42a7-bbe8-d7b381252ff7",
            "name": "Accurate Clinical Research /ID# 160052",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "66",
            "type": {
              "id": "9816e43c-bf90-40d8-a45e-628afa197f0b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d2efd92b-db14-4724-b28b-4b18985cb2c5",
            "name": "P&I Clinical Research /ID# 159837",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "67",
            "type": {
              "id": "82036a09-93cb-4eb3-a614-229bb247b5f8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "501b1bd6-8937-4096-97dc-2c4a55f55c2d",
            "name": "SW Rheumatology Res. LLC /ID# 160014",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "68",
            "type": {
              "id": "7970583d-7850-42e7-8ad7-ca01797eac7c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e52cff1d-3c23-4cde-a59d-98bf1ecdb82c",
            "name": "DM Clinical Research - Tomball /ID# 161753",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "69",
            "type": {
              "id": "19e4d78f-585b-458c-aeed-0c4cd3379049",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "71095fe3-efee-4a27-b592-bcfbc848a4a8",
            "name": "Arthritis & Osteoporosis Clinic /ID# 161400",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "70",
            "type": {
              "id": "225adb45-71d9-43dc-a1c7-c30d831408a0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7f712697-7d7a-4f8d-85a9-4d0ea21097c4",
            "name": "Arthritis Clinic of N. VA, P.C /ID# 159858",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "71",
            "type": {
              "id": "5ab2fa26-662d-4347-a507-443e51a2663e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "55f5f437-3490-424f-aaa8-b8aff2d04108",
            "name": "Duplicate_Swedish Medical Center /ID# 159918",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "72",
            "type": {
              "id": "1c5379a4-1e8a-4091-8a98-1ba6ec853d07",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6aef61e0-40aa-4d90-b5a1-1998aa39ffe1",
            "name": "Emeritus Research Sydney /ID# 166751",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "73",
            "type": {
              "id": "bff4f151-4980-48d9-b261-5dc0b87d30a5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "17dba013-5c91-4ead-be08-646e5dc7175e",
            "name": "The Queen Elizabeth Hospital /ID# 200840",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "74",
            "type": {
              "id": "78175a62-2b5e-4d1c-a3c9-0f190ba136be",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "71a7c44e-f75a-4a74-aee3-cd78c638ce26",
            "name": "Box Hill Hospital /ID# 166752",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "75",
            "type": {
              "id": "cae12e8f-e7fc-404c-a96c-a8d83cf6c75a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "358349d1-8fbb-4ce5-806d-2b0d7ce4b610",
            "name": "Heidelberg Repatriation Hospital /ID# 167441",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "76",
            "type": {
              "id": "11bcbaf8-5598-472a-8f67-9769f8875965",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2338c824-033f-4c77-bd46-0b80ef5f85f8",
            "name": "ReumaClinic /ID# 164214",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "77",
            "type": {
              "id": "c934a647-f30e-4a08-8a71-fe558a982319",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e0fb4416-a559-49c8-8227-6a9f9f0e9d03",
            "name": "UZ Gent /ID# 164210",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "78",
            "type": {
              "id": "774826db-7b1a-4c4a-baeb-48144d900b26",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cc140b3c-9d03-4eae-85cc-bbb6c9f562b4",
            "name": "CIP - Centro Internacional de Pesquisa /ID# 161808",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "79",
            "type": {
              "id": "4d59d2ff-3b16-4c08-9b2b-8549040a194d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "19dcb848-b2fa-4090-b79d-2d756ac13145",
            "name": "Faculdade de Medicina do ABC /ID# 163489",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "80",
            "type": {
              "id": "e0ad1370-8a2e-4d1c-8d7c-d769977cab14",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8bd3cc6e-7746-433d-b501-441515bf390a",
            "name": "Hospital de Clnicas da Universidade Federal de Uberlndia /ID# 161794",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "81",
            "type": {
              "id": "e883a755-0dfd-46bc-859b-eba70f23fb17",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3ee12d69-84a8-4f6f-a4e0-f3d9c1ba6fe1",
            "name": "Hospital de Clinicas de Porto Alegre /ID# 161795",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "82",
            "type": {
              "id": "5cdeb251-d4dd-41f0-b9c8-b29507389615",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "69980b59-0abe-41fd-a7f7-d9503ba91eab",
            "name": "LMK Sevicos Medicos S/S /ID# 161806",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "83",
            "type": {
              "id": "761dde8d-35e9-40ac-b97b-e9c6ae51ff0b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "486fbcda-41b5-4417-b9c8-4a64aed71d6f",
            "name": "Duplicate_Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 163317",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "84",
            "type": {
              "id": "b357ed71-15cf-44f5-9615-0a8e55a17106",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "160ba42f-e502-409a-a380-b75d1a831aa3",
            "name": "Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 161793",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "85",
            "type": {
              "id": "e218a748-85aa-4a28-84e5-f9af60a1a5c4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e6c10345-6668-470f-82e1-96c30ed2d47e",
            "name": "Percuro Clinical Research, Ltd /ID# 157835",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "86",
            "type": {
              "id": "489e3b74-8ec5-433c-b889-4baa5f41965c",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8edcb010-85c5-41a8-9a9a-6df4298d5fb3",
            "name": "CIADS Research Co Ltd /ID# 157843",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "87",
            "type": {
              "id": "3fcfe296-3dce-4640-bb3f-83a4031b0478",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8350ea15-5e2f-4721-8e36-44c99aa16a0f",
            "name": "The Waterside Clinic /ID# 157838",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "88",
            "type": {
              "id": "7c24984a-2071-46fd-acb0-fd17cb2f8759",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "42097697-1e6d-4591-9155-8222f81ce937",
            "name": "Groupe de Recherche en Maladies Osseuses Inc /ID# 157836",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "89",
            "type": {
              "id": "3d18bf8e-b190-48f8-a490-2fd49be5a950",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2c4c32f6-86b5-4e96-b327-fd48f133e1d8",
            "name": "Centre de Recherche Musculo-Squelettique /ID# 163557",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "90",
            "type": {
              "id": "f1a7fa76-209d-4c28-8fb5-f647007ed97b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fa088bbd-363b-423b-8752-08bc3f7fd228",
            "name": "CTR Estudios Clinicos /ID# 206038",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "91",
            "type": {
              "id": "c82143d5-f8b4-4c53-9c12-5bd9ccfc57d8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "952bc87f-fe08-47f4-87c6-53b5333323ab",
            "name": "Duplicate_Clinica Dermacross /ID# 169537",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "92",
            "type": {
              "id": "98dbfa9d-8adf-4a19-af22-6f2101c14a84",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b4f02e18-e772-4270-b511-00284eb4b765",
            "name": "Duplicate_Centro Internacional de Estudios Clinicos /ID# 169543",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "93",
            "type": {
              "id": "b810e223-7344-4fd1-bd33-64c6581d5d01",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "eb5b6fd7-316f-4323-a842-26dbb149e33a",
            "name": "Prosalud Ltda. /ID# 169542",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "94",
            "type": {
              "id": "f81f0438-45f6-40f3-bf29-72329e04b719",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "34211cfa-65d6-40b0-98cf-33a79a44ab5d",
            "name": "Revmatologie Bruntal, s.r.o /ID# 159632",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "95",
            "type": {
              "id": "e27a8c99-7066-412e-897a-8cc462f34ddd",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "95453313-0c9a-4fd0-ba29-8a15a52a85cf",
            "name": "Medical Plus, s.r.o. /ID# 159631",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "96",
            "type": {
              "id": "e97a23cd-4929-4b79-aa61-72b1a2235369",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "50989be9-f66c-4c09-b7bc-9ede038d941b",
            "name": "Hopital Saint Joseph /ID# 163755",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "97",
            "type": {
              "id": "8c801f25-f208-40cc-ab97-678103d5874f",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "1fd22ba0-f9f4-4fc6-bb2c-d264304cd034",
            "name": "CHU Toulouse /ID# 163743",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "98",
            "type": {
              "id": "2f193535-eb4e-401d-95bf-912edb49046b",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e91d1ce1-599e-4a57-ab23-3fd17201a48b",
            "name": "Centre Hospitalier du Mans /ID# 163746",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "99",
            "type": {
              "id": "37ecf000-d640-42aa-8ecc-30f6231d8f05",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "e3b7c4f5-64c8-42de-a79e-b4eb8ab79da4",
            "name": "CHRU Tours - Hopital Trousseau /ID# 163772",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "100",
            "type": {
              "id": "42c4db3a-4a4d-4e72-aa5b-c414d35d0ea2",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f5be6372-fe32-4a1b-ace3-13de22f09112",
            "name": "Duplicate_CHU-Hospital Henri Mondor /ID# 163895",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "101",
            "type": {
              "id": "cfc0c37c-7bcd-43a2-b699-cb2d1a9958ea",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3da4c360-81fb-4b0b-9300-80f16a8f097a",
            "name": "Duplicate_AP-HP - Hopital Lariboisiere /ID# 163773",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "102",
            "type": {
              "id": "e766bfa7-fdc4-40bf-a227-76e4814f0333",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "08b71dfa-8cd7-4ed6-a957-4807b31db31f",
            "name": "General Hospital of Athens Laiko /ID# 163474",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "103",
            "type": {
              "id": "921e479c-8778-4467-a861-c805b50aad11",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ef7045d2-ca26-45e5-8e96-a2f9a2fdcff9",
            "name": "Naval Hospital of Athens /ID# 163495",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "104",
            "type": {
              "id": "e542f328-5dcc-4d80-9a42-9ac4bc6287cf",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c215ee72-541f-47bc-9784-e2748b11acc5",
            "name": "Reg Gen Univ Hosp Larissa /ID# 163493",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "105",
            "type": {
              "id": "68d3a8b1-b754-447f-9404-7e500795cd92",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "132b0228-8f12-433b-80ad-46f2478b631c",
            "name": "Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 162573",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "106",
            "type": {
              "id": "3036d0c8-1b7e-4da1-a93b-56872877476e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "87ad68dc-bc29-4991-be65-c6c9a629d6df",
            "name": "Vital Medicina Kft /ID# 162571",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "107",
            "type": {
              "id": "05ecab94-6380-4b42-962c-a0ba861a52fa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "90e13aa9-7b0c-4b56-b981-75c1e0eae870",
            "name": "Betegapolo Irgalmasrend Budai Irgalmasrendi Korhaz /ID# 170911",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "108",
            "type": {
              "id": "70870fd6-6909-4ac1-b435-7314572a80c8",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "33f16402-9962-43d0-958f-02ad62f11bca",
            "name": "Revita Reumatologiai Rendelo /ID# 162575",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "109",
            "type": {
              "id": "3325ab8f-0c89-4621-9aa9-f8e80ca49351",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d7dcba33-8f03-410f-9e35-e240c920bc64",
            "name": "Obudai Egeszsegugyi Centrum Kft. /ID# 162576",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "110",
            "type": {
              "id": "0a5fea7c-cae7-4ee6-a71d-d2bc8c2360a3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9bd4593d-a419-4577-8a45-b4ef0ec16e9a",
            "name": "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz /ID# 162572",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "111",
            "type": {
              "id": "7af00b07-523d-444e-90e2-2dabbe94a7fa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "934c6ecb-82d2-4ed5-b8ff-6fe462bf2692",
            "name": "MV Krhz /ID# 162574",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "112",
            "type": {
              "id": "f1c13630-5c24-4378-8937-c2d42373172a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "f62eec02-e408-4f8a-86dc-933ccb2bfa9f",
            "name": "Azienda Ospedaliera Universitaria Federico II /ID# 202410",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "113",
            "type": {
              "id": "8759149d-5bba-4743-b68c-4ca7ac176c78",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7a626ce7-2525-4de9-9934-06ad797f1bb3",
            "name": "Duplicate_Fondazione Policlinico Universitario Campus Bio-Medico di Roma /ID# 164123",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "114",
            "type": {
              "id": "22a77901-14e6-443b-9225-c06cbdb2f0fa",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fb437f08-0e7e-46a4-88e6-0cfef07a2136",
            "name": "Duplicate_Fondazione PTV Policlinico Tor Vergata /ID# 162749",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "115",
            "type": {
              "id": "62555cbb-a126-4128-bd55-09e2cc2eb74e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "02dd480c-0b37-496c-9b3a-eba24866df5e",
            "name": "Duplicate_Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 162748",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "116",
            "type": {
              "id": "b894455d-3aec-4645-b2bf-359cb20b4f76",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "58c01731-2dee-4c80-acaa-193c1fefae88",
            "name": "Duplicate_A.O.U. Policlinico G. Rodolico S.Marco- Presidio G.Rodolico /ID# 164126",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "117",
            "type": {
              "id": "bee8546f-1022-495f-8b8b-28481f4adf11",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a8230ebf-00b1-47a4-904c-43d254d9f800",
            "name": "Duplicate_AOU Arcispedale Sant Anna di /ID# 164127",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "118",
            "type": {
              "id": "0bdd4211-d45e-46b1-9766-18466d879a25",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dfd8daac-5acd-43f7-9aa7-fb7ad828a67f",
            "name": "ASST Gaetano Pini/Presidio Ospedaliero Pini /ID# 164125",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "119",
            "type": {
              "id": "220890e4-fe1f-41c4-8729-f45eacbde9ef",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a5487560-727d-430e-8c48-646da4cc00cb",
            "name": "Duplicate_Azienda Unita Sanitaria Locale/IRCCS /ID# 162751",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "120",
            "type": {
              "id": "359b9559-e718-47af-b65f-774dc2c4c397",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ac117c83-c3fe-4be7-9b02-134c300bd6af",
            "name": "Daido Hospital /ID# 163639",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "121",
            "type": {
              "id": "8cd92fdb-a830-405a-8168-51e55225ecf4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "364451d3-0e13-4601-ae6c-3ff88f1d269e",
            "name": "Nagoya City University Hospital /ID# 162563",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "122",
            "type": {
              "id": "e331d660-c436-4ad9-93f8-ca57cc7bd38e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c2a20b93-12c9-4a38-868b-3bcc884c0d91",
            "name": "Fukuoka University Hospital /ID# 161774",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "123",
            "type": {
              "id": "ae6719a7-970a-4d4c-8454-3a8c5ff77f58",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a6cfa4c8-9f2c-4325-aad6-bcc3f5fe4dad",
            "name": "Duplicate_Kitakyushu Municipal Medical Center /ID# 163516",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "124",
            "type": {
              "id": "8a016439-f3ee-4674-84b1-00755839de24",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "6a7d1768-8666-4e7a-b186-893fc97d293f",
            "name": "Hospital of the University of Occupational and Environmental Health, Japan /ID# 161472",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "125",
            "type": {
              "id": "15ccce2b-a6a8-4639-b6d2-8d242f941113",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "cda4f12a-dc3b-47ec-a762-b59db7788baa",
            "name": "Asahikawa Medical University Hospital /ID# 200684",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "126",
            "type": {
              "id": "bb17d018-5f4e-4223-b264-24bf3db84281",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d5227397-e484-4508-ae1a-c3ec019a7708",
            "name": "Mie University Hospital /ID# 162085",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "127",
            "type": {
              "id": "8cbd985a-6372-4fe8-b318-68cfc247dd8d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c4cff6c8-7dec-4f67-9208-4d096cf2b9d6",
            "name": "Tohoku University Hospital /ID# 164035",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "128",
            "type": {
              "id": "a4c6e27e-bd4e-49d3-ba79-2e56e1e6edb9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b83ad9e7-79d4-4cb5-b05d-b6ca10c85952",
            "name": "Oribe Clinic of Rheumatism and Medicine /ID# 163704",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "129",
            "type": {
              "id": "34c476ef-58b5-46fa-8456-96eab5226617",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ed63914f-fe27-4078-b4f3-5f26a1883c09",
            "name": "Kansai Medical University Hospital /ID# 162081",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "130",
            "type": {
              "id": "7b9094d9-307a-444d-b0bc-a0020e12af94",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3106374c-3e50-4d31-b5b9-a22cade59902",
            "name": "National Hospital Organization Osaka Minami Medical Center /ID# 162589",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "131",
            "type": {
              "id": "cfb865ad-a2a4-4928-9bb6-025b71bb1bce",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a47a7007-e0e2-4899-9d40-f03f75db75b9",
            "name": "Osaka Metropolitan University Hospital /ID# 162082",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "132",
            "type": {
              "id": "a11c0c66-7e47-43a9-9e45-3a49df75f7e5",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d73a8d12-4316-4355-b70b-8f9ada566bfd",
            "name": "Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 161773",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "133",
            "type": {
              "id": "4784d250-969c-4243-a8ae-09c04dfe4db3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "8eb4fb5e-9e59-4e0e-ab2e-20e76d416140",
            "name": "Juntendo University Hospital /ID# 162089",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "134",
            "type": {
              "id": "aea6f735-647a-4e69-9161-05f6047b0fbb",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "64e949bb-5ea0-4966-9617-176eacaa9f5f",
            "name": "St.Luke's International Hospital /ID# 162013",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "135",
            "type": {
              "id": "9b1b0a88-95ce-491e-b509-f1991a2bf252",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "06dac7d2-95d0-44de-bd3b-593fd7ed9d4c",
            "name": "Keio University Hospital /ID# 162130",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "136",
            "type": {
              "id": "3be70409-987b-44eb-a174-380a63533168",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "ac75a31c-424d-4131-b596-f700147e8d9e",
            "name": "Medisch Centrum Leeuwarden /ID# 163049",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "137",
            "type": {
              "id": "d79c136e-6436-49e6-ba0b-31aac273d6cc",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "08d04c13-244f-4882-878c-e23aafb3219f",
            "name": "Duplicate_Erasmus Medisch Centrum /ID# 163052",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "138",
            "type": {
              "id": "297881c3-51b9-47e1-a5f2-defd65c422f3",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c64d082a-ecce-4cb3-a25c-6adfafdfd1a8",
            "name": "Maasstad Ziekenhuis /ID# 163050",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "139",
            "type": {
              "id": "8da2df2f-a214-45b1-95ae-50b5b1de9025",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "eff4a7ab-40ca-4420-91d6-068e456a98a7",
            "name": "Sint Maartenskliniek /ID# 163703",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "140",
            "type": {
              "id": "51aa99b2-9655-4ff4-a904-303efb7d1fa4",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "c55baaed-d900-4c7c-a960-808316117343",
            "name": "Duplicate_Middlemore Hospital /ID# 166411",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "141",
            "type": {
              "id": "0232cf03-5873-4aec-a4e1-d748310b676a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "94a6ed1b-6add-4429-a598-13cf85320cb1",
            "name": "Timaru Medical Specialists Ltd /ID# 166410",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "142",
            "type": {
              "id": "126fd06a-14b1-431b-adc4-d71e2cf7dbba",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a1aaa17a-41d1-4591-8566-c84d616ff289",
            "name": "Waikato Hospital /ID# 166412",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "143",
            "type": {
              "id": "e88622ad-fb02-440b-8fd2-917966744b07",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "b7e4f1f4-b48c-4ab6-af47-f310d2bb7a94",
            "name": "Porter Rheumatology Ltd /ID# 200422",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "144",
            "type": {
              "id": "d0601213-3fb2-41cc-8512-bde05d667911",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "187ec9f6-cd7a-4944-8770-0abce32b9090",
            "name": "Duplicate_Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE /ID# 165897",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "145",
            "type": {
              "id": "7298e4e0-a1d3-4a99-9079-14b0a32d7a59",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9f91c71e-5ea1-41da-aceb-8c62bb04c569",
            "name": "Unidade Local de Sade do Alto Minho, EPE - Hospital Conde de Bertiandos /ID# 165898",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "146",
            "type": {
              "id": "1f84f4ac-efa8-45fe-8192-151ec77505e1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2e87537d-411a-496b-8624-98416a4491a8",
            "name": "Instituto Portugues De Reumatologia /ID# 165894",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "147",
            "type": {
              "id": "7ea8e4bc-e756-4857-93aa-e4e1d74fc97e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "fbb448f8-4ba3-41b5-ba5f-f046c5807c5a",
            "name": "Centro Hospitalar de Lisboa Ocidental, EPE - Hospital Egas Moniz /ID# 165896",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "148",
            "type": {
              "id": "ec9c1b2b-95f6-4f43-87c7-e0ed658ec52a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "a2f27c90-f7d9-4ad3-9445-de763fb8f7a8",
            "name": "Unidade Local de Saude de Santa Maria, EPE /ID# 165895",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "149",
            "type": {
              "id": "61e14f3e-acb4-402c-af4d-6d8c9667e08a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9fbf900f-dcbd-496e-80fb-319f5da0b0b7",
            "name": "Alma M. Cruz Santana, MD-Private practice /ID# 163308",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "150",
            "type": {
              "id": "dee2edb7-87ae-41a7-bf84-4aff6b28855d",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d2deb0d8-0334-4524-8848-1757a263b352",
            "name": "Ponce Medical School Foundation /ID# 163918",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "151",
            "type": {
              "id": "f4cdeedc-a964-42b4-a159-1d359738f5f9",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "3155d8a6-f4a4-4817-a2e0-faed31897d1d",
            "name": "GCM Medical Group PSC /ID# 163716",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "152",
            "type": {
              "id": "9a2056ca-e947-4cba-9434-9674c5767144",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "dda6669c-5b4d-4a71-ba50-30805ca77c32",
            "name": "Duplicate_Ajou University Hospital /ID# 163893",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "153",
            "type": {
              "id": "da5377c7-be07-4322-9514-ceb72b307b52",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "429b3017-7b37-44ed-a762-a6fdc96172b9",
            "name": "Duplicate_Inha University Hospital /ID# 163892",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "154",
            "type": {
              "id": "24dad279-c09a-49a1-98ab-f5970349ec8e",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "054368ba-50d1-4d93-ace5-2a8585f24095",
            "name": "Hospital Clinico Universitario Virgen de la Arrixaca /ID# 163138",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "155",
            "type": {
              "id": "a1f77db2-c481-4c35-80ef-e19d51d47bb7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "d64a9898-b2a3-4d10-a2b2-0607f6a87162",
            "name": "Duplicate_Hospital Universitario A Coruna - CHUAC /ID# 161019",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "156",
            "type": {
              "id": "8df19d15-34ed-4629-bc2b-f824ddd42bd6",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2c1c4659-5704-4ac2-88e7-99582c50d8c5",
            "name": "Duplicate_Hospital Universitario Reina Sofia /ID# 170764",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "157",
            "type": {
              "id": "9d549cf8-9d96-4707-b8c3-f6275314ca22",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "300b175c-c432-49cc-bafd-03743fe9ca49",
            "name": "Hospital Campus de la Salud /ID# 170768",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "158",
            "type": {
              "id": "ffa93747-c4b2-4c78-9941-e2185aee98c0",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "2df99695-308a-4938-8ad7-3eee5a5db916",
            "name": "Hospital Universitario Ramon y Cajal /ID# 161020",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "159",
            "type": {
              "id": "e600018d-128f-4a9b-9ebd-45f4b458a222",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "7cc3f42a-847c-4735-887f-74c70994d8fd",
            "name": "Royal United Hospitals Bath /ID# 161054",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "160",
            "type": {
              "id": "0b5e3719-4233-4a83-a94b-38ca3c684672",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "41a715db-034d-437c-bbbc-ec1139ed2236",
            "name": "Barts Health NHS Trust /ID# 161053",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "161",
            "type": {
              "id": "f309fa30-7049-4a8d-a756-aa17ce6912d1",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "de047215-27df-427b-839b-8bf1a34d09a6",
            "name": "Guys and St Thomas NHS Foundation Trust /ID# 161063",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "162",
            "type": {
              "id": "347b8096-1ec1-49eb-a063-7de64f230320",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "07d0fcd1-bfc8-48a0-828d-04e06abc620a",
            "name": "Duplicate_NHS Greater Glasgow and Clyde /ID# 162712",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "163",
            "type": {
              "id": "a0a89503-426f-4ecb-9f35-8efdb288f91a",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "9c197209-3605-4fd8-982f-cc3796ae8246",
            "name": "Duplicate_Bedfordshire Hospitals NHS Foundation Trust /ID# 162713",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "164",
            "type": {
              "id": "d246551f-3c1d-4322-8a3e-603e88cc5150",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          },
          {
            "id": "da7f93aa-3679-45b9-9a7c-f479f402ef51",
            "name": "Duplicate_Christchurch University Hospitals Dorset NHS University Hospitals Dors /ID# 162711",
            "identifierScheme": "SITE_NUMBER",
            "identifier": "165",
            "type": {
              "id": "98aa9f01-d472-48af-9538-6eead81cdba7",
              "code": "C70793",
              "codeSystem": "http://www.cdisc.org",
              "codeSystemVersion": "2024-03-29",
              "decode": "Clinical Study Site",
              "instanceType": "Code"
            },
            "instanceType": "Organization"
          }
        ],
        "studyPhase": {
          "id": "15625e17-246c-4aca-a30b-6045c202f743",
          "code": "Phase3",
          "codeSystem": "USDM",
          "codeSystemVersion": "2024-09-27",
          "decode": "Phase3",
          "instanceType": "Code"
        },
        "eligibilityCriterionItems": [
          {
            "id": "62e1f8da-7bd6-43bd-aa36-78f19677c333",
            "name": "Age requirement",
            "text": "Adult male or female, at least  18 years old at Screening.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "ab28d78e-3114-4869-941b-cec334301e2a",
            "name": "PsA Diagnosis and CASPAR",
            "text": "Clinical diagnosis of PsA with symptom onset at least 6 months prior to the Screening Visit and fulfillment of the Classification Criteria for PsA (CASPAR).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d51e77fd-f3dc-4ebb-ab56-f8e2bfc0fb2b",
            "name": "Active Disease at Baseline",
            "text": "Subject has active disease at Baseline defined as  3 tender joints (based on 68 joint counts) and  3 swollen joints (based on 66 joint counts) at Screening and Baseline Visits.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b64440ed-2a4e-48ab-8892-b4c8ccac5444",
            "name": "Plaque Psoriasis History",
            "text": "Diagnosis of active plaque psoriasis or documented history of plaque psoriasis.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "0605e011-2ba0-4bc5-a83a-0f9d66466809",
            "name": "bDMARD Inadequate Response",
            "text": "Subject has had an inadequate response (lack of efficacy after a minimum 12 week duration of therapy) or intolerance to treatment with at least 1 bDMARD.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "8aaf317d-0d8b-4af8-bc82-6cb2b4983f9f",
            "name": "bDMARD Discontinuation",
            "text": "Subjects must have discontinued all bDMARDs prior to the first dose of study drug. Subjects who need to discontinue bDMARDs prior to the Baseline Visit to comply with this inclusion criterion must follow the procedure specified below or at least five times the mean terminal elimination half-life of a drug:  4 weeks for etanercept;  8 weeks for adalimumab, infliximab, certolizumab, golimumab, abatacept, tocilizumab, and ixekizumab;  16 weeks for secukinumab;  12 weeks for ustekinumab;  1 year for rituximab OR  6 months if B cells have returned to pretreatment level or normal reference range (local lab) if pretreatment levels are not available.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "506672a9-40cd-42a3-ae48-b42b4a68545e",
            "name": "Concomitant non-biologic DMARDs",
            "text": "Subject who is on current treatment with concomitant non-biologic DMARDs at study entry must be on  2 non-biologic DMARDs (except the combination of MTX and leflunomide) at the following doses: MTX ( 25 mg/week), SSZ (3000 mg/day), leflunomide (LEF) (20 mg/day), apremilast (60 mg/day), HCQ ( 400 mg/day), bucillamine (300 mg/day) and iguratimod (50 mg/day) for  12 weeks and at stable dose for 4 weeks prior to the Baseline Visit. No other DMARDs are permitted during the study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "f0e3d450-6dc5-4e8c-beae-237dcbfefb73",
            "name": "Stable NSAIDs/Corticosteroids",
            "text": "Stable doses of NSAIDs, acetaminophen/paracetamol, low-potency opiates (tramadol or combination of acetaminophen and codeine or hydrocodone), oral corticosteroids (equivalent to prednisone  10 mg/day), or inhaled corticosteroids for stable medical conditions are allowed, but must have been at a stable dose for 1 weeks prior to the Baseline Visit.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "488e071e-9240-4e88-b6a2-eae7e0322036",
            "name": "Opiate and TCM Discontinuation",
            "text": "Subjects must have discontinued all opiates (except for tramadol or combination of acetaminophen and codeine or hydrocodone) at least 1 week and oral Traditional Chinese Medicine for at least 4 weeks prior to the first dose of study drug.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "2a6d020c-3b51-47ae-9719-63857e3ce6ef",
            "name": "Pregnancy Test",
            "text": "Women of childbearing potential, must not have a positive serum pregnancy test at the Screening Visit and must have a negative urine pregnancy test at the Baseline Visit prior to study drug dosing.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d4ca05b8-9915-4f39-ad72-60b2d06188fd",
            "name": "Contraception Requirement",
            "text": "If female, subject must be postmenopausal OR permanently surgically sterile OR for Women of Childbearing Potential practicing at least one protocol specified method of birth control, that is effective from the Baseline visit through at least 30 days after the last dose of study drug.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "5d43a97e-78ae-492b-9a49-baedd69fca57",
            "name": "Informed Consent",
            "text": "Subjects must voluntarily sign and date an informed consent, approved by an Independent Ethics Committee (IEC)/Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "78088085-6cf2-417e-a8ff-f8eebf4a0560",
            "name": "JAK Inhibitor Exposure",
            "text": "Prior exposure to any Janus Kinase (JAK) inhibitor (including but not limited to ruxolitinib, tofacitinib, baricitinib, and filgotinib).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "b4f115f4-72f2-4de7-b6aa-f727e40b02b7",
            "name": "Excessive DMARDs",
            "text": "Current treatment with > 2 non-biologic DMARDs or use of DMARDs other than MTX, SSZ, LEF, apremilast, HCQ, bucillamine or iguratimod or use of MTX in combination with LEF at Baseline.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d3579150-0ceb-4c18-ba45-6ca5e7b919b7",
            "name": "Investigational Drug Use",
            "text": "Has been treated with any investigational drug within 30 days or five half-lives of the drug (whichever is longer) prior to the first dose of study drug or is currently enrolled in another interventional clinical study.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "d60f6892-4320-488a-99ce-a2f1ef82613c",
            "name": "Infection History",
            "text": "Current or past history of infection including: History of recurrent or disseminated (even a single episode) herpes zoster; History of disseminated (even a single episode) herpes simplex; History of known invasive infection (e.g., listeriosis and histoplasmosis); Active human immunodeficiency virus (HIV) or immunodeficiency syndrome; Subject has active TB or meets TB exclusionary parameters; Active infection(s) requiring treatment with parenteral anti-infectives within 30 days, or oral anti-infectives within 14 days prior to the Baseline Visit; Chronic recurring infection and/or active viral infection; Active HBV or HCV.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "6b36af64-68e4-489c-ae91-b90300277d87",
            "name": "Underlying Medical Diseases",
            "text": "Underlying medical diseases or problems including but not limited to: History of cardiovascular conditions (recent CVA, MI, stenting, uncontrolled hypertension); Organ transplant recipient; History of gastrointestinal perforation, diverticulitis; Conditions interfering with drug absorption; History of malignancy except NMSC or CIS of cervix; Clinically significant medical conditions; Wheelchair-bound or bedridden.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "62edeee8-28b1-4839-b7d1-b950e9734331",
            "name": "Psoriasis Treatments",
            "text": "Use of concomitant psoriasis treatments within specified timeframe: Phototherapy (4 weeks), Laser therapy (4 weeks), Topical psoriasis treatments (2 weeks).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "46dda81e-cece-4e5f-b3f6-e699847c6c05",
            "name": "Other Inflammatory Diseases",
            "text": "History of fibromyalgia, any arthritis with onset prior to age 17 years, or current diagnosis of inflammatory joint disease other than PsA (including, but not limited to rheumatoid arthritis, gout, overlap connective tissue diseases, scleroderma, polymyositis, dermatomyositis, systemic lupus erythematosus).",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "79a7104b-bd8a-4c2b-8ba0-49747c1d5688",
            "name": "Drug or Alcohol Abuse",
            "text": "History of clinically significant (per Investigator's judgment) drug or alcohol abuse within the last 6 months preceding the Baseline Visit.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "383d8062-3b7b-428e-8e95-0de4d16f2b6a",
            "name": "Pregnancy and Breastfeeding",
            "text": "Female subject who is pregnant, breastfeeding or is considering becoming pregnant during the study or within 30 days after the last dose of study drug.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "7d63b9e1-34f9-4dc6-b19c-4cd5f453d0d9",
            "name": "Laboratory Values",
            "text": "Laboratory values meeting the following criteria within the Screening period: AST/ALT > 2 x ULN; GFR < 40 mL/min/1.73m2; WBC < 2,500/L; ANC < 1,500/L; Platelet count < 100,000/L; ALC < 800/L; Hemoglobin < 10 g/dL.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "32c26b84-8ad3-4bcb-8da6-db24be3a945c",
            "name": "Other Skin Disease",
            "text": "Active skin disease other than psoriasis that would interfere with the assessment of psoriasis.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "33bee306-8931-4d90-a5bb-94af2014af49",
            "name": "Extra-articular Manifestations",
            "text": "Subject with extra-articular manifestations of PsA (e.g., PsO, uveitis, or IBD) that are not clinically stable for at least 30 days prior to study entry.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "59cb9295-a928-4bbd-a98a-b852b80cebad",
            "name": "Joint Surgery or Injections",
            "text": "Subject has had joint surgery at joints to be assessed within this study or has been treated with intra-articular, intramuscular, intravenous, trigger point or tender point, intra-bursa, or intra-tendon sheath corticosteroids in the preceding 8 weeks prior to the Baseline visit.",
            "instanceType": "EligibilityCriterionItem"
          },
          {
            "id": "70f39fc0-a43f-48f1-8653-0afaf4b5edc8",
            "name": "Investigator Discretion",
            "text": "Consideration by the Investigator, for any reason, that the subject is an unsuitable candidate to receive upadacitinib.",
            "instanceType": "EligibilityCriterionItem"
          }
        ],
        "studyInterventions": [
          {
            "id": "e456f75c-faad-4d3d-95b6-e9b8e4fe5a99",
            "name": "Upadacitinib",
            "type": {
              "id": "cdf1c1b6-9267-4ee7-b33a-8566f0be6081",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "role": {
              "id": "a2b23685-3407-4aeb-9c52-a5959fdf6928",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Selective JAK1 inhibitor for the treatment of active psoriatic arthritis.",
            "productIds": [
              "75cac9d6-7864-4974-aa87-d34bcaee5d67"
            ],
            "administrationIds": [
              "dfea7a79-e476-4815-be46-998b48370edd",
              "6f8292f6-3c1f-4813-a7ae-ab197ad9921c"
            ]
          },
          {
            "id": "17f1c1f6-ace1-48d9-8e52-d8da39b5ea0b",
            "name": "Placebo",
            "type": {
              "id": "737b0c03-6aff-4a66-b877-7b60af5422d4",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "role": {
              "id": "53ffcafe-6ebd-4c1a-b1b0-b02e7d1cb256",
              "code": "C41132",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Placebo",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Matching placebo for upadacitinib.",
            "productIds": [
              "f93ffc4f-f75b-45c3-b23c-c135eba0cc94"
            ],
            "administrationIds": [
              "d8f0a624-f403-415b-a53b-3fe8a57f83b1",
              "ea34a4f7-4383-4859-9a16-03c1d2fc2cb9"
            ]
          },
          {
            "id": "9c82e1bf-7cf5-49f9-974a-5ad14d4dcff4",
            "name": "Methotrexate (MTX)",
            "type": {
              "id": "1e235ae2-cfc6-42e3-be76-77c4883eeb62",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "747c04cb-a4f5-44bf-8e37-b3e30e706b5f",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted non-biologic DMARD at doses  25 mg/week.",
            "productIds": [
              "3afc22ed-f01c-4ff2-8ec4-5c8625625f5a"
            ],
            "administrationIds": [
              "f526ecfc-bc9a-446b-91f4-631861cd08d5"
            ]
          },
          {
            "id": "09bbb7cf-153a-4a76-83b8-6ca3f52c496a",
            "name": "Sulfasalazine (SSZ)",
            "type": {
              "id": "912475eb-c5f5-44b2-bea3-48864f004705",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "c7ea6271-f632-41e0-8d46-5d26cb4bdc65",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted non-biologic DMARD at doses  3000 mg/day."
          },
          {
            "id": "ce50f56b-c59b-4c80-9913-2c7643e27c9d",
            "name": "Leflunomide (LEF)",
            "type": {
              "id": "e39abaa3-7dbe-4c5a-9d03-4480ab3468a9",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "91b09204-0608-43db-9e57-91668e8ff4d1",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted non-biologic DMARD at doses  20 mg/day."
          },
          {
            "id": "0bab0570-c368-419f-bab3-536b8d5850ef",
            "name": "Apremilast",
            "type": {
              "id": "5b47e54e-33b5-4fe7-a629-97ee4add660d",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "3bf62e01-1046-44ea-917c-bb75a76e5273",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted non-biologic DMARD at doses  60 mg/day."
          },
          {
            "id": "5d3352a4-69d6-4110-bca1-edb9cb334a49",
            "name": "Hydroxychloroquine (HCQ)",
            "type": {
              "id": "39199459-4ca0-4a6f-a81d-67335814d333",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "65495fe0-d5b3-4fa7-85c3-159db781d2fe",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted non-biologic DMARD at doses  400 mg/day."
          },
          {
            "id": "c4e93b01-5e01-4038-bc92-d394a52567ac",
            "name": "Bucillamine",
            "type": {
              "id": "b5591ba5-511a-4c8c-899f-4db5792ee536",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "41743a10-6b9d-4174-b3b8-f2baf6fcb9a5",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted non-biologic DMARD at doses  300 mg/day."
          },
          {
            "id": "e63b66f3-7299-40ab-a15c-444d3e33f4cb",
            "name": "Iguratimod",
            "type": {
              "id": "2be501f9-937c-47f5-8e94-5ad192de3779",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "role": {
              "id": "6f2ae610-c29b-41f6-bb48-158aa8c00837",
              "code": "C54127",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Background Therapy",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted non-biologic DMARD at doses  50 mg/day."
          },
          {
            "id": "5b16e6ee-cc12-4f16-b6e1-bd319bded974",
            "name": "Folic acid",
            "type": {
              "id": "49c0b406-eb94-4a92-bd49-a37843b81c4e",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "a25d87ee-5610-4119-8bc4-0d52e455c102",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Required dietary supplement for all subjects taking MTX."
          },
          {
            "id": "9b3eba34-baa0-41b1-803e-e5e3e45f7f1f",
            "name": "NSAIDs",
            "type": {
              "id": "76ded22d-3a84-4b2e-82fb-9def5b8b2e47",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "41e63f02-0d5d-4079-985e-ac8b120bdbca",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
          },
          {
            "id": "3d59851a-fe5f-40b5-82ce-48b54208fa2b",
            "name": "Acetaminophen/paracetamol",
            "type": {
              "id": "0965698e-0ad8-4d4f-a56e-e0e3f41c23d7",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "d8b83c79-7e5f-4d31-aaa4-98c17140dfb6",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted at stable doses; can be used as rescue therapy after Week 16."
          },
          {
            "id": "cd7b0ea7-0a62-4d17-bd8f-25f3141c2edb",
            "name": "Oral corticosteroids",
            "type": {
              "id": "0d65e4f0-3817-457a-8293-87fda14035b7",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "777614b0-77e2-4381-b0af-aaa600749f09",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Permitted at stable doses equivalent to prednisone  10 mg/day."
          },
          {
            "id": "d84c946c-78df-4818-8954-bae43f7eeb54",
            "name": "Low-potency opiates",
            "type": {
              "id": "648a3ba5-5388-498b-86d4-0b64b9a82a6a",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "cd426d61-f3be-402f-a54d-56f4571b89a4",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Tramadol or combination of acetaminophen and codeine/hydrocodone permitted."
          },
          {
            "id": "dd8fc9d4-9385-47b9-a3ad-63d5172e0270",
            "name": "Intra-articular corticosteroid injection",
            "type": {
              "id": "49b87d69-2f66-4e4d-89f2-d27da2acbf0a",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "3f218e73-4e9f-4853-b0ba-d2becd52ad73",
              "code": "C54125",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Rescue Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Offered to non-responders at Week 16 for one peripheral joint/site."
          },
          {
            "id": "27071a89-559a-43c2-82c7-27a7f692c622",
            "name": "Strong CYP3A inhibitors/inducers",
            "type": {
              "id": "3e7a96c8-c58c-4a81-b3c0-4e4c732dc911",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "2206b5c9-7175-4320-b6a1-d49e98a1f9cc",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited from Screening through the last dose of study drug."
          },
          {
            "id": "7a664d24-f674-49b5-9b74-fa2ffe514c66",
            "name": "Live vaccines",
            "type": {
              "id": "5defffef-5e6e-47a0-a45c-b79b91fa1afc",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "role": {
              "id": "ca68ba3b-4334-421e-befa-b1837c381a34",
              "code": "C54126",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Concomitant Medication",
              "instanceType": "Code"
            },
            "instanceType": "StudyIntervention",
            "description": "Prohibited within 4 weeks (8 weeks in Japan) prior to Baseline and during study."
          }
        ],
        "administrableProducts": [
          {
            "id": "75cac9d6-7864-4974-aa87-d34bcaee5d67",
            "name": "Upadacitinib (ABT-494)",
            "administrableDoseForm": {
              "id": "b868a142-a3bf-4bb4-a44e-da39a813839a",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "da6c0648-675a-4bb0-969f-73110764405f",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "5d0c9737-ddb3-4376-9da8-ff50db081fdf",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "15 mg",
            "substanceIds": [
              "fce17f26-54e0-40e1-bf70-7f2398247677"
            ],
            "manufacturer": "AbbVie"
          },
          {
            "id": "f93ffc4f-f75b-45c3-b23c-c135eba0cc94",
            "name": "Upadacitinib (ABT-494)",
            "administrableDoseForm": {
              "id": "8a6fe997-678f-4949-af2f-b236dadcfba8",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "2b68feb6-6862-456d-beb7-7ee3639bd916",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "7fda021c-f0fd-4bd6-a9a7-792f111fb4bd",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "30 mg",
            "manufacturer": "AbbVie"
          },
          {
            "id": "3afc22ed-f01c-4ff2-8ec4-5c8625625f5a",
            "name": "Placebo",
            "administrableDoseForm": {
              "id": "2538280d-c851-4430-8ad1-2c0b13695da3",
              "code": "C42998",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Tablet",
              "instanceType": "Code",
              "standardCode": {
                "id": "7aa7b43c-f978-4d97-a053-916394e96189",
                "code": "C42998",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Tablet",
                "instanceType": "Code"
              }
            },
            "productDesignation": {
              "id": "b6c65f1e-e09a-4b84-b4f6-f9a6c040beac",
              "code": "C54121",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "25.01d",
              "decode": "Investigational Product",
              "instanceType": "Code"
            },
            "instanceType": "AdministrableProduct",
            "strength": "Matching",
            "manufacturer": "AbbVie"
          }
        ],
        "narrativeContents": [
          {
            "id": "e24a6804-2423-4377-8d38-e9e9f64e88dc",
            "name": "Title Page",
            "text": "Title Page",
            "order": 0,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1.0",
            "sectionTitle": "Title Page",
            "sectionType": {
              "id": "f4b8fa7c-e153-410f-8186-012c8ce380d0",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "609f7e9b-ea01-430f-844c-4428347d5b8d",
            "name": "Protocol Amendment: Summary of Changes",
            "text": "Protocol Amendment: Summary of Changes",
            "order": 1,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1.1",
            "sectionTitle": "Protocol Amendment: Summary of Changes",
            "sectionType": {
              "id": "9ff8587d-b977-4edc-82d6-21cf724b75aa",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "a4605bfb-c061-4b68-b978-c3c3576f1d37",
            "name": "Synopsis",
            "text": "Synopsis",
            "order": 2,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1.2",
            "sectionTitle": "Synopsis",
            "sectionType": {
              "id": "c6e16806-ea77-4a4f-8c5a-eef12cff5ae6",
              "code": "Synopsis",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Synopsis",
              "instanceType": "Code"
            }
          },
          {
            "id": "ad5f7c0a-47c8-46a6-8a30-5954903d8c3d",
            "name": "List of Abbreviations and Definition of Terms",
            "text": "List of Abbreviations and Definition of Terms",
            "order": 3,
            "instanceType": "NarrativeContent",
            "sectionNumber": "1.3",
            "sectionTitle": "List of Abbreviations and Definition of Terms",
            "sectionType": {
              "id": "2609bdfc-919b-4ed9-b834-3829ff852fa6",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "86bcd445-ae65-4d6d-8bb0-bbeb9df8eb37",
            "name": "Table of Contents",
            "text": "Table of Contents",
            "order": 4,
            "instanceType": "NarrativeContent",
            "sectionNumber": "2.0",
            "sectionTitle": "Table of Contents",
            "sectionType": {
              "id": "4acf2542-317a-4c50-8474-0c70addafa4b",
              "code": "Other",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Other",
              "instanceType": "Code"
            }
          },
          {
            "id": "1eef1c8a-864d-47fb-9206-e32acbdc586c",
            "name": "Introduction",
            "text": "Introduction",
            "order": 5,
            "instanceType": "NarrativeContent",
            "sectionNumber": "3.0",
            "sectionTitle": "Introduction",
            "sectionType": {
              "id": "117f5c49-0e34-4f63-a631-3bf2ca78e6c9",
              "code": "Introduction",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Introduction",
              "instanceType": "Code"
            },
            "childIds": [
              "aa336b21-00d0-4df3-b10d-d6c5ee3c4fa5",
              "59bfab61-6bea-4993-abfe-9e3817a94f3c"
            ]
          },
          {
            "id": "bf0c534e-f177-4964-af0d-467222ae230a",
            "name": "Study Objective",
            "text": "Study Objective",
            "order": 6,
            "instanceType": "NarrativeContent",
            "sectionNumber": "4.0",
            "sectionTitle": "Study Objective",
            "sectionType": {
              "id": "a24af2d1-0419-4d69-a3ac-8894597fda29",
              "code": "Objectives",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Objectives",
              "instanceType": "Code"
            }
          },
          {
            "id": "44db6bf9-dabb-48b5-9bdf-0cb3ee2e248e",
            "name": "Investigational Plan",
            "text": "Investigational Plan",
            "order": 7,
            "instanceType": "NarrativeContent",
            "sectionNumber": "5.0",
            "sectionTitle": "Investigational Plan",
            "sectionType": {
              "id": "1668ad0e-21a4-41e5-91ba-b394ff64c291",
              "code": "Study Design",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Study Design",
              "instanceType": "Code"
            },
            "childIds": [
              "f5594173-a707-49c3-83c5-8f325c05b345",
              "498276a4-8b18-4af6-8c4c-6316aa775cef",
              "2dee8591-9393-4e18-ad3b-9a83fc948273",
              "aa3466bb-bd34-4552-9a67-f7e6f2fceac4",
              "44d1beb4-7f96-4172-b026-fde3ef8050cd",
              "c394be10-9340-40f8-9108-fa07d79ec1d8",
              "401cb08c-e039-47f3-9025-b55ba9d60edd",
              "7b886a2f-fcea-49ca-a2f0-8c9110d4f7a8",
              "703bbc43-6f12-4e88-a02c-d7fa15dc11b7",
              "efd68277-0ada-4b32-b356-6043cf80ce36",
              "f8207f43-dc9b-43f6-9d13-c4d07870182e",
              "06ac9c5b-28eb-49e1-93b7-4534fb3dcd3e",
              "d99cf9d2-e7a9-48fc-8414-ce55a127c8a9",
              "7462ceae-e22a-4711-abfd-6406e2b880ae",
              "c7edcb8e-b3f1-49af-911f-a90d3a8e2571",
              "06b41313-2334-4354-9138-0ddd1b53cdf0",
              "8d3f4f69-ee56-43e3-bd4f-a9959c91f5fc",
              "53871f27-3506-4eaa-bafa-faddcbe760c9",
              "0f85817c-2aa5-48dd-8909-a1b164252909",
              "ea20aa2b-6d2b-449b-b33f-fcae4adee983"
            ]
          }
        ],
        "narrativeContentItems": [
          {
            "id": "aa336b21-00d0-4df3-b10d-d6c5ee3c4fa5",
            "name": "Differences Statement",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.1",
            "sectionTitle": "Differences Statement"
          },
          {
            "id": "59bfab61-6bea-4993-abfe-9e3817a94f3c",
            "name": "Benefits and Risks",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "3.2",
            "sectionTitle": "Benefits and Risks"
          },
          {
            "id": "f5594173-a707-49c3-83c5-8f325c05b345",
            "name": "Overall Study Design and Plan: Description",
            "text": "",
            "order": 0,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.1",
            "sectionTitle": "Overall Study Design and Plan: Description"
          },
          {
            "id": "498276a4-8b18-4af6-8c4c-6316aa775cef",
            "name": "Selection of Study Population",
            "text": "",
            "order": 1,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2",
            "sectionTitle": "Selection of Study Population"
          },
          {
            "id": "2dee8591-9393-4e18-ad3b-9a83fc948273",
            "name": "Inclusion Criteria",
            "text": "",
            "order": 2,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2.1",
            "sectionTitle": "Inclusion Criteria"
          },
          {
            "id": "aa3466bb-bd34-4552-9a67-f7e6f2fceac4",
            "name": "Exclusion Criteria",
            "text": "",
            "order": 3,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2.2",
            "sectionTitle": "Exclusion Criteria"
          },
          {
            "id": "44d1beb4-7f96-4172-b026-fde3ef8050cd",
            "name": "Prior, Concomitant, and Prohibited Therapy",
            "text": "",
            "order": 4,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2.3",
            "sectionTitle": "Prior, Concomitant, and Prohibited Therapy"
          },
          {
            "id": "c394be10-9340-40f8-9108-fa07d79ec1d8",
            "name": "Prior Therapy",
            "text": "",
            "order": 5,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2.3.1",
            "sectionTitle": "Prior Therapy"
          },
          {
            "id": "401cb08c-e039-47f3-9025-b55ba9d60edd",
            "name": "Permitted Background Therapy",
            "text": "",
            "order": 6,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2.3.2",
            "sectionTitle": "Permitted Background Therapy"
          },
          {
            "id": "7b886a2f-fcea-49ca-a2f0-8c9110d4f7a8",
            "name": "Prohibited Therapy",
            "text": "",
            "order": 7,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2.3.3",
            "sectionTitle": "Prohibited Therapy"
          },
          {
            "id": "703bbc43-6f12-4e88-a02c-d7fa15dc11b7",
            "name": "Rescue Therapy",
            "text": "",
            "order": 8,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2.3.4",
            "sectionTitle": "Rescue Therapy"
          },
          {
            "id": "efd68277-0ada-4b32-b356-6043cf80ce36",
            "name": "Contraception Recommendations",
            "text": "",
            "order": 9,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.2.4",
            "sectionTitle": "Contraception Recommendations"
          },
          {
            "id": "f8207f43-dc9b-43f6-9d13-c4d07870182e",
            "name": "Efficacy and Safety Assessments/Variables",
            "text": "",
            "order": 10,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3",
            "sectionTitle": "Efficacy and Safety Assessments/Variables"
          },
          {
            "id": "06ac9c5b-28eb-49e1-93b7-4534fb3dcd3e",
            "name": "Efficacy and Safety Measurements Assessed",
            "text": "",
            "order": 11,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.1",
            "sectionTitle": "Efficacy and Safety Measurements Assessed"
          },
          {
            "id": "d99cf9d2-e7a9-48fc-8414-ce55a127c8a9",
            "name": "Study Procedures",
            "text": "",
            "order": 12,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.1.1",
            "sectionTitle": "Study Procedures"
          },
          {
            "id": "7462ceae-e22a-4711-abfd-6406e2b880ae",
            "name": "Optional Samples for Exploratory Research and Validation Studies",
            "text": "",
            "order": 13,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.1.2",
            "sectionTitle": "Optional Samples for Exploratory Research and Validation Studies"
          },
          {
            "id": "c7edcb8e-b3f1-49af-911f-a90d3a8e2571",
            "name": "Drug Concentration Measurements",
            "text": "",
            "order": 14,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.2",
            "sectionTitle": "Drug Concentration Measurements"
          },
          {
            "id": "06b41313-2334-4354-9138-0ddd1b53cdf0",
            "name": "Measurement Methods",
            "text": "",
            "order": 15,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.2.1",
            "sectionTitle": "Measurement Methods"
          },
          {
            "id": "8d3f4f69-ee56-43e3-bd4f-a9959c91f5fc",
            "name": "Efficacy Variables",
            "text": "",
            "order": 16,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.3",
            "sectionTitle": "Efficacy Variables"
          },
          {
            "id": "53871f27-3506-4eaa-bafa-faddcbe760c9",
            "name": "Primary Variables",
            "text": "",
            "order": 17,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.3.1",
            "sectionTitle": "Primary Variables"
          },
          {
            "id": "0f85817c-2aa5-48dd-8909-a1b164252909",
            "name": "Key Secondary Variables",
            "text": "",
            "order": 18,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.3.2",
            "sectionTitle": "Key Secondary Variables"
          },
          {
            "id": "ea20aa2b-6d2b-449b-b33f-fcae4adee983",
            "name": "Additional Variables",
            "text": "",
            "order": 19,
            "instanceType": "NarrativeContentItem",
            "sectionNumber": "5.3.3.3",
            "sectionTitle": "Additional Variables"
          }
        ],
        "abbreviations": [
          {
            "id": "4990170c-a714-43fe-b71e-26b5a9685c5c",
            "abbreviatedText": "QD",
            "expandedText": "once daily",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f653ee27-86d5-432e-8704-d50310cc5ac8",
            "abbreviatedText": "PsA",
            "expandedText": "Psoriatic Arthritis",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9a6f23e0-9537-4a72-87ba-f08c223b43a0",
            "abbreviatedText": "bDMARD",
            "expandedText": "Biologic Disease Modifying Anti-Rheumatic Drug",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9d67e0a7-67ab-40ea-9295-7970757523b4",
            "abbreviatedText": "Bio-IR",
            "expandedText": "inadequate response to bDMARDs",
            "instanceType": "Abbreviation"
          },
          {
            "id": "2d45ca50-5d0c-4006-a4e9-d3698b010880",
            "abbreviatedText": "ACR",
            "expandedText": "American College of Rheumatology",
            "instanceType": "Abbreviation"
          },
          {
            "id": "b181d6ea-5424-46c4-838d-43d93cb2edf6",
            "abbreviatedText": "ADL",
            "expandedText": "Activities of Daily Living",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a1a3a2c1-7e60-43e7-8e7e-fbecdd25bfb6",
            "abbreviatedText": "AE",
            "expandedText": "Adverse Event",
            "instanceType": "Abbreviation"
          },
          {
            "id": "7ac50786-0880-4cd3-9947-e902d544b13b",
            "abbreviatedText": "AESI",
            "expandedText": "Adverse Events of Special Interest",
            "instanceType": "Abbreviation"
          },
          {
            "id": "de89ad04-3a22-4ed0-8b68-36b9690b54b0",
            "abbreviatedText": "ALC",
            "expandedText": "Absolute Lymphocyte Count",
            "instanceType": "Abbreviation"
          },
          {
            "id": "45153e16-ba06-4a9f-91e8-69ce7a04e52b",
            "abbreviatedText": "ALT",
            "expandedText": "ALT",
            "instanceType": "Abbreviation"
          },
          {
            "id": "c91f298b-4fce-4cd1-a47f-fb91478da6a8",
            "abbreviatedText": "ANC",
            "expandedText": "Absolute Neutrophil Count",
            "instanceType": "Abbreviation"
          },
          {
            "id": "f7fa4b3b-bf4a-4225-99ed-e46a2a2b59f6",
            "abbreviatedText": "Anti-CCP",
            "expandedText": "Anti-Cyclic Citrullinated Peptide",
            "instanceType": "Abbreviation"
          },
          {
            "id": "55d8ad90-83f4-462b-8325-db2fcc1d4350",
            "abbreviatedText": "ASDAS",
            "expandedText": "Ankylosing Spondylitis Disease Activity Score",
            "instanceType": "Abbreviation"
          },
          {
            "id": "937d95cd-7c92-4c9c-a66d-13d2d0ea5f0c",
            "abbreviatedText": "AST",
            "expandedText": "Aspartate Transaminase",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cb1dcb62-c666-4ce2-a793-48e9178416ee",
            "abbreviatedText": "AUC",
            "expandedText": "Area under the plasma concentration-time curve",
            "instanceType": "Abbreviation"
          },
          {
            "id": "25049714-78e7-4d27-859d-1d8ba1e95ca6",
            "abbreviatedText": "BASDAI",
            "expandedText": "Bath Ankylosing Spondylitis Disease Activity Index",
            "instanceType": "Abbreviation"
          },
          {
            "id": "3200bc01-e14c-42dc-843f-4ca97519e3b8",
            "abbreviatedText": "BCG",
            "expandedText": "Bacillus Calmette-Guerin",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9911f8dc-82ba-4e16-8311-4875876bbe2a",
            "abbreviatedText": "BSA",
            "expandedText": "Body Surface Area",
            "instanceType": "Abbreviation"
          },
          {
            "id": "8c9dec69-c101-4012-bcb0-4d3d50536345",
            "abbreviatedText": "BUN",
            "expandedText": "Blood Urea Nitrogen",
            "instanceType": "Abbreviation"
          },
          {
            "id": "1129c4bf-cdb1-4c90-b7c7-32c229ee6a32",
            "abbreviatedText": "CASPAR",
            "expandedText": "Classification Criteria for Psoriatic Arthritis",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cdfc1d78-05bc-4f8c-a60c-5795a9c25332",
            "abbreviatedText": "CBC",
            "expandedText": "Complete Blood Count",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4c4e8de9-10f3-4fd0-b783-6d15658131f4",
            "abbreviatedText": "CCP",
            "expandedText": "Cyclic Citrullinated Peptide",
            "instanceType": "Abbreviation"
          },
          {
            "id": "97fe1961-c290-41ee-8ce9-0dd7d96acc59",
            "abbreviatedText": "CDAI",
            "expandedText": "Clinical Disease Activity Index",
            "instanceType": "Abbreviation"
          },
          {
            "id": "7aad0087-9365-4706-a16d-4a39b5d6aee3",
            "abbreviatedText": "CL/F",
            "expandedText": "Apparent Clearance",
            "instanceType": "Abbreviation"
          },
          {
            "id": "6828705f-efd1-4671-86d3-10b8ece74a2e",
            "abbreviatedText": "Cmax",
            "expandedText": "Maximum Observed Plasma Concentration",
            "instanceType": "Abbreviation"
          },
          {
            "id": "353194d8-bb7b-4eeb-9da0-d45c7f77e1d9",
            "abbreviatedText": "Cmin",
            "expandedText": "Minimum Observed Plasma Concentration",
            "instanceType": "Abbreviation"
          },
          {
            "id": "cfa2d957-668b-4ed6-9966-6c1e248ca1c2",
            "abbreviatedText": "COVID-19",
            "expandedText": "Coronavirus Disease  2019",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9cff9ff7-b40b-4709-8ad1-cbdf7e7b6aa6",
            "abbreviatedText": "CRF",
            "expandedText": "Case Report Form",
            "instanceType": "Abbreviation"
          },
          {
            "id": "4fe958ad-d10a-48b5-b0e9-a11330f9d81a",
            "abbreviatedText": "CS",
            "expandedText": "Clinically Significant",
            "instanceType": "Abbreviation"
          },
          {
            "id": "a2479c9e-3235-4e72-9c8d-666262497259",
            "abbreviatedText": "csDMARD",
            "expandedText": "Conventionally synthetic Disease Modifying Anti-Rheumatic Drug",
            "instanceType": "Abbreviation"
          },
          {
            "id": "dfe45931-2b2f-4112-94b1-a9e23d84ba10",
            "abbreviatedText": "CSR",
            "expandedText": "Clinical Study Report",
            "instanceType": "Abbreviation"
          },
          {
            "id": "0b7923f5-641b-497d-9004-9cc1ef6a506f",
            "abbreviatedText": "CTCAE",
            "expandedText": "Common Terminology Criteria for Adverse Events",
            "instanceType": "Abbreviation"
          },
          {
            "id": "80ec52c1-147e-47c4-8595-6bd15cdd766b",
            "abbreviatedText": "CXR",
            "expandedText": "Chest X-Ray",
            "instanceType": "Abbreviation"
          },
          {
            "id": "9b7b494a-067b-4453-8982-4d1982a2e050",
            "abbreviatedText": "CYP3A",
            "expandedText": "Cytochrome P450 3A",
            "instanceType": "Abbreviation"
          }
        ],
        "amendments": [
          {
            "id": "017490b1-1e1d-4b76-b0df-1ce87b66f134",
            "number": "1",
            "name": "Amendment 1",
            "scope": {
              "id": "bafd6537-b061-477e-870d-1cff6af4a84f",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "0275454d-c905-4cdf-862f-3193ed286833",
              "code": {
                "id": "f4242d7e-235c-41b9-9f7e-9cd83dd334b8",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "c5fc532d-c052-4780-904a-5f55eda428a5",
                "type": {
                  "id": "36269331-b34a-40c5-a9c0-2163eecf81c6",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Not provided in the summary of changes text for Amendment 8.",
            "effectiveDate": "2017-02-27",
            "reasonIds": [
              "a9b53503-4bb8-4870-8cdc-6a9b54ec03f4"
            ],
            "previousVersion": "Original",
            "newVersion": "Amendment 1"
          },
          {
            "id": "5f70a8e7-38cf-4239-89b7-778bae2e4a87",
            "number": "2",
            "name": "Amendment 2",
            "scope": {
              "id": "edec38f1-5e8c-4917-9773-81380cee0a06",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "11c5c600-5fbd-43d4-86de-c1511e6f1671",
              "code": {
                "id": "f8a00aec-07f5-4468-bd10-09010e61000f",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "5a0e92a5-8c8e-42f4-acd6-bcbb8e756c9f",
                "type": {
                  "id": "b696c34a-579e-47b5-ac82-396083fb2ba8",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Not provided in the summary of changes text for Amendment 8.",
            "effectiveDate": "2017-03-03",
            "reasonIds": [
              "1995910c-5709-42ec-b53d-89ff4a5a91f0"
            ],
            "previousVersion": "Amendment 1",
            "newVersion": "Amendment 2"
          },
          {
            "id": "52b4bad3-af04-4e0d-94d2-1f2c61c6ef74",
            "number": "2.01 (VHP Countries)",
            "name": "Amendment 2.01 (VHP Countries)",
            "scope": {
              "id": "51f3c845-6466-40f2-895b-abdc019c2469",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "3b42977a-ebf5-4477-b104-41e191d92025",
              "code": {
                "id": "76971c48-2e76-4bca-8a32-3d0b950ecd53",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "f6a6e366-f5e4-48c7-8176-bd9c567a733b",
                "type": {
                  "id": "f1a723fc-411b-40be-ab4c-8e62e0f4caeb",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Not provided in the summary of changes text for Amendment 8.",
            "effectiveDate": "2017-06-21",
            "reasonIds": [
              "973ace73-d125-4047-9b1a-b5763c0dae21"
            ],
            "previousVersion": "Amendment 2",
            "newVersion": "Amendment 2.01"
          },
          {
            "id": "009616ea-8634-4441-8751-7b4c6149d9ea",
            "number": "3",
            "name": "Amendment 3",
            "scope": {
              "id": "fb7db862-d7ed-492a-ac50-0921c7556b90",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "00918ab8-1123-43d8-8569-962d56c9af98",
              "code": {
                "id": "43de3673-2baa-4bcf-b203-a909f928ad3d",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "c8d1a710-b7af-4a4c-8cad-2b5a3a83cba9",
                "type": {
                  "id": "e6151219-ac8c-44f1-b76e-2d42b287d5f2",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Not provided in the summary of changes text for Amendment 8.",
            "effectiveDate": "2017-07-07",
            "reasonIds": [
              "7edb27e3-d5f3-432c-a237-6934766390ef"
            ],
            "previousVersion": "Amendment 2.01",
            "newVersion": "Amendment 3"
          },
          {
            "id": "b53b4b0a-6b8e-47bd-94ae-555cca8b652d",
            "number": "4",
            "name": "Amendment 4",
            "scope": {
              "id": "f881fa90-c325-4d62-bd74-30cea1393171",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "4a80d19a-6d34-4769-bd89-64a1a98b99d2",
              "code": {
                "id": "9bbe8ed0-c774-4290-8a76-0c2f8b15e3af",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "39f828dd-51e0-448d-8037-b49a008e21b8",
                "type": {
                  "id": "c4cf3170-f7ed-4df4-9029-ec1ac7f427c5",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Not provided in the summary of changes text for Amendment 8.",
            "effectiveDate": "2018-03-23",
            "reasonIds": [
              "349e0c8d-dbad-43d6-b94f-fd27173cb9bd"
            ],
            "previousVersion": "Amendment 3",
            "newVersion": "Amendment 4"
          },
          {
            "id": "229177c2-f4a9-4b93-bd27-4d0496348ef6",
            "number": "5",
            "name": "Amendment 5",
            "scope": {
              "id": "2f2d3987-77c1-4b8f-affa-e1df4522a2cd",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "2d0fb304-b4a8-463d-85d6-d68379159486",
              "code": {
                "id": "41639aae-b9a6-43ee-b95c-fe17d634781b",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "27ecc30b-8797-4067-bf75-784d79cec8ea",
                "type": {
                  "id": "be2f124f-5c66-4c77-b4eb-7831421d5d04",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Not provided in the summary of changes text for Amendment 8.",
            "effectiveDate": "2019-01-14",
            "reasonIds": [
              "375e67e7-ae3a-44c3-ab40-093fd95a9ea7"
            ],
            "previousVersion": "Amendment 4",
            "newVersion": "Amendment 5"
          },
          {
            "id": "d14575e3-d0d4-4cc4-98ac-90eec95b183f",
            "number": "6",
            "name": "Amendment 6",
            "scope": {
              "id": "783e774d-be6c-4b38-ae35-ca1cc694473b",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "ae39915d-0279-43f1-a26b-685d76c0b838",
              "code": {
                "id": "27642ad9-259c-45a9-9c42-01e5ddd6debc",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "01385216-cc82-47fe-890c-362c519c2e26",
                "type": {
                  "id": "16a44fad-b83e-451f-b20b-6e8b349a2238",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Not provided in the summary of changes text for Amendment 8.",
            "effectiveDate": "2019-10-04",
            "reasonIds": [
              "2b4540a0-49ac-45b2-9ace-dae3c0f21b4a"
            ],
            "previousVersion": "Amendment 5",
            "newVersion": "Amendment 6"
          },
          {
            "id": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
            "number": "7",
            "name": "Amendment 7",
            "scope": {
              "id": "7f669342-b9b0-4126-bbba-747fd7eb53ab",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "bd96b73d-9043-4f28-ae2a-f2039f7b3295",
              "code": {
                "id": "bbc512e0-22d0-4962-8a3a-cdf910e706ae",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "fb203ad1-30e6-4b95-a030-72b0729127b4",
                "type": {
                  "id": "a3a97526-6381-497d-a510-4e76d6fd7af1",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "Not provided in the summary of changes text for Amendment 8.",
            "effectiveDate": "2020-04-01",
            "reasonIds": [
              "0c3ba288-2f42-4878-8b19-c5f591516c9f"
            ],
            "previousVersion": "Amendment 6",
            "newVersion": "Amendment 7"
          },
          {
            "id": "950bbda8-5a56-41ee-81fa-7bc4aa0ebf14",
            "number": "8",
            "name": "Amendment 8",
            "scope": {
              "id": "21205158-8043-43e5-9e68-73f9aa4f080d",
              "code": "Global",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Global",
              "instanceType": "Code"
            },
            "primaryReason": {
              "id": "7dfa27d8-c8b4-4967-a60f-6c7401c554a3",
              "code": {
                "id": "054cce94-36fc-46c0-bcef-215fe05ffd76",
                "code": "C98782",
                "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
                "codeSystemVersion": "25.01d",
                "decode": "Protocol Amendment",
                "instanceType": "Code"
              },
              "otherReason": "Protocol Amendment",
              "instanceType": "StudyAmendmentReason"
            },
            "geographicScopes": [
              {
                "id": "db335ddf-cb1d-46cf-807a-adc049a350bc",
                "type": {
                  "id": "551c86bd-6f61-46c0-b54a-233e7e087fee",
                  "code": "Global",
                  "codeSystem": "USDM",
                  "codeSystemVersion": "2024-09-27",
                  "decode": "Global",
                  "instanceType": "Code"
                },
                "instanceType": "GeographicScope"
              }
            ],
            "instanceType": "StudyAmendment",
            "summary": "The purpose of this amendment is to apply administrative changes for consistency, update the study drug name to upadacitinib, switch subjects on 30 mg QD to 15 mg QD based on optimal dose determination, and provide flexibility for study procedures (virtual visits, local labs, DTP shipment) during state of emergency or pandemic situations.",
            "effectiveDate": "2021-01-29",
            "reasonIds": [
              "0ffd66cb-a5d0-44d7-995d-d624eaac9b9d",
              "bbf6cbbb-9a7b-4860-a799-7b477d99b5c7",
              "c10cf696-0a25-4f40-ae92-7fb8ca33cff4",
              "ec2707ec-cf9c-4c31-9bbd-1ba7b0241cb5",
              "d179ecfc-d6cb-4de3-bb68-5b3d55f973bc"
            ],
            "previousVersion": "Amendment 7",
            "newVersion": "Amendment 8"
          }
        ],
        "medicalDevices": [
          {
            "id": "f50e7045-80d4-4d86-b86f-7bc80e87168b",
            "name": "X-ray Machine",
            "instanceType": "MedicalDevice",
            "label": "Imaging Equipment",
            "description": "Device used for performing chest x-rays and hand/foot x-rays",
            "deviceType": {
              "id": "293a86a1-03ee-4748-85f1-8c27f520a19e",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "4c20af8a-9445-4a64-89b5-7e7790a5475c",
            "name": "Electrocardiograph",
            "instanceType": "MedicalDevice",
            "label": "ECG Device",
            "description": "Device used to record 12-lead ECG",
            "deviceType": {
              "id": "64e043cc-7115-4120-866c-e2f69cbb8d6b",
              "code": "Diagnostic Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Diagnostic Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "fcfe34b5-8fd7-475f-93a6-c54ae9ba2734",
            "name": "Sphygmomanometer",
            "instanceType": "MedicalDevice",
            "label": "Blood Pressure Monitor",
            "description": "Device used to measure systolic and diastolic blood pressure",
            "deviceType": {
              "id": "a9ffe586-e3c5-410b-b33f-7b65876cca0b",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "48371ad6-556e-48c3-b72a-1d94607c5913",
            "name": "Thermometer",
            "instanceType": "MedicalDevice",
            "label": "Temperature Probe",
            "description": "Device used to measure body temperature",
            "deviceType": {
              "id": "3bf0e8e0-4a03-4ce2-aa0e-ade1137339dd",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "cc35a622-5aba-432d-b0bd-44d48ab33e14",
            "name": "Scale",
            "instanceType": "MedicalDevice",
            "label": "Weight Scale",
            "description": "Device used to measure body weight",
            "deviceType": {
              "id": "df2d07f1-d71c-4074-b9d7-ad0f60b41af2",
              "code": "Monitoring Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Monitoring Device",
              "instanceType": "Code"
            }
          },
          {
            "id": "1efb443f-6404-4ef7-a837-677d87fedddb",
            "name": "Pacemaker",
            "instanceType": "MedicalDevice",
            "label": "Cardiac Pacemaker",
            "description": "Implanted device mentioned in context of ECG interpretation limitations",
            "deviceType": {
              "id": "d862fb6a-e08e-4d86-ac92-b384db14d47c",
              "code": "Implantable Device",
              "codeSystem": "USDM",
              "codeSystemVersion": "2024-09-27",
              "decode": "Implantable Device",
              "instanceType": "Code"
            }
          }
        ],
        "conditions": [
          {
            "id": "f4b6141e-8060-4460-9abc-122467cf5a09",
            "name": "Active Disease Criteria",
            "instanceType": "Condition",
            "description": "Joint count requirements for enrollment",
            "text": ">= 3 tender joints (68 count) and >= 3 swollen joints (66 count) at Screening and Baseline"
          },
          {
            "id": "4db2a6d3-3ebf-466a-9e3f-b238acf7edae",
            "name": "Non-Responder Definition",
            "instanceType": "Condition",
            "description": "Criteria for rescue therapy eligibility",
            "text": "Not achieving at least 20% improvement in TJC and/or SJC at both Week 12 and Week 16"
          },
          {
            "id": "1754c99e-be76-456c-b564-5d3c91fcfcc6",
            "name": "Liver Function Exclusion",
            "instanceType": "Condition",
            "description": "Safety threshold for ALT/AST",
            "text": "Serum AST or ALT > 2 x ULN during screening"
          }
        ],
        "studySites": [
          {
            "id": "1a697db5-207c-498a-9f30-d67a0bd14582",
            "name": "Alabama Medical Group, PC /ID# 159836",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "1",
            "organizationId": "38de3542-f964-4228-869b-36f61d400161",
            "country": "United States"
          },
          {
            "id": "8224e76e-3e78-4915-a55b-2640e0b7b4c5",
            "name": "Arizona Arthritis & Rheumatology Research, PLLC /ID# 160047",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "2",
            "organizationId": "ba988083-246b-455f-b5cf-3e7aa3b1d2d8",
            "country": "United States"
          },
          {
            "id": "9ee279ba-06d3-49c6-87d7-edfd54e33625",
            "name": "Sun Valley Arthritis Center Ltd. /ID# 161203",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "3",
            "organizationId": "a98a3e48-edeb-4f0b-a923-f226c768aba2",
            "country": "United States"
          },
          {
            "id": "ea6bb2bf-6d81-455d-8636-07cd47ab6550",
            "name": "Duplicate_AZ Arthritis and Rheumotology Research, PLLC /ID# 160006",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "4",
            "organizationId": "7700dce3-03a8-4758-a407-66b0826e0ef3",
            "country": "United States"
          },
          {
            "id": "b35a2c2b-1ced-406c-8f4b-4bd1ee67725f",
            "name": "Osteoporosis Medical Center /ID# 161411",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "5",
            "organizationId": "6943ca5b-b228-468a-ae88-b8af5ec6b856",
            "country": "United States"
          },
          {
            "id": "7ce73618-8cda-4945-a475-4a5b13aa9edb",
            "name": "Covina Arthritis Clinic /ID# 159919",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "6",
            "organizationId": "5031a9df-1a4f-4043-b87b-0a26dabf24f6",
            "country": "United States"
          },
          {
            "id": "53a0d5db-acf5-4e35-b33b-d357328304b8",
            "name": "Triwest Research Associates /ID# 159915",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "7",
            "organizationId": "f366ebb1-f6e1-4adb-9b3e-756782edeabd",
            "country": "United States"
          },
          {
            "id": "8a362723-0c68-4add-a1ee-673ab3720819",
            "name": "Duplicate_Providence Medical Foundation /ID# 160005",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "8",
            "organizationId": "2ea8a229-3178-4fbd-8971-995b470bbafc",
            "country": "United States"
          },
          {
            "id": "f9f66ad9-e21b-4904-a8ae-e2514db28605",
            "name": "C.V. Mehta MD, Med Corporation /ID# 161192",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "9",
            "organizationId": "30cc116c-113a-4fe5-b44a-f395007fea95",
            "country": "United States"
          },
          {
            "id": "65aa186d-5167-40a8-a6ba-cab257da0c33",
            "name": "Care Access Research, Huntington Beach /ID# 160049",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "10",
            "organizationId": "91bce9c9-616f-4bf0-9e45-149eedebd3f0",
            "country": "United States"
          },
          {
            "id": "86a1c7e7-fc95-44f5-ac3f-ebf6c3a0d552",
            "name": "Purushotham & Akther Kotha MD, Inc /ID# 159834",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "11",
            "organizationId": "99abd5c3-36a5-49a7-8224-22de0f7e46e2",
            "country": "United States"
          },
          {
            "id": "46000346-5e1f-451a-acd5-b322f0dc6f5c",
            "name": "Stanford University School of Med /ID# 161402",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "12",
            "organizationId": "066083ab-d38b-4cc2-ae7a-d2ac5242e76f",
            "country": "United States"
          },
          {
            "id": "6d76422a-3733-4483-8ca0-09ad404e41f8",
            "name": "Inland Rheum Clin Trials Inc. /ID# 159839",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "13",
            "organizationId": "9d6a2a6f-2bea-4ed5-96b6-f99854f27537",
            "country": "United States"
          },
          {
            "id": "36691f77-5440-4da7-944c-691134929f7d",
            "name": "Medvin Clinical Research /ID# 160045",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "14",
            "organizationId": "80a40dee-4d93-4069-ab00-00a9cdd3077b",
            "country": "United States"
          },
          {
            "id": "e813ec21-8edf-4221-8f02-7dacfe719652",
            "name": "Denver Arthritis Clinic /ID# 159899",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "15",
            "organizationId": "b01fbd24-1b79-4f60-ad27-2a01087dfb4f",
            "country": "United States"
          },
          {
            "id": "79649da0-105d-46db-b42e-870a82aa933c",
            "name": "Colorado Arthritis Associates /ID# 159856",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "16",
            "organizationId": "116536f0-6081-4a86-8ceb-87e558ac0a59",
            "country": "United States"
          },
          {
            "id": "cc35b969-25c0-4fd8-92d5-8e1cf4e72403",
            "name": "Duplicate_Arthritis & Rheumatic Disease Specialties /ID# 161409",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "17",
            "organizationId": "53e12e7e-9900-4f97-af55-d06d531bea2a",
            "country": "United States"
          },
          {
            "id": "f2be58c5-8813-4604-8d1c-e777714c9166",
            "name": "International Medical Research /ID# 160051",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "18",
            "organizationId": "438866c4-04a8-488a-b56f-1ccff2db9a17",
            "country": "United States"
          },
          {
            "id": "0be947a6-e0cc-4dda-bc5c-b1e38deebe47",
            "name": "Precision Research Organization /ID# 161293",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "19",
            "organizationId": "5f8c5137-7bd1-4a86-b986-2f0c8ac85eef",
            "country": "United States"
          },
          {
            "id": "7de4ad4c-481f-45b3-8aba-8103320299b3",
            "name": "Duplicate_Suncoast Clinical Research /ID# 161417",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "20",
            "organizationId": "4bbd9c82-4c9a-4dee-8a45-b8bb11fd48c1",
            "country": "United States"
          },
          {
            "id": "8b6de175-7d21-4510-aedf-70ac7bd02b21",
            "name": "Millennium Research /ID# 159833",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "21",
            "organizationId": "0ec5859b-7189-49df-9850-5a6f29a9b99a",
            "country": "United States"
          },
          {
            "id": "737922e3-0fc6-4cb0-a68c-7fabc6a24cab",
            "name": "Arthritis Center, Inc. /ID# 163463",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "22",
            "organizationId": "1e62e514-9b72-49d8-ae9b-0eeb9fbc9fa5",
            "country": "United States"
          },
          {
            "id": "245fcac1-23b0-4144-85bd-0595527c6fea",
            "name": "Gulf Region Clinical Res Inst /ID# 159860",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "23",
            "organizationId": "e8c1117d-493e-49eb-8583-d8820363ef60",
            "country": "United States"
          },
          {
            "id": "79db0372-a068-452c-b95c-be6353658c11",
            "name": "Sarasota Arthritis Center /ID# 159854",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "24",
            "organizationId": "7710ccf6-e036-40cb-882b-7e59b791c125",
            "country": "United States"
          },
          {
            "id": "a57c7cdd-68f1-479f-8513-d413e1cba6b6",
            "name": "BayCare Medical Group /ID# 161405",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "25",
            "organizationId": "733e9055-cb5b-4b83-9f3d-a0aa7447b38d",
            "country": "United States"
          },
          {
            "id": "7ceeb370-1eed-4b58-9256-453dfdd54b67",
            "name": "West Broward Rheumatology Associates /ID# 161412",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "26",
            "organizationId": "2e31e24d-5787-405a-b7c4-d288ed38a311",
            "country": "United States"
          },
          {
            "id": "fa874031-fe4f-4f62-8a03-564b15bfcad8",
            "name": "Clinical Research of West Florida - Tampa /ID# 160069",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "27",
            "organizationId": "fe8e7258-9698-4fa8-a3f7-cb9eadcae4db",
            "country": "United States"
          },
          {
            "id": "4fd199ee-6295-4d58-bf31-96d10b7ae13a",
            "name": "Clinical Research of West Florida, Inc /ID# 159840",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "28",
            "organizationId": "34129287-fa2e-43e2-bdf1-6adeb3907538",
            "country": "United States"
          },
          {
            "id": "d21ef461-aa93-4f4e-9b67-7e8d567b4a0d",
            "name": "USF Health Morsani Center for /ID# 161291",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "29",
            "organizationId": "5fcd19bc-4ee7-4305-94d5-db3733727cce",
            "country": "United States"
          },
          {
            "id": "fc1d2e36-422a-4f6b-a226-d76166d16783",
            "name": "BayCare Medical Group, Inc. /ID# 159912",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "30",
            "organizationId": "4a268a3f-fe67-4069-811b-0fabfa8d775a",
            "country": "United States"
          },
          {
            "id": "48ab45c8-dcb8-4874-b621-65f8cdf76891",
            "name": "Florida Medical Clinic /ID# 160013",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "31",
            "organizationId": "d68088ff-1819-4ca7-90d8-331120a5af42",
            "country": "United States"
          },
          {
            "id": "e81ef712-2cbf-4f34-b1c7-4197ef3d2d22",
            "name": "Jefrey D. Lieberman, MD, P.C. /ID# 159842",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "32",
            "organizationId": "00fb0999-ee71-4488-9cc2-f2addfb3e979",
            "country": "United States"
          },
          {
            "id": "058d090c-1f70-419e-a61c-1d4c0627ad1a",
            "name": "Atlanta Research Center for Rheumatology /ID# 161201",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "33",
            "organizationId": "c30268bc-094a-4e07-ad92-06f95ead14f3",
            "country": "United States"
          },
          {
            "id": "6cceb8e0-c8ad-495a-be89-9e4ece08dc10",
            "name": "Velocity Clinical Research - Boise /ID# 159922",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "34",
            "organizationId": "cda4c63e-b07b-417b-a3b6-370ff1321a35",
            "country": "United States"
          },
          {
            "id": "7bdc36a2-90b3-43de-8901-6ca3bf26f06c",
            "name": "Great Lakes Clinical Trials /ID# 163438",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "35",
            "organizationId": "4c42fc1b-8070-47ab-9073-92c54fd0d392",
            "country": "United States"
          },
          {
            "id": "6ceda17b-9288-4b3f-aa52-62bd45e39b91",
            "name": "Deerbrook Medical Associates /ID# 159815",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "36",
            "organizationId": "f62078aa-8ddc-46b5-a13a-1ff0854dfeae",
            "country": "United States"
          },
          {
            "id": "d75e30f7-0ac7-482a-9c44-378564691435",
            "name": "Duplicate_Clinic of Robert Hozman/Clinical Investigation Specialists /ID# 160068",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "37",
            "organizationId": "855d51af-c650-41eb-ae18-51ce3f5b4fad",
            "country": "United States"
          },
          {
            "id": "891756fd-1f78-4641-a5c7-815e33c3fedf",
            "name": "The Arthritis & Diabetes Clinic, Inc. /ID# 161294",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "38",
            "organizationId": "8c10a19d-9008-43a5-9101-20003dffbe41",
            "country": "United States"
          },
          {
            "id": "805d4827-c80d-4c5a-9807-7afdf1550cb2",
            "name": "Arthritis Treatment Center /ID# 160053",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "39",
            "organizationId": "ee55b859-f5cf-4070-b8e1-9eae5fab4b83",
            "country": "United States"
          },
          {
            "id": "16463af5-0fa8-4285-be41-d937ab91a5e3",
            "name": "The Center for Rheumatology and Bone Research /ID# 159900",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "40",
            "organizationId": "c3064c2c-8515-413e-8c29-aa9632c09ecd",
            "country": "United States"
          },
          {
            "id": "254af030-8f1a-46d5-a6b0-713f929c642e",
            "name": "Clinical Pharmacology Study Group /ID# 158712",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "41",
            "organizationId": "dcb23b04-2e39-457d-b250-f56cecee5322",
            "country": "United States"
          },
          {
            "id": "981c3303-262b-499b-9b87-9d643384772e",
            "name": "Clinvest Research LLC /ID# 161208",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "42",
            "organizationId": "6967bbc0-67f4-480f-8c2d-a695040e4197",
            "country": "United States"
          },
          {
            "id": "bc9d9ccb-8806-408d-8a77-84b384cc8856",
            "name": "Westroads Clinical Research /ID# 160004",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "43",
            "organizationId": "b2bd5996-52cd-4493-8745-c99bd68ccd33",
            "country": "United States"
          },
          {
            "id": "4640a948-ed21-47f3-98a8-d50223ffd24e",
            "name": "Atlantic Coast Research /ID# 159810",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "44",
            "organizationId": "ca919438-518f-4dcd-aece-cb036bd3dba2",
            "country": "United States"
          },
          {
            "id": "e9614102-8ee2-43c0-beb5-09ecc690b4ca",
            "name": "Duplicate_Arthritis and Osteo Assoc /ID# 160015",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "45",
            "organizationId": "9d7a765c-0a6f-4ad2-9209-86153208e9fe",
            "country": "United States"
          },
          {
            "id": "22cac957-fe0d-4021-a0da-62d93ec7f104",
            "name": "Center for Rheumatology LLP /ID# 167046",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "46",
            "organizationId": "9de175bd-5787-4d63-b022-c4f0ee76b6fb",
            "country": "United States"
          },
          {
            "id": "9663f86e-d720-4a62-a00e-29ef6a8ac3c4",
            "name": "St. Lawrence Health System /ID# 159857",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "47",
            "organizationId": "deb9c1f3-645b-4abe-a2bf-af0905d25984",
            "country": "United States"
          },
          {
            "id": "2e704fff-4162-4096-b977-dda418d05774",
            "name": "DJL Clinical Research, PLLC /ID# 161414",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "48",
            "organizationId": "a9e1dd4e-0ebe-428d-ad9c-e895cd4cdf35",
            "country": "United States"
          },
          {
            "id": "b9097292-0791-4f4a-a93e-a0494ac3a009",
            "name": "Physicians East, PA /ID# 159898",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "49",
            "organizationId": "06ba12a8-7fe2-489e-b56a-67aaef848d4c",
            "country": "United States"
          },
          {
            "id": "17fd01f6-abea-4c39-bb4b-abcd7e2cbd3a",
            "name": "Shanahan Rheuma & Immuno /ID# 160012",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "50",
            "organizationId": "5386582a-d443-4e42-84e8-e4f567d6838a",
            "country": "United States"
          },
          {
            "id": "a252a194-b822-4b36-a80c-8c69b1a12244",
            "name": "PMG Research of Wilmington LLC /ID# 161403",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "51",
            "organizationId": "f91f30d7-2216-430b-848a-541159bb4cb8",
            "country": "United States"
          },
          {
            "id": "40d7cd45-7ee8-4b1e-b743-a2600a052793",
            "name": "Trinity Health Med Arts Clinic /ID# 159811",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "52",
            "organizationId": "e9e4e973-4b51-49af-95ee-4081a863bfbc",
            "country": "United States"
          },
          {
            "id": "b39fdf90-253f-4b2b-992a-0fc4da434107",
            "name": "STAT Research, Inc. /ID# 161416",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "53",
            "organizationId": "bcc874a4-f85a-44cf-ac7a-feb3e236717c",
            "country": "United States"
          },
          {
            "id": "767ff3a4-27ee-4076-b263-e6a5cf466dca",
            "name": "Health Research of Oklahoma /ID# 159913",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "54",
            "organizationId": "0ecc75e2-6283-4ca4-85ac-445924eff292",
            "country": "United States"
          },
          {
            "id": "599c06c1-4b97-46e2-8a68-4d4330e2f109",
            "name": "Altoona Ctr Clinical Res /ID# 159861",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "55",
            "organizationId": "1a49bfd3-acd4-445c-b47e-a1248d7d59bb",
            "country": "United States"
          },
          {
            "id": "dd813548-0dfa-4773-a3ca-1cc8f8833c7f",
            "name": "University of Pittsburgh MC /ID# 161193",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "56",
            "organizationId": "b0c2f54d-59ec-4d28-b113-dc8326b572ed",
            "country": "United States"
          },
          {
            "id": "a4ddfde5-9c7e-47f4-891b-a8fc6d1b66c5",
            "name": "Articularis Healthcare Group, Inc d/b/a Low Country Rheumatology /ID# 163462",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "57",
            "organizationId": "5f5b1cb4-7e44-40f3-b952-5b6a14457e4b",
            "country": "United States"
          },
          {
            "id": "4df0daa3-0842-44ed-9784-d21bfe0dc8dd",
            "name": "Rheumatology Consultants, PLLC /ID# 161408",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "58",
            "organizationId": "809155a9-6ae9-4949-b6aa-c902ce358b43",
            "country": "United States"
          },
          {
            "id": "23f4962f-d218-46f3-8141-c1ac9afa0b54",
            "name": "Dr. Ramesh Gupta /ID# 160067",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "59",
            "organizationId": "0325899c-c5e7-4911-a155-d57be4b060da",
            "country": "United States"
          },
          {
            "id": "690bfecf-dd71-4556-a546-bb280d9971f8",
            "name": "Tekton Research, Inc. /ID# 160008",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "60",
            "organizationId": "0a1f772a-3ac0-4e1f-9dad-858ad4fe5cf9",
            "country": "United States"
          },
          {
            "id": "aab2a776-dee2-4cfa-8d04-5135b97d662a",
            "name": "Diagnostic Group /ID# 161406",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "61",
            "organizationId": "7cb19065-a55a-4e2b-a5cf-84b283bce625",
            "country": "United States"
          },
          {
            "id": "c45ee1b2-6cbf-4454-8cd5-2f2b74750a8b",
            "name": "Arthritis and Osteoporosis Clinic Of Brazos Valley /ID# 163439",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "62",
            "organizationId": "eb499d59-e17a-4bdd-90e9-b017c099b2b2",
            "country": "United States"
          },
          {
            "id": "9cfcc6de-d56a-43d9-b0ad-795431700bc9",
            "name": "Adriana Pop-Moody MD Clinic PA /ID# 160009",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "63",
            "organizationId": "22ecb887-30da-4045-91d6-67ffe2c9cdbb",
            "country": "United States"
          },
          {
            "id": "8807215d-ea76-483e-80ab-5fa99da93c35",
            "name": "Metroplex Clinical Research /ID# 159818",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "64",
            "organizationId": "0b54f25c-5cd0-4d79-8aa6-7211c13a1c13",
            "country": "United States"
          },
          {
            "id": "0ab29ad0-6576-4c9b-b372-dff65cffe3c5",
            "name": "Rheumatic Disease Clin Res Ctr /ID# 161252",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "65",
            "organizationId": "fa0f2f6f-cb53-4998-9335-a0dbd71ba7f5",
            "country": "United States"
          },
          {
            "id": "1ed7265b-ca7b-4b91-9179-f1021076e7bb",
            "name": "Accurate Clinical Research /ID# 160052",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "66",
            "organizationId": "4af14fbc-b3ea-42a7-bbe8-d7b381252ff7",
            "country": "United States"
          },
          {
            "id": "16fccb59-0c6f-42d8-bfa8-465ee7b20587",
            "name": "P&I Clinical Research /ID# 159837",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "67",
            "organizationId": "d2efd92b-db14-4724-b28b-4b18985cb2c5",
            "country": "United States"
          },
          {
            "id": "e68c065d-0331-4817-b336-4e7ca2dcad48",
            "name": "SW Rheumatology Res. LLC /ID# 160014",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "68",
            "organizationId": "501b1bd6-8937-4096-97dc-2c4a55f55c2d",
            "country": "United States"
          },
          {
            "id": "507df6c3-433e-43ed-9ddd-fad9d69cca25",
            "name": "DM Clinical Research - Tomball /ID# 161753",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "69",
            "organizationId": "e52cff1d-3c23-4cde-a59d-98bf1ecdb82c",
            "country": "United States"
          },
          {
            "id": "49ec89bf-c30f-433d-8639-60b6d1b508ee",
            "name": "Arthritis & Osteoporosis Clinic /ID# 161400",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "70",
            "organizationId": "71095fe3-efee-4a27-b592-bcfbc848a4a8",
            "country": "United States"
          },
          {
            "id": "2088b9a9-3f63-4776-a21a-4ba5dd9c9de8",
            "name": "Arthritis Clinic of N. VA, P.C /ID# 159858",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "71",
            "organizationId": "7f712697-7d7a-4f8d-85a9-4d0ea21097c4",
            "country": "United States"
          },
          {
            "id": "bd4f6635-34ef-41bd-ad3e-c446a6241b82",
            "name": "Duplicate_Swedish Medical Center /ID# 159918",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "72",
            "organizationId": "55f5f437-3490-424f-aaa8-b8aff2d04108",
            "country": "United States"
          },
          {
            "id": "9bac3ea9-1961-47ac-abe4-97195e10f18e",
            "name": "Emeritus Research Sydney /ID# 166751",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "73",
            "organizationId": "6aef61e0-40aa-4d90-b5a1-1998aa39ffe1",
            "country": "Australia"
          },
          {
            "id": "28998cd9-2f6d-46df-89fc-3786efd36eb0",
            "name": "The Queen Elizabeth Hospital /ID# 200840",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "74",
            "organizationId": "17dba013-5c91-4ead-be08-646e5dc7175e",
            "country": "Australia"
          },
          {
            "id": "20e07ba3-28ca-482d-b667-4101f73fbe50",
            "name": "Box Hill Hospital /ID# 166752",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "75",
            "organizationId": "71a7c44e-f75a-4a74-aee3-cd78c638ce26",
            "country": "Australia"
          },
          {
            "id": "db7ab07a-4555-437e-b4e3-1300b83e32e1",
            "name": "Heidelberg Repatriation Hospital /ID# 167441",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "76",
            "organizationId": "358349d1-8fbb-4ce5-806d-2b0d7ce4b610",
            "country": "Australia"
          },
          {
            "id": "56b4eb80-0f74-497a-8b70-00ef15adcf53",
            "name": "ReumaClinic /ID# 164214",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "77",
            "organizationId": "2338c824-033f-4c77-bd46-0b80ef5f85f8",
            "country": "Belgium"
          },
          {
            "id": "1c6cc448-ddc5-4c0b-b140-847ed8da45f4",
            "name": "UZ Gent /ID# 164210",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "78",
            "organizationId": "e0fb4416-a559-49c8-8227-6a9f9f0e9d03",
            "country": "Belgium"
          },
          {
            "id": "59211bf5-8e75-48a5-9a1e-b8bbd4804c0c",
            "name": "CIP - Centro Internacional de Pesquisa /ID# 161808",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "79",
            "organizationId": "cc140b3c-9d03-4eae-85cc-bbb6c9f562b4",
            "country": "Brazil"
          },
          {
            "id": "b5e1416e-89b4-49e4-89ea-8c87d50dc022",
            "name": "Faculdade de Medicina do ABC /ID# 163489",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "80",
            "organizationId": "19dcb848-b2fa-4090-b79d-2d756ac13145",
            "country": "Brazil"
          },
          {
            "id": "1a54ce30-29f0-4ad1-9143-00d1cf12cda7",
            "name": "Hospital de Clnicas da Universidade Federal de Uberlndia /ID# 161794",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "81",
            "organizationId": "8bd3cc6e-7746-433d-b501-441515bf390a",
            "country": "Brazil"
          },
          {
            "id": "2f40d045-0bf9-4ccf-a9a3-c1fd0ecbc09a",
            "name": "Hospital de Clinicas de Porto Alegre /ID# 161795",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "82",
            "organizationId": "3ee12d69-84a8-4f6f-a4e0-f3d9c1ba6fe1",
            "country": "Brazil"
          },
          {
            "id": "ea8cb700-65fb-4524-aa39-262e7911b503",
            "name": "LMK Sevicos Medicos S/S /ID# 161806",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "83",
            "organizationId": "69980b59-0abe-41fd-a7f7-d9503ba91eab",
            "country": "Brazil"
          },
          {
            "id": "75583a8a-c63c-4ab8-867c-d9feb1e20fca",
            "name": "Duplicate_Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto - USP /ID# 163317",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "84",
            "organizationId": "486fbcda-41b5-4417-b9c8-4a64aed71d6f",
            "country": "Brazil"
          },
          {
            "id": "38f7c065-9e8b-416d-8460-e77e760c8615",
            "name": "Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao /ID# 161793",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "85",
            "organizationId": "160ba42f-e502-409a-a380-b75d1a831aa3",
            "country": "Brazil"
          },
          {
            "id": "0346c79c-4eda-41fd-9010-0bab9d315795",
            "name": "Percuro Clinical Research, Ltd /ID# 157835",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "86",
            "organizationId": "e6c10345-6668-470f-82e1-96c30ed2d47e",
            "country": "Canada"
          },
          {
            "id": "4338031d-8b2b-40bb-a887-05eb922c015d",
            "name": "CIADS Research Co Ltd /ID# 157843",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "87",
            "organizationId": "8edcb010-85c5-41a8-9a9a-6df4298d5fb3",
            "country": "Canada"
          },
          {
            "id": "75b1afc9-ffe1-4e73-ac05-c13814f09a8e",
            "name": "The Waterside Clinic /ID# 157838",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "88",
            "organizationId": "8350ea15-5e2f-4721-8e36-44c99aa16a0f",
            "country": "Canada"
          },
          {
            "id": "09ae11ea-a85d-44d2-82b9-d4bbf8ca399f",
            "name": "Groupe de Recherche en Maladies Osseuses Inc /ID# 157836",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "89",
            "organizationId": "42097697-1e6d-4591-9155-8222f81ce937",
            "country": "Canada"
          },
          {
            "id": "f9ccd097-3ba7-468d-83e4-49b224cd2b61",
            "name": "Centre de Recherche Musculo-Squelettique /ID# 163557",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "90",
            "organizationId": "2c4c32f6-86b5-4e96-b327-fd48f133e1d8",
            "country": "Canada"
          },
          {
            "id": "183407fe-8125-43b0-97b5-5eafb4b51565",
            "name": "CTR Estudios Clinicos /ID# 206038",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "91",
            "organizationId": "fa088bbd-363b-423b-8752-08bc3f7fd228",
            "country": "Chile"
          },
          {
            "id": "fa7d1548-6313-4d5e-9f94-c6a583725037",
            "name": "Duplicate_Clinica Dermacross /ID# 169537",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "92",
            "organizationId": "952bc87f-fe08-47f4-87c6-53b5333323ab",
            "country": "Chile"
          },
          {
            "id": "c2855b9a-2dcc-44e3-9fff-afcd0a964f0f",
            "name": "Duplicate_Centro Internacional de Estudios Clinicos /ID# 169543",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "93",
            "organizationId": "b4f02e18-e772-4270-b511-00284eb4b765",
            "country": "Chile"
          },
          {
            "id": "8e01fb5c-7bff-4e71-b180-b0d7b8963687",
            "name": "Prosalud Ltda. /ID# 169542",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "94",
            "organizationId": "eb5b6fd7-316f-4323-a842-26dbb149e33a",
            "country": "Chile"
          },
          {
            "id": "4f01b51a-4f86-43da-b064-ba27759a91f2",
            "name": "Revmatologie Bruntal, s.r.o /ID# 159632",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "95",
            "organizationId": "34211cfa-65d6-40b0-98cf-33a79a44ab5d",
            "country": "Czechia"
          },
          {
            "id": "5f47f47c-e589-4ac2-90a6-663ff9421bbd",
            "name": "Medical Plus, s.r.o. /ID# 159631",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "96",
            "organizationId": "95453313-0c9a-4fd0-ba29-8a15a52a85cf",
            "country": "Czechia"
          },
          {
            "id": "a746623a-f5ce-41bd-97ae-45a886983d3a",
            "name": "Hopital Saint Joseph /ID# 163755",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "97",
            "organizationId": "50989be9-f66c-4c09-b7bc-9ede038d941b",
            "country": "France"
          },
          {
            "id": "e8596b80-ec7e-4c89-a695-1df7c0c39c49",
            "name": "CHU Toulouse /ID# 163743",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "98",
            "organizationId": "1fd22ba0-f9f4-4fc6-bb2c-d264304cd034",
            "country": "France"
          },
          {
            "id": "d548df5f-e244-46b6-bd3b-9d8ca4c37bc7",
            "name": "Centre Hospitalier du Mans /ID# 163746",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "99",
            "organizationId": "e91d1ce1-599e-4a57-ab23-3fd17201a48b",
            "country": "France"
          },
          {
            "id": "fc508024-c109-4eb5-914a-78d7f30f6e54",
            "name": "CHRU Tours - Hopital Trousseau /ID# 163772",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "100",
            "organizationId": "e3b7c4f5-64c8-42de-a79e-b4eb8ab79da4",
            "country": "France"
          },
          {
            "id": "e8fd172b-1702-44ac-9c47-8cb2305fa5e1",
            "name": "Duplicate_CHU-Hospital Henri Mondor /ID# 163895",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "101",
            "organizationId": "f5be6372-fe32-4a1b-ace3-13de22f09112",
            "country": "France"
          },
          {
            "id": "d8db6827-ae52-4384-8b8c-6af4fe041d62",
            "name": "Duplicate_AP-HP - Hopital Lariboisiere /ID# 163773",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "102",
            "organizationId": "3da4c360-81fb-4b0b-9300-80f16a8f097a",
            "country": "France"
          },
          {
            "id": "66842b48-e9c4-4ba3-a633-120fcd2196bb",
            "name": "General Hospital of Athens Laiko /ID# 163474",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "103",
            "organizationId": "08b71dfa-8cd7-4ed6-a957-4807b31db31f",
            "country": "Greece"
          },
          {
            "id": "2b503c18-18c8-4b32-8be5-28a5808c79db",
            "name": "Naval Hospital of Athens /ID# 163495",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "104",
            "organizationId": "ef7045d2-ca26-45e5-8e96-a2f9a2fdcff9",
            "country": "Greece"
          },
          {
            "id": "b681f4f6-0726-4610-9874-fc17fbeeb148",
            "name": "Reg Gen Univ Hosp Larissa /ID# 163493",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "105",
            "organizationId": "c215ee72-541f-47bc-9784-e2748b11acc5",
            "country": "Greece"
          },
          {
            "id": "d79c33ed-4200-4ac4-ad4f-07f9d1ac3c41",
            "name": "Gyor-Moson-Sopron Varmegyei Petz Aladar Egyetemi Oktato Korhaz /ID# 162573",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "106",
            "organizationId": "132b0228-8f12-433b-80ad-46f2478b631c",
            "country": "Hungary"
          },
          {
            "id": "4b3a2422-406a-47bc-b791-e5e5dc283afb",
            "name": "Vital Medicina Kft /ID# 162571",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "107",
            "organizationId": "87ad68dc-bc29-4991-be65-c6c9a629d6df",
            "country": "Hungary"
          },
          {
            "id": "d9f9f0c7-8cd6-4c6e-b099-c601183a07ce",
            "name": "Betegapolo Irgalmasrend Budai Irgalmasrendi Korhaz /ID# 170911",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "108",
            "organizationId": "90e13aa9-7b0c-4b56-b981-75c1e0eae870",
            "country": "Hungary"
          },
          {
            "id": "93d44a9f-627e-493d-9637-f68665c2c4e4",
            "name": "Revita Reumatologiai Rendelo /ID# 162575",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "109",
            "organizationId": "33f16402-9962-43d0-958f-02ad62f11bca",
            "country": "Hungary"
          },
          {
            "id": "81a5e44a-e1a9-4e7e-81d3-062b7eec6519",
            "name": "Obudai Egeszsegugyi Centrum Kft. /ID# 162576",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "110",
            "organizationId": "d7dcba33-8f03-410f-9e35-e240c920bc64",
            "country": "Hungary"
          },
          {
            "id": "fddbf087-440b-4c4b-b7d3-2c4d1b2e4853",
            "name": "Debreceni Egyetem Kenezy Gyula Egyetemi Korhaz /ID# 162572",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "111",
            "organizationId": "9bd4593d-a419-4577-8a45-b4ef0ec16e9a",
            "country": "Hungary"
          },
          {
            "id": "3473c1ae-1b6f-49ee-b1c9-fcef984b1f5c",
            "name": "MV Krhz /ID# 162574",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "112",
            "organizationId": "934c6ecb-82d2-4ed5-b8ff-6fe462bf2692",
            "country": "Hungary"
          },
          {
            "id": "849d7748-f1ec-4a1e-9405-6e244b9d55c4",
            "name": "Azienda Ospedaliera Universitaria Federico II /ID# 202410",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "113",
            "organizationId": "f62eec02-e408-4f8a-86dc-933ccb2bfa9f",
            "country": "Italy"
          },
          {
            "id": "bbb2e1d5-afe4-4f01-a9bb-f076257d3efd",
            "name": "Duplicate_Fondazione Policlinico Universitario Campus Bio-Medico di Roma /ID# 164123",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "114",
            "organizationId": "7a626ce7-2525-4de9-9934-06ad797f1bb3",
            "country": "Italy"
          },
          {
            "id": "130a6157-4d77-4646-b70e-4098828fbb56",
            "name": "Duplicate_Fondazione PTV Policlinico Tor Vergata /ID# 162749",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "115",
            "organizationId": "fb437f08-0e7e-46a4-88e6-0cfef07a2136",
            "country": "Italy"
          },
          {
            "id": "090fdfea-9117-46a6-8925-a635a6462f45",
            "name": "Duplicate_Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona /ID# 162748",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "116",
            "organizationId": "02dd480c-0b37-496c-9b3a-eba24866df5e",
            "country": "Italy"
          },
          {
            "id": "4bb0c7cb-6647-4460-9e94-37505cf340ed",
            "name": "Duplicate_A.O.U. Policlinico G. Rodolico S.Marco- Presidio G.Rodolico /ID# 164126",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "117",
            "organizationId": "58c01731-2dee-4c80-acaa-193c1fefae88",
            "country": "Italy"
          },
          {
            "id": "7b069dad-ed00-4f85-906f-45e776a5efd6",
            "name": "Duplicate_AOU Arcispedale Sant Anna di /ID# 164127",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "118",
            "organizationId": "a8230ebf-00b1-47a4-904c-43d254d9f800",
            "country": "Italy"
          },
          {
            "id": "8f9718f9-1e1a-4829-965b-65298957742a",
            "name": "ASST Gaetano Pini/Presidio Ospedaliero Pini /ID# 164125",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "119",
            "organizationId": "dfd8daac-5acd-43f7-9aa7-fb7ad828a67f",
            "country": "Italy"
          },
          {
            "id": "8e085f97-b8c2-42d9-a0ed-3b2a90f5c9d2",
            "name": "Duplicate_Azienda Unita Sanitaria Locale/IRCCS /ID# 162751",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "120",
            "organizationId": "a5487560-727d-430e-8c48-646da4cc00cb",
            "country": "Italy"
          },
          {
            "id": "0d94bda0-206f-4c84-b99a-711ae0066191",
            "name": "Daido Hospital /ID# 163639",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "121",
            "organizationId": "ac117c83-c3fe-4be7-9b02-134c300bd6af",
            "country": "Japan"
          },
          {
            "id": "bb9d5855-09f1-4b8b-96f1-1a08b9f65702",
            "name": "Nagoya City University Hospital /ID# 162563",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "122",
            "organizationId": "364451d3-0e13-4601-ae6c-3ff88f1d269e",
            "country": "Japan"
          },
          {
            "id": "c6717674-3317-47b1-bba4-3d7b8b4a163d",
            "name": "Fukuoka University Hospital /ID# 161774",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "123",
            "organizationId": "c2a20b93-12c9-4a38-868b-3bcc884c0d91",
            "country": "Japan"
          },
          {
            "id": "2c5d063a-56fa-4602-b1b7-56cc3a561df8",
            "name": "Duplicate_Kitakyushu Municipal Medical Center /ID# 163516",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "124",
            "organizationId": "a6cfa4c8-9f2c-4325-aad6-bcc3f5fe4dad",
            "country": "Japan"
          },
          {
            "id": "ce9cd7fd-6b83-4928-ae84-756fbbbcb77b",
            "name": "Hospital of the University of Occupational and Environmental Health, Japan /ID# 161472",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "125",
            "organizationId": "6a7d1768-8666-4e7a-b186-893fc97d293f",
            "country": "Japan"
          },
          {
            "id": "4ebd2291-f800-47ed-b34c-53901a33674a",
            "name": "Asahikawa Medical University Hospital /ID# 200684",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "126",
            "organizationId": "cda4f12a-dc3b-47ec-a762-b59db7788baa",
            "country": "Japan"
          },
          {
            "id": "e617180f-9453-4f58-9bb8-4ce94161fae8",
            "name": "Mie University Hospital /ID# 162085",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "127",
            "organizationId": "d5227397-e484-4508-ae1a-c3ec019a7708",
            "country": "Japan"
          },
          {
            "id": "dc93197f-b357-43c4-87c1-84b49d42e1f6",
            "name": "Tohoku University Hospital /ID# 164035",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "128",
            "organizationId": "c4cff6c8-7dec-4f67-9208-4d096cf2b9d6",
            "country": "Japan"
          },
          {
            "id": "59cd3171-4008-4005-af4f-4801bffad1e3",
            "name": "Oribe Clinic of Rheumatism and Medicine /ID# 163704",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "129",
            "organizationId": "b83ad9e7-79d4-4cb5-b05d-b6ca10c85952",
            "country": "Japan"
          },
          {
            "id": "2d078976-711b-43ca-9fb5-7794f65c77e3",
            "name": "Kansai Medical University Hospital /ID# 162081",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "130",
            "organizationId": "ed63914f-fe27-4078-b4f3-5f26a1883c09",
            "country": "Japan"
          },
          {
            "id": "4e96ffc8-8855-4261-a0e8-0da9cdaaee64",
            "name": "National Hospital Organization Osaka Minami Medical Center /ID# 162589",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "131",
            "organizationId": "3106374c-3e50-4d31-b5b9-a22cade59902",
            "country": "Japan"
          },
          {
            "id": "3f4d7b79-bee2-4499-8578-4ff4313a5483",
            "name": "Osaka Metropolitan University Hospital /ID# 162082",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "132",
            "organizationId": "a47a7007-e0e2-4899-9d40-f03f75db75b9",
            "country": "Japan"
          },
          {
            "id": "e05eae7a-25a2-478a-a19a-e76165f89fc1",
            "name": "Nippon Life Saiseikai Public Interest Foundation Nippon Life Hospital /ID# 161773",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "133",
            "organizationId": "d73a8d12-4316-4355-b70b-8f9ada566bfd",
            "country": "Japan"
          },
          {
            "id": "3516a974-109d-4025-94b2-d40d6811eaaa",
            "name": "Juntendo University Hospital /ID# 162089",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "134",
            "organizationId": "8eb4fb5e-9e59-4e0e-ab2e-20e76d416140",
            "country": "Japan"
          },
          {
            "id": "92ba270d-83a6-4478-903b-42bdd53819fb",
            "name": "St.Luke's International Hospital /ID# 162013",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "135",
            "organizationId": "64e949bb-5ea0-4966-9617-176eacaa9f5f",
            "country": "Japan"
          },
          {
            "id": "503a64b4-800c-4067-b3cf-e145a3c8cc8e",
            "name": "Keio University Hospital /ID# 162130",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "136",
            "organizationId": "06dac7d2-95d0-44de-bd3b-593fd7ed9d4c",
            "country": "Japan"
          },
          {
            "id": "0cc73d37-04a4-4d9d-b469-5d437d72bc76",
            "name": "Medisch Centrum Leeuwarden /ID# 163049",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "137",
            "organizationId": "ac75a31c-424d-4131-b596-f700147e8d9e",
            "country": "Netherlands"
          },
          {
            "id": "5cb9f49e-385d-4f3a-a249-ecece8fed0e4",
            "name": "Duplicate_Erasmus Medisch Centrum /ID# 163052",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "138",
            "organizationId": "08d04c13-244f-4882-878c-e23aafb3219f",
            "country": "Netherlands"
          },
          {
            "id": "770ccacc-3b50-4658-b4d6-09b8c45bab9b",
            "name": "Maasstad Ziekenhuis /ID# 163050",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "139",
            "organizationId": "c64d082a-ecce-4cb3-a25c-6adfafdfd1a8",
            "country": "Netherlands"
          },
          {
            "id": "c21da853-5dd5-49bb-97a3-8698ded18c1f",
            "name": "Sint Maartenskliniek /ID# 163703",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "140",
            "organizationId": "eff4a7ab-40ca-4420-91d6-068e456a98a7",
            "country": "Netherlands"
          },
          {
            "id": "1b755faa-0abe-4a13-bf31-41babe728c79",
            "name": "Duplicate_Middlemore Hospital /ID# 166411",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "141",
            "organizationId": "c55baaed-d900-4c7c-a960-808316117343",
            "country": "New Zealand"
          },
          {
            "id": "4b60fa66-10fd-4df1-b1c6-901659f7dc90",
            "name": "Timaru Medical Specialists Ltd /ID# 166410",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "142",
            "organizationId": "94a6ed1b-6add-4429-a598-13cf85320cb1",
            "country": "New Zealand"
          },
          {
            "id": "c85139e3-64b5-4d28-8f18-8e8153f43894",
            "name": "Waikato Hospital /ID# 166412",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "143",
            "organizationId": "a1aaa17a-41d1-4591-8566-c84d616ff289",
            "country": "New Zealand"
          },
          {
            "id": "c72f8ba7-d08d-46d7-a729-d58cb0c5b70d",
            "name": "Porter Rheumatology Ltd /ID# 200422",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "144",
            "organizationId": "b7e4f1f4-b48c-4ab6-af47-f310d2bb7a94",
            "country": "New Zealand"
          },
          {
            "id": "04b71dbf-6e8b-4f63-bf8f-064cc0b1db84",
            "name": "Duplicate_Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE /ID# 165897",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "145",
            "organizationId": "187ec9f6-cd7a-4944-8770-0abce32b9090",
            "country": "Portugal"
          },
          {
            "id": "00a05a57-c3e8-4ce4-9a73-0ba67a058fd0",
            "name": "Unidade Local de Sade do Alto Minho, EPE - Hospital Conde de Bertiandos /ID# 165898",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "146",
            "organizationId": "9f91c71e-5ea1-41da-aceb-8c62bb04c569",
            "country": "Portugal"
          },
          {
            "id": "0ac103b0-1070-4dd1-a421-48f363f9be55",
            "name": "Instituto Portugues De Reumatologia /ID# 165894",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "147",
            "organizationId": "2e87537d-411a-496b-8624-98416a4491a8",
            "country": "Portugal"
          },
          {
            "id": "defad93c-cbfe-477a-8b63-85adcbd7be66",
            "name": "Centro Hospitalar de Lisboa Ocidental, EPE - Hospital Egas Moniz /ID# 165896",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "148",
            "organizationId": "fbb448f8-4ba3-41b5-ba5f-f046c5807c5a",
            "country": "Portugal"
          },
          {
            "id": "5cc81178-784f-419f-bf30-76e09c1dfe93",
            "name": "Unidade Local de Saude de Santa Maria, EPE /ID# 165895",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "149",
            "organizationId": "a2f27c90-f7d9-4ad3-9445-de763fb8f7a8",
            "country": "Portugal"
          },
          {
            "id": "d9f6349b-39d7-42dc-a0c7-eabba15325b9",
            "name": "Alma M. Cruz Santana, MD-Private practice /ID# 163308",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "150",
            "organizationId": "9fbf900f-dcbd-496e-80fb-319f5da0b0b7",
            "country": "Puerto Rico"
          },
          {
            "id": "76420ca6-e255-4b1a-874d-1b95e324dd6f",
            "name": "Ponce Medical School Foundation /ID# 163918",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "151",
            "organizationId": "d2deb0d8-0334-4524-8848-1757a263b352",
            "country": "Puerto Rico"
          },
          {
            "id": "87c3347d-1ee4-4d4a-82b3-179ceb6a8e23",
            "name": "GCM Medical Group PSC /ID# 163716",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "152",
            "organizationId": "3155d8a6-f4a4-4817-a2e0-faed31897d1d",
            "country": "Puerto Rico"
          },
          {
            "id": "ff23b7c4-d9ff-40c0-a3ef-a42cb3c1f142",
            "name": "Duplicate_Ajou University Hospital /ID# 163893",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "153",
            "organizationId": "dda6669c-5b4d-4a71-ba50-30805ca77c32",
            "country": "South Korea"
          },
          {
            "id": "abbf93a7-2279-4d44-88b5-b07ed375d247",
            "name": "Duplicate_Inha University Hospital /ID# 163892",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "154",
            "organizationId": "429b3017-7b37-44ed-a762-a6fdc96172b9",
            "country": "South Korea"
          },
          {
            "id": "a7156e88-a06c-4486-b066-03aaff32a108",
            "name": "Hospital Clinico Universitario Virgen de la Arrixaca /ID# 163138",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "155",
            "organizationId": "054368ba-50d1-4d93-ace5-2a8585f24095",
            "country": "Spain"
          },
          {
            "id": "8b0f688f-6b8a-47ed-baf7-ddf11cac38f4",
            "name": "Duplicate_Hospital Universitario A Coruna - CHUAC /ID# 161019",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "156",
            "organizationId": "d64a9898-b2a3-4d10-a2b2-0607f6a87162",
            "country": "Spain"
          },
          {
            "id": "6e4b17d0-b2aa-4b7d-b595-7f613e749644",
            "name": "Duplicate_Hospital Universitario Reina Sofia /ID# 170764",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "157",
            "organizationId": "2c1c4659-5704-4ac2-88e7-99582c50d8c5",
            "country": "Spain"
          },
          {
            "id": "7fab1f1b-ac6c-47d6-8293-08685cd0fb70",
            "name": "Hospital Campus de la Salud /ID# 170768",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "158",
            "organizationId": "300b175c-c432-49cc-bafd-03743fe9ca49",
            "country": "Spain"
          },
          {
            "id": "ad28345e-6c90-44f7-bd92-2912e654f47a",
            "name": "Hospital Universitario Ramon y Cajal /ID# 161020",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "159",
            "organizationId": "2df99695-308a-4938-8ad7-3eee5a5db916",
            "country": "Spain"
          },
          {
            "id": "257c16c6-65c6-4810-9c1f-bab89ea68b1e",
            "name": "Royal United Hospitals Bath /ID# 161054",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "160",
            "organizationId": "7cc3f42a-847c-4735-887f-74c70994d8fd",
            "country": "United Kingdom"
          },
          {
            "id": "caa63a50-5db6-41c6-b1e7-468840fb6183",
            "name": "Barts Health NHS Trust /ID# 161053",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "161",
            "organizationId": "41a715db-034d-437c-bbbc-ec1139ed2236",
            "country": "United Kingdom"
          },
          {
            "id": "128db05d-5b55-4e93-b5d4-2b36cdcc5b3d",
            "name": "Guys and St Thomas NHS Foundation Trust /ID# 161063",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "162",
            "organizationId": "de047215-27df-427b-839b-8bf1a34d09a6",
            "country": "United Kingdom"
          },
          {
            "id": "d65b942e-f93b-4a7d-9863-5ae36c731603",
            "name": "Duplicate_NHS Greater Glasgow and Clyde /ID# 162712",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "163",
            "organizationId": "07d0fcd1-bfc8-48a0-828d-04e06abc620a",
            "country": "United Kingdom"
          },
          {
            "id": "fcd61dab-fd7c-4581-b198-ccb15f3fb6e8",
            "name": "Duplicate_Bedfordshire Hospitals NHS Foundation Trust /ID# 162713",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "164",
            "organizationId": "9c197209-3605-4fd8-982f-cc3796ae8246",
            "country": "United Kingdom"
          },
          {
            "id": "090d72ef-efd8-4c7f-acc8-030df8005d14",
            "name": "Duplicate_Christchurch University Hospitals Dorset NHS University Hospitals Dors /ID# 162711",
            "status": "Completed",
            "instanceType": "StudySite",
            "siteNumber": "165",
            "organizationId": "da7f93aa-3679-45b9-9a7c-f479f402ef51",
            "country": "United Kingdom"
          }
        ],
        "administrations": [
          {
            "id": "6f8292f6-3c1f-4813-a7ae-ab197ad9921c",
            "name": "Administration of Upadacitinib",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "f1dbeca1-6dc9-479b-ac20-a3d66a742cd7",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          },
          {
            "id": "ea34a4f7-4383-4859-9a16-03c1d2fc2cb9",
            "name": "Administration of Placebo",
            "description": "RouteOfAdministration.ORAL DosingFrequency.ONCE_DAILY",
            "instanceType": "Administration",
            "route": {
              "id": "4efa85ca-42f2-4712-bb7b-bfef8ee452b2",
              "code": "C38288",
              "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
              "codeSystemVersion": "2024-09-27",
              "decode": "Oral",
              "instanceType": "Code"
            }
          }
        ],
        "rationale": "Protocol version"
      }
    ],
    "name": "A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (bDMARD)  SELECT  PsA 2"
  },
  "administrations": [
    {
      "id": "dfea7a79-e476-4815-be46-998b48370edd",
      "name": "Upadacitinib 15 mg QD",
      "instanceType": "Administration",
      "dose": "15 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "127ec500-0e41-44e3-9eaa-9739055df49b",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Up to approximately 3 years"
    },
    {
      "id": "d8f0a624-f403-415b-a53b-3fe8a57f83b1",
      "name": "Upadacitinib 30 mg QD",
      "instanceType": "Administration",
      "dose": "30 mg",
      "doseFrequency": "once daily",
      "route": {
        "id": "d8a89491-65ff-4986-b8e3-d7ddadadc1b0",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "Until Protocol Amendment 8 approval (then switched to 15 mg)"
    },
    {
      "id": "f526ecfc-bc9a-446b-91f4-631861cd08d5",
      "name": "Placebo QD",
      "instanceType": "Administration",
      "dose": "1 tablet",
      "doseFrequency": "once daily",
      "route": {
        "id": "b773cd81-40de-4024-ab40-162dc90c966e",
        "code": "Oral",
        "codeSystem": "USDM",
        "codeSystemVersion": "2024-09-27",
        "decode": "Oral",
        "instanceType": "Code"
      },
      "duration": "24 weeks"
    }
  ],
  "substances": [
    {
      "id": "fce17f26-54e0-40e1-bf70-7f2398247677",
      "name": "Upadacitinib",
      "instanceType": "Substance",
      "description": "Janus Kinase (JAK) 1 inhibitor"
    }
  ],
  "studyDefinitionDocument": {
    "id": "02d7a318-1cba-422c-b8db-bad3c47a2b39",
    "name": "A Phase 3, Randomized, Double-Blind, Study Comparing Upadacitinib (ABT-494) to Placebo in Subjects with Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (bDMARD)  SELECT  PsA 2",
    "documentType": "Protocol",
    "language": "en",
    "instanceType": "StudyDefinitionDocument",
    "version": "Amendment 8",
    "versionDate": "29 January 2021",
    "contentIds": [
      "e24a6804-2423-4377-8d38-e9e9f64e88dc",
      "609f7e9b-ea01-430f-844c-4428347d5b8d",
      "a4605bfb-c061-4b68-b978-c3c3576f1d37",
      "ad5f7c0a-47c8-46a6-8a30-5954903d8c3d",
      "86bcd445-ae65-4d6d-8bb0-bbeb9df8eb37",
      "1eef1c8a-864d-47fb-9206-e32acbdc586c",
      "bf0c534e-f177-4964-af0d-467222ae230a",
      "44db6bf9-dabb-48b5-9bdf-0cb3ee2e248e"
    ]
  },
  "geographicScope": {
    "id": "4fe68b0a-1e22-45d9-90d1-74a0366b0c69",
    "name": "Study Geographic Scope",
    "scopeType": "Global",
    "instanceType": "GeographicScope",
    "countryIds": [
      "8012ac25-f1d7-41f3-ad94-bedf5ed11907",
      "2a9aa254-7cd2-4002-8bd3-e7f341b3193c",
      "0e48c299-e40b-4493-b856-69382cc12cee",
      "e9ab504a-be15-483f-a942-08e1685b248d",
      "af5c2151-c08d-457f-b464-c437f154f068",
      "3c10358b-3914-4f03-8354-8305d496d27a",
      "e97d281c-3624-4e29-9bac-bb4bebc4f7c5",
      "e67687f3-c7d4-4128-bb66-36899fd3f604",
      "9652a9fb-b7bd-47e9-8271-f26ba6cc740c",
      "c5c4ea66-e8d0-4794-b973-00309e7a7742"
    ],
    "regions": [
      "North America",
      "South America",
      "Europe",
      "Africa",
      "Middle East",
      "Asia"
    ]
  },
  "countries": [
    {
      "id": "8012ac25-f1d7-41f3-ad94-bedf5ed11907",
      "name": "United States",
      "instanceType": "Country",
      "code": "US"
    },
    {
      "id": "2a9aa254-7cd2-4002-8bd3-e7f341b3193c",
      "name": "Germany",
      "instanceType": "Country",
      "code": "DE"
    },
    {
      "id": "0e48c299-e40b-4493-b856-69382cc12cee",
      "name": "Japan",
      "instanceType": "Country",
      "code": "JP"
    },
    {
      "id": "e9ab504a-be15-483f-a942-08e1685b248d",
      "name": "Belgium",
      "instanceType": "Country",
      "code": "BE"
    },
    {
      "id": "af5c2151-c08d-457f-b464-c437f154f068",
      "name": "Czech Republic",
      "instanceType": "Country",
      "code": "CZ"
    },
    {
      "id": "3c10358b-3914-4f03-8354-8305d496d27a",
      "name": "France",
      "instanceType": "Country",
      "code": "FR"
    },
    {
      "id": "e97d281c-3624-4e29-9bac-bb4bebc4f7c5",
      "name": "Greece",
      "instanceType": "Country",
      "code": "GR"
    },
    {
      "id": "e67687f3-c7d4-4128-bb66-36899fd3f604",
      "name": "Hungary",
      "instanceType": "Country",
      "code": "HU"
    },
    {
      "id": "9652a9fb-b7bd-47e9-8271-f26ba6cc740c",
      "name": "New Zealand",
      "instanceType": "Country",
      "code": "NZ"
    },
    {
      "id": "c5c4ea66-e8d0-4794-b973-00309e7a7742",
      "name": "Portugal",
      "instanceType": "Country",
      "code": "PT"
    }
  ],
  "ingredients": [
    {
      "id": "760b175c-ed64-4f99-9f41-fe54ba3c1b44",
      "name": "Upadacitinib",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "710d5f22-7492-4572-9c28-de733e8a4c2f"
    },
    {
      "id": "053f3694-fcae-465a-ad97-592b61f1e5b7",
      "name": "Methotrexate",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "MTX"
    },
    {
      "id": "aab95700-1344-49dc-adc9-56628a4d79e5",
      "name": "Leflunomide",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "LEF"
    },
    {
      "id": "b03a5304-4d0b-4008-9651-7a496bb4331d",
      "name": "Sulfasalazine",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "SSZ"
    },
    {
      "id": "ee78e82b-5024-42fe-b54f-621d13096e4d",
      "name": "Hydroxychloroquine",
      "role": "Active",
      "instanceType": "Ingredient",
      "substanceId": "HCQ"
    },
    {
      "id": "05df1a7b-eba0-493a-abc4-e05a09700244",
      "name": "Apremilast",
      "role": "Active",
      "instanceType": "Ingredient"
    },
    {
      "id": "e4e9b6f6-79d0-4d6d-a0f5-8293e0ce835b",
      "name": "Edetic acid",
      "role": "Inactive",
      "instanceType": "Ingredient",
      "substanceId": "EDTA"
    }
  ],
  "strengths": [
    {
      "id": "dcdb3892-18f1-4ef5-b389-889fd1897333",
      "instanceType": "Strength",
      "value": 15,
      "unit": "mg",
      "numerator": {
        "value": 15,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "QD"
      }
    },
    {
      "id": "e6ac1022-5623-4a3e-9e67-58938c8c5054",
      "instanceType": "Strength",
      "value": 30,
      "unit": "mg",
      "numerator": {
        "value": 30,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "QD"
      }
    },
    {
      "id": "6f1126a8-9007-495d-9272-61e35f9bfe79",
      "instanceType": "Strength",
      "value": 25,
      "unit": "mg",
      "numerator": {
        "value": 25,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "week"
      }
    },
    {
      "id": "3a6df677-bc27-4844-bbb7-8f7e94b65a64",
      "instanceType": "Strength",
      "value": 20,
      "unit": "mg",
      "numerator": {
        "value": 20,
        "unit": "mg"
      },
      "denominator": {
        "value": 1,
        "unit": "day"
      }
    }
  ],
  "transitionRules": [
    {
      "id": "ddd1750a-99ed-4723-81c7-4a1ffdf86c37",
      "name": "Screening to Baseline Transition",
      "instanceType": "TransitionRule",
      "transitionType": "Epoch Transition",
      "fromElementId": "c9b17b5e-a2ba-4a78-a02e-d5c2e4a49636",
      "toElementId": "a38c6edf-bc71-46f8-be2f-1f0d95128fb1",
      "text": "Subjects must meet all inclusion and no exclusion criteria at Baseline Visit (Day 1)"
    },
    {
      "id": "45dfc7e7-4521-4847-997f-05bef37ae3a6",
      "name": "Rescue Therapy Eligibility",
      "instanceType": "TransitionRule",
      "transitionType": "Rescue Therapy",
      "text": "After Week 16, non-responders may add or modify doses of non-biologic DMARDs or corticosteroids"
    },
    {
      "id": "b8d56436-b12d-4dda-992d-4bb980bf6731",
      "name": "Placebo Switch",
      "instanceType": "TransitionRule",
      "transitionType": "Arm Transition",
      "text": "At Week 24, all placebo subjects switch to upadacitinib 15 mg or 30 mg QD"
    },
    {
      "id": "8b66d6dc-7ddb-4c5b-b317-37dc8ccbec82",
      "name": "Dose Reduction (Amendment 8)",
      "instanceType": "TransitionRule",
      "transitionType": "Dose Modification",
      "text": "Subjects receiving 30 mg QD will be switched to 15 mg QD at their next scheduled visit"
    },
    {
      "id": "c0f8b058-4b88-468f-9721-bbfa8e9f90fc",
      "name": "Lack of Efficacy Discontinuation",
      "instanceType": "TransitionRule",
      "transitionType": "Discontinuation",
      "text": "Starting at Week 36, subjects failing to show 20% improvement in TJC/SJC at 2 consecutive visits must discontinue study drug"
    }
  ],
  "documentContentReferences": [
    {
      "id": "929e871b-c179-4abb-8e85-f28ffd6326c3",
      "name": "Prior and Concomitant DMARD Details",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.2.3.1",
      "sectionTitle": "Prior Therapy",
      "description": "Reference for additional details related to prior DMARD therapy"
    },
    {
      "id": "398a9960-365e-4ed3-b968-f5965be76993",
      "name": "Concomitant DMARD Details",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.2.3.2",
      "sectionTitle": "Permitted Background Therapy",
      "description": "Reference for additional details related to concomitant DMARD therapy"
    },
    {
      "id": "9524c525-9811-4824-85e8-c0672be62be5",
      "name": "Maximum Doses Reference",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.2.3.3",
      "sectionTitle": "Prohibited Therapy",
      "description": "Reference for maximum doses of background PsA medications"
    },
    {
      "id": "22d58930-b2cd-49b9-892f-634e3900e9fc",
      "name": "Discontinuation Details",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.4.1",
      "sectionTitle": "Discontinuation of Individual Subjects",
      "description": "Reference for details on subjects choosing to continue study participation after drug discontinuation"
    },
    {
      "id": "08d64ef3-e88d-413a-944c-4ff5463291aa",
      "name": "TB Testing Requirements",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "5.3.1.1",
      "sectionTitle": "Study Procedures",
      "description": "Reference for specific requirements for TB testing and exclusionary parameters"
    },
    {
      "id": "c8151f1a-ce9f-4bf8-92c1-f8b44c55fc13",
      "name": "CYP3A Inhibitors Table",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "Table 1",
      "sectionTitle": "Examples of Commonly Used Strong CYP3A Inhibitors and Inducers",
      "description": "Reference for examples of strong CYP3A inhibitors and inducers"
    },
    {
      "id": "9f51e51e-c5ac-4aee-80f4-23964c97e8f6",
      "name": "Screening Procedures",
      "instanceType": "DocumentContentReference",
      "sectionNumber": "Appendix C",
      "sectionTitle": "Study Activities",
      "description": "Reference for screening procedures outline"
    }
  ],
  "commentAnnotations": [
    {
      "id": "66627e3f-2734-4c90-aa07-d69d00c883dd",
      "text": "The specific contact details of the AbbVie legal/regulatory entity (person) within the relevant country are provided within the clinical trial agreement.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Title Page",
      "pageNumber": 2
    },
    {
      "id": "f37cbf1d-c6b8-4d12-ba2d-1d4832c1cd3c",
      "text": "Upon approval of protocol amendment 8, subjects receiving upadacitinib 30 mg QD will be switched to upadacitinib 15 mg QD at their next scheduled study visit.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Study Design Figure 1",
      "pageNumber": 37
    },
    {
      "id": "9c7e0c8f-3649-4c1f-ab5d-e23adce5b844",
      "text": "Subjects with a borderline serum pregnancy test at Screening must have a serum pregnancy test  3 days later to document continued lack of a positive result.",
      "annotationType": "Note",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Inclusion Criteria",
      "pageNumber": 42
    },
    {
      "id": "7474c852-fd12-40fd-9f0d-b18bcb8ce0f9",
      "text": "At Week 16 rescue therapy will be offered to subjects classified as non-responders.",
      "annotationType": "Footnote",
      "instanceType": "CommentAnnotation",
      "sourceSection": "Study Design",
      "pageNumber": 37
    }
  ],
  "studyDefinitionDocumentVersions": [
    {
      "id": "00db4aac-0a4d-49d6-b75c-a099f89eb371",
      "versionNumber": "8.0",
      "status": "Approved",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2021-01-29",
      "description": "Incorporating Administrative Changes 1, 2 and Amendments 1 through 8; includes dose switch from 30mg to 15mg.",
      "amendmentNumber": "Amendment 8"
    },
    {
      "id": "ed8cd6c7-92fc-4ea5-aa84-56dc4b8c9aff",
      "versionNumber": "7.01",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-07-23",
      "description": "Specific to Belgium, Czech Republic, France, Greece, Hungary, Japan, New Zealand, and Portugal.",
      "amendmentNumber": "Amendment 7.01"
    },
    {
      "id": "104716e8-1673-48c8-9326-7287a66cdbac",
      "versionNumber": "7.0",
      "status": "Final",
      "instanceType": "StudyDefinitionDocumentVersion",
      "versionDate": "2020-04-01",
      "description": "Previous protocol version",
      "amendmentNumber": "Amendment 7"
    }
  ],
  "studyAmendmentImpacts": [
    {
      "id": "fa758230-f13f-4342-9df3-e3dfa33082ea",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "affectedSection": "Section 5.1 - Overall Study Design and Plan",
      "impactLevel": "Major",
      "instanceType": "StudyAmendmentImpact",
      "description": "Mandatory dose reduction for all subjects currently on 30 mg QD to 15 mg QD."
    },
    {
      "id": "ac5dde0b-3454-43ee-8ec9-2aebe81b3195",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "affectedSection": "Section 5.3.1.1 - Study Procedures",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Implementation of virtual visits, remote monitoring, and direct-to-patient drug shipment due to pandemic conditions."
    },
    {
      "id": "7c6c99e0-67a6-47bc-92c0-082602bb802d",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "affectedSection": "Section 6.1.7 - Toxicity Management",
      "impactLevel": "Minor",
      "instanceType": "StudyAmendmentImpact",
      "description": "Updated AST/ALT laboratory toxicity management guidelines and COVID-19 interruption rules."
    }
  ],
  "studyAmendmentReasons": [
    {
      "id": "42f49c31-8d25-4b09-ab1f-d8d6ad1fa0bb",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "reasonText": "The dose of 15 mg QD has been determined to be the optimal dose and is the proposed dose for marketing authorization globally.",
      "category": "Scientific",
      "isPrimary": true,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "84587510-65e3-4b85-9a16-d5d5f546fce5",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "reasonText": "To provide flexibility in conduct of study visits and procedures during state of emergency/pandemic times.",
      "category": "Operational",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    },
    {
      "id": "66b31e60-dafc-4a2f-a2fc-949b89a470c7",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "reasonText": "To update study drug name to the appropriate generic name.",
      "category": "Administrative",
      "isPrimary": false,
      "instanceType": "StudyAmendmentReason"
    }
  ],
  "studyChanges": [
    {
      "id": "9a4044c3-442b-4151-be91-d15747a69d9b",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "5.1",
      "beforeText": "Subjects will continue to receive upadacitinib 15 mg QD or upadacitinib 30 mg QD, respectively",
      "afterText": "Upon approval of protocol amendment 8, subjects receiving upadacitinib 30 mg QD will be switched to upadacitinib 15 mg QD at their next scheduled study visit.",
      "summary": "Global dose switch from 30mg to 15mg for all active subjects."
    },
    {
      "id": "a2dfc62d-5559-4218-b2ad-c258ad7bd40f",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "1.0",
      "beforeText": "ABT-494",
      "afterText": "upadacitinib",
      "summary": "Updated investigational product name to generic name throughout protocol."
    },
    {
      "id": "d77af764-660b-4f77-ae82-3186bdfd4c19",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "changeType": "Addition",
      "instanceType": "StudyChange",
      "sectionNumber": "5.3.1.1",
      "beforeText": "Not previously specified",
      "afterText": "subject visits may be conducted via phone or video conference and that vital signs and weight may be performed by the subject or caregiver as needed",
      "summary": "Added provisions for virtual study visits and remote assessments."
    },
    {
      "id": "23b194dc-a976-4f49-add2-5bbe743a0531",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "changeType": "Clarification",
      "instanceType": "StudyChange",
      "sectionNumber": "5.4.1",
      "beforeText": "Not specified",
      "afterText": "acute, spontaneous perforation of the gastrointestinal tract that requires inpatient medical care or urgent surgical intervention",
      "summary": "Refined definition of gastrointestinal perforation for toxicity management."
    },
    {
      "id": "773f2581-a18a-4668-84f0-b3e9505c6030",
      "amendmentId": "695fc062-a1ba-4e8f-aea3-a476ac025f13",
      "changeType": "Modification",
      "instanceType": "StudyChange",
      "sectionNumber": "6.1.7",
      "beforeText": "Previous AST/ALT guidelines",
      "afterText": "update AST/ALT laboratory toxicity management guidelines for ALT or AST > 8  ULN",
      "summary": "Updated threshold and management for hepatic lab abnormalities."
    }
  ],
  "computationalExecution": {
    "ready": true,
    "supportedSystems": [
      "EDC",
      "ePRO",
      "CTMS",
      "RTSM"
    ],
    "validationStatus": "complete"
  }
}